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Abstract 
The seven transmembrane-spanning G Protein-coupled Receptor (GPCR) super family is the 
largest family of cell-surface receptors, comprising greater than 650 members. GPCRs 
represent the primary targets of most therapeutic drugs. Desensitization, endocytosis and 
recycling are major mechanisms of receptor regulation and intracellular trafficking of GPCRs 
is linked to the Rab family of small G proteins. In the present study, we examined whether 
multiple Rab GTPase regulate receptor trafficking through endosomal cellular compartments 
as a consequence of their direct association with GPCRs.  We find that Rab4, Rab7 and 
Rab11 all bind to the last 10 amino acid residues of the angiotensin II Type 1 (AT1R) 
carboxyl-terminal tail. We show that the Rab GTPases compete with one another for receptor 
binding and that Rab4 effectively displaces Rab11 from the receptor.  In contrast, Rab11 
overexpression does not prevent Rab4 binding to the AT1R.  Overexpression of wild-type 
Rab4, but not Rab11, facilitates AT1R dephosphorylation, and a constitutively active Rab4-
Q67L mutant reduces AT1R desensitization and promotes AT1R resensitization.  We also 
find that Rab8, a RabGTPase involved in the regulation of secretory/recycling vesicles, 
modulation of the actin cytoskeleton and cell polarity, interacts with the carboxyl-terminal 
tail of metabotropic glutamate receptor 1 (mGluR1a) and attenuates mGluR1a signalling and 
endocytosis in a protein kinase C-dependent manner.  Finally, we have examined several 
previously uncharacterised but naturally occurring mutaions in mGluR1a that have been 
associated with cancer that may alter mGluR1a signalling.  We find that mutations found 
within the ligand binding domain of mGluR1a result in both decreased cell surface 
expression and basal inositol 1,4,5, trisphosphate formation and bias mGluR1a signalling via 
the ERK1/2 pathway.  Additional mGluR1a mutations localized to the mGluR1a glutamate 
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binding site, intracellular regulatory domains and Homer binding site also result in changes 
in mGluR1a subcellular localization, signalling and cell morphology.  Taken together, these 
results indicate that GPCR signalling is significantly modulated by the association of 
intracellular regulatory proteins that can be influenced by receptor structure. 
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 1.1. THE G PROTEIN-COUPLED RECEPTOR SUPERFAMILY 
 The seven transmembrane-spanning G Protein-Coupled Receptor (GPCR) 
superfamily is the largest family of cell-surface receptors that is comprised of more than 
650 receptor proteins. Based on structure-function and crystallographic structure of 
rhodopsin and, more recently the β2-adrenergic receptor (β2AR), GPCRs are 
characterised by extracellular amino-terminal regions, followed by seven transmembrane-
spanning domains separated by three extracellular and three intracellular loop domains 
and finally an intracellular carboxyl-terminal tail (Palczewski et al., 2000; Cherezov et 
al., 2007; Rasmussen et al., 2011; Tebben and Schnur, 2011). GPCRs are categorized into 
six classes based on sequence homology, ligand activation and G protein coupling: the 
largest class A or rhodopsin-like receptors; class B, secretin-like, many of which are 
regulated by peptide hormones from the glucagon hormone family and class C, the 
metabotropic glutamate receptors characterized by the large venus fly trap like amino 
terminus ligand binding pocket; Class D the Gαi-associated pheromone receptors; Class E 
the D. discoïdeum - specific cAMP receptors; and finally the Frizzled/Smoothened 
family, activated by Wnt ligands (Bockaert and Pin, 1999; Foord et al., 2005; Fredriksson 
et al., 2003; Kolakowski, 1994; Sharman et al., 2011; Bockaert and Pin, 1999).  
1.2. RECEPTOR SIGNALLING 
1.2.1. G Protein-Dependent Signal Transduction Paradigm 
 
 GPCRs couple to and activate cognate heterotrimeric guanine-nucleotide binding 
(G) proteins, which in turn transduce the GPCR signal through coupling to downstream 
effector molecules (Neer, 1995). Heterotrimeric G proteins are comprised of α, β and γ 
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 subunits, which associate with the plasma membrane in a variety of ways, including lipid 
modification and association with membrane-bound proteins (Casey, 1994). Also called 
molecular switch proteins, the α subunit of the G protein cycles between the inactive 
guanosine 5’-diphosphate (GDP) bound state and becomes activated when GDP is 
exchanged for guanosine 5’-triphosphate (GTP) (Neer, 1995). In addition to the G 
protein’s endogenous GTP hydrolysis activity, several proteins assist the G protein 
through this cycle including: 1) guanine nucleotide exchange proteins (GEFs), which 
facilitate the exchange of GDP for GTP, and 2) GTPase activating proteins (GAPs), 
which enhance GTP hydrolysis and regulators of G protein signalling (RGS) (Siderovski, 
2005). The classical GPCR signalling paradigm begins with ligand activation of the 
GPCR, which induces a conformational change in the receptor, such that it can associate 
with its cognate heterotrimeric G protein and act as a GEF by exchanging GDP for GTP 
on the α subunit, thereby activating it. Once activated, the heterotrimeric G protein 
dissociates into the functional α and the βγ subunits to target downstream effector 
molecules.  
 There are four classes of α subunits (Neer, 1995; Gilman, 1987). Gαs activates 
membrane-bound adenylyl cyclase (AC) stimulating the formation of the second 
messenger molecule cyclic adenosine 5’ monophosphate (cAMP) and the activation of 
cAMP-dependent protein kinase-A (PKA). Conversely, Gαi inhibits AC, decreasing 
cAMP generation and decreasing PKA activity. Gαq/11 proteins activate phospholipase C 
(PLC), which in turn hydrolyzes the membrane phospholipid, phosphatidylinositol 4,5-
bisphosphate (PtdIns (4,5)P2, or PIP2), into inositol trisphosphate (IP3) and 
diacylglycerol (DAG). IP3 then activates endoplasmic reticulum localized IP-gated 
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 calcium channels, releasing intracellular calcium stores, which triggers protein kinase C 
(PKC) translocation to the plasma membrane, where it is co-activated by DAG. Finally, 
Gα12/13 activates Rho and other small G proteins leading to the rearrangement of the actin 
cytoskeleton (Suzuki et al., 2009). The activation of these second messenger-dependent 
kinases triggers a phosphorylation cascade of membrane associated, intracellular and 
nuclear signalling scaffolding proteins and transcription factors leading to immediate and 
long term functional changes in the cell. 
1.2.2. G Protein-Independent and Non-Classical Signal Transduction  
In addition to these classical heterotrimeric G protein signalling pathways, Gαq/11-
coupled receptor-mediated activation of PKC also triggers the phosphorylation of Raf-1, 
thus activating mitogen activated kinases (MAPK) and extracellular signal-related 
kinases (ERK) (Luttrell, 2002). ERK activation by GPCRs is also mediated by adaptor 
molecules such as β-arrestin, transactivation of receptor tyrosine kinases and ion 
channels, downstream activation of intracellular tyrosine and serine/threonine kinases 
such as Src and Pyk2 and Gβγ-mediated mechanisms (Luttrell, 2002; van Biesen et al., 
1995).  For example, Pyk2 uncouples metabotropic glutamate receptor G protein 
signalling, but facilitates ERK1/2 activation (Nicodemo et al., 2010). Meanwhile, 
endothelin-1-induced ERK activation and is predominantly regulated by EGFR 
transactivation (Kodama et al., 2003). Activated MAP kinases then regulate the 
phosphorylation and activation of transcription factors related to cell growth.  
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 1.2.3. Agonists and Functional Agonism 
Ligands are characterized via their affinity for cognate receptors, and their 
efficacy of signalling and functional responses. Therefore, ligands can be classified as 
full agonists (eliciting maximal possible receptor response), partial agonists (sub-
maximal response), neutral antagonists (occupies ligand binding region of receptor, yet 
elicits no signalling response, positive or negative), or inverse agonists (reduced ligand-
independent, basal receptor activity) (Kenakin, 2002). Traditionally, ligand functionality 
was considered to be constant at a given receptor, eliciting the same response regardless 
of receptor location, and differences in receptor response were considered to be due to 
differentially expressed signal transduction machinery. For example, several GPCRs, 
including the vasopressin and angiotensin II receptors have been shown to couple to 
multiple G proteins generating divergent signal transduction pathways (Gudermann et al., 
1996). Additionally, although β-arrestin was traditionally thought only to participate in 
receptor desensitization and endocytosis, it is now clear that this adaptor molecule can 
facilitate signal transduction through multiple pathways including MAPK, Src and PI3K 
(Rajagopal et al., 2010).  
However, emerging evidence suggests that ligands can induce unique, ligand-
specific receptor conformations resulting in differential activation of signal transduction 
pathways. Additionally, ligands with the same intrinsic activity can display different 
relative potency to divergent signalling pathways activated by the same receptor. This 
phenomenon, sometimes termed functional selectivity or biased agonism has been 
reviewed by Kenakin and Miller, 2010, Rajagopal et al., 2010 and Kenakin, 2011. 
Ligand-induced functional selectivity has been well-characterized for dopamine and 
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 serotonin receptors. Activation of the 5-HT2C receptor by agonists such as quipazine 
preferentially activates PLC while other agonists including LSD activate PLA2 (Berg et 
al., 1998).   
One way biased agonists may function is by stabilizing a receptor conformation 
favourable for association with different downstream molecules. For example, the βAR 
inverse agonist carvedilol triggers Gαs-independent, β-arrestin-dependent EGFR 
activation leading to downstream ERK phosphorylation while β2AR activation by 
cyclopentylbutanephrine biases the receptor toward β-arrestin-dependent MAPK 
activation relative to isoproterenol (Azzi et al., 2003; Noma et al., 2007; Drake et al., 
2008).  
Multiple amino acid residues in various GPCRs have been shown to play a role in 
functional selectivity. For example, μ-opioid receptor stimulation by different agonists 
results in site-specific patterns of serine (ser) and threonine (thr) phosphorylation in the 
second intracellular loop of the receptor, resulting in differential receptor endocytosis 
patterns and targeting the receptor toward either PKCε or ERK signal transduction 
pathways (Doll et al., 2011; Zheng et al., 2011). Mutation of histidine 393 in the sixth 
transmembrane domain of the dopamine D2L receptor abolishes the functional selectivity 
exhibited by the wild type receptor whereas ligand modification at the site of histidine 
393 interaction biases the signalling towards ERK1/2 phosphorylation (Tschammer et al., 
2011).   
1.2.4. Receptor Desensitization 
 Ligand activation of GPCRs also results in a cascade of events ultimately leading 
to decreased receptor signalling. This process, termed desensitization, is crucial to 
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 prevent aberrant or chronic receptor over-stimulation. There are multiple mechanisms of 
receptor desensitization ranging from immediate G protein uncoupling to degradation of 
the receptors and transcriptional down-regulation (Ferguson, 2001).  
1.2.4.1. Receptor Phosphorylation 
 Phosphorylation is the most rapid desensitization response to receptor activation, 
occurring within seconds to minutes after receptor activation. GPCR phosphorylation 
occurs mainly at Ser and Thr residues within the carboxyl-terminal tail and third 
intracellular loop (Ferguson and Caron, 1998; Kohout and Lefkowitz, 2003; Krupnick 
and Benovic, 1998; Pierce et al., 2002). The addition of large, negatively charged 
phosphates to the intracellular loops and C-tail of receptors desensitizes receptor 
signalling by interfering with G protein-coupling, as well as facilitating recruitment of 
adaptor proteins for internalization. Receptor phosphorylation can be carried out both 
homologously and heterologously by second messenger-dependent protein kinases (PKA 
and PKC) or homologously by G protein-coupled receptor kinases (GRKs) (Figure 1.1.). 
Phosphorylation by either type of kinase can lead to decreased receptor signalling. 
However, GRK phosphorylation results in desensitization via recruitment of the adaptor 
molecules called β-arrestins (Benovic et al., 1987; Lohse et al., 1990b; Pippig et al., 
1993). β-arrestins associate exclusively with ligand-activated and GRK-phosphorylated 
GPCRs and functions in two ways to desensitize the receptor: first, β-arrestin physically 
uncouples the receptor from the G protein and secondly they recruit the endocytic 
machinery required to facilitate the endocytosis of the receptor. 
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Figure 1.1. Schematic diagram illustrating the agonist-induced desensitization of 
GPCRs via phosphorylation. Agonist binding triggers second messenger generation, 
leading to activation of second messenger-dependent kinases (PKA and PKC). Receptor 
activation also allows for the recruitment of G protein-coupled receptor kinases (GRK), 
which associate with and phosphorylate exclusively agonist-activated receptors 
(homologous desensitization). In addition to homologously phosphorylating agonist-
activated receptors, second messenger-dependent protein kinases can also phosphorylate 
non-activated receptors (heterologous desensitization).   
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 1.2.2.4. Second-Messenger-Dependent Protein Kinase 
 GPCR-stimulated second messenger generation of molecules such as cAMP and 
ca2+ leads to the activation of second messenger dependent kinases, which in turn 
phosphorylate downstream target proteins. Second messenger dependent kinases PKC 
and PKA function to transfer the high energy γ phosphate from adenosine 5’ triphosphate 
(ATP) to target serine and threonine residues contained within specific consensus sites of 
proteins (Taylor et al., 1988). Protein phosphorylation cascades generate short and long 
term changes in cell signalling and function, however, these kinases can also feedback 
phosphorylate GPCRs within their intracellular loops and carboxyl terminal tails (Smith, 
1998; Eason et al., 1995; Bouvier et al., 1988). However, so long as the necessary 
consensus sequence is present on the target GPCR, second messenger dependent kinases 
do not discriminate upon receptor activation state or, indeed receptor type. This process is 
termed heterologous desensitization (Hausdorff et al., 1989; Lohse et al., 1990a).  
1.2.4.2. G Protein-Coupled Receptor Kinases 
 The GRK family of protein kinases contain a central catalytic domain flanked by 
a carboxyl terminal membrane targeting domain and an amino terminal RGS-like domain 
hypothesised to be responsible for substrate recognition (Pitcher et al., 1998; Stoffel et 
al., 1997). The seven GRK family members are sub-classified into three groups based on 
sequence homology and functional similarity (Figure 1.2). The groups are: 1) visual 
GRKs, GRK1 (rhodopsin kinase) and GRK7, (Shichi and Somers, 1978; Weiss et al., 
1998), 2) GRK2 (β adrenergic receptor kinase 1, βARK1) and GRK3 (β adrenergic 
receptor kinase 2, βARK2) (Benovic et al., 1986; Benovic et al., 1991) and 3) GRK4, 
GRK5 and GRK6 (Benovic and Gomez, 1993; Kunapuli and Benovic, 1993; Premont et 
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 al., 1994; Sallese et al., 1994). The plasma membrane targeting of the different GRK 
groups is mediated by mechanisms involving their carboxyl-terminal domains. GRK1 
and GRK7 are farnesylated at CAAX motifs in their carboxyl termini while GRK2 and 
GRK3 contain a carboxyl-terminal βγ-subunit binding pleckstrin homology domain 
(Pitcher et al., 1998). The GRK5 carboxyl-terminal domain contains a stretch of 46 basic 
amino acids that allow plasma membrane phospholipid interactions and finally, GRK4 
and GRK6 are palmitoylated at cysteine residues (Premont et al., 1996; Shaw, 1996; 
Stoffel et al., 1994; Stoffel et al., 1998).  
1.2.4.3. Arrestin 
 GRK phosphorylation is usually not sufficient for GPCR desensitization and 
requires the association of arrestin molecules to agonist-activated, GRK-phosphorylated 
GPCRs. There are four arrestin family members categorized into two groups; 1) visual 
and cone arrestin are expressed exclusively in the retina while 2) β-arrestin-1 (arrestin 2) 
and β-arrestin-2 (arrestin 3) are ubiquitously expressed, though they show enhanced 
localization in neuronal tissues (Ferguson, 2001; Krupnick and Benovic, 1998; 
Lefkowitz, 1993). Arrestins associate preferentially with agonist-activated, GRK-
phosphorylated GPCRs, as opposed to unphosphorylated or second messenger-dependent 
kinase phosphorylated receptors (Lohse et al., 1990b; Lohse et al., 1992). β-arrestin is an 
important player in clathrin-mediated GPCR internalization. Once β-arrestin associates 
with agonist-activated and GRK-phosphorylated GPCRs, it recruits AP2 and clathrin, 
initiating receptor endocytosis (Ferguson et al., 1996; Goodman et al., 1996; Laporte et al 
1999).  The role of β-arrestin in GPCR desensitization and endocytosis is discussed in 
detail in section 1.3.2.1.  
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Figure 1.2. Schematic representation of the GRK family structure. The amino-
terminus contains the conserved regulator of G protein signalling (RGS) homology 
domain (RH) while the divergent carboxyl-terminal domains participate in GRK plasma 
membrane targeting. GRK1 and 7 are farnesylated within the CAAX motifs, GRK4 and 6 
are palmitoylated and GRK5 contains a 46 basic amino acid stretch that allows 
association with membrane phospholipids. Finally, GRK2 and 3 contain Gβγ binding 
motifs similar to pleckstrin homology domains. Figure adapted from Ferguson, 2001. 
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 1.2.4.4. Phosphorylation-Independent Desensitization 
 Phosphorylation of intracellular residues of agonist activated receptors is the most 
widely studied and best understood form of receptor desensitization. However, it is now 
appreciated that phosphorylation-independent mechanisms of receptor desensitization 
also exist. Phosphorylation-independent desensitization has been shown for the 
endothelin A and B receptors, as well as the follicle-stimulating hormone receptor, 
histamine H2 receptor, m3 muscarinic acetylcholine and metabotropic glutamate receptor 
1a (mGluR1a) (Dhami et al., 2002; Ferguson, 2007; Fernandez et al., 2011; Reiter et al., 
2001; Shibasaki et al., 1999; Willets et al., 2004).  
 GRK catalytically inactive mutants are sufficient for desensitization of 5HT1B 
and parathyroid hormone receptors. While GRK2 does phosphorylate agonist activated 
mGluR1a, physical association between GRK2, Gαq/11 and mGluR1a is sufficient for 
this receptor’s desensitization in a phosphorylation independent manner, partially though 
the GRK2 RGS homology (RH) domain (Dhami et al., 2002; Flannery and Spurney, 
2001; Lembo et al., 1999).  Other proteins have been implicated in phosphorylation-
independent GPCR desensitization. For example, the huntingtin-binding and Rab8 
effector molecule optineurin has been shown to associate with group I mGluRs to 
physically uncouple the receptor from G protein (Anborgh et al., 2005).   
1.2.4.5. GPCR Down-Regulation 
 In addition to the immediate phosphorylation by GRKs and second messenger-
dependent kinases and clathrin-mediated internalization of activated receptors, other 
down-regulation mechanisms are employed to decrease the total cellular compliment of 
receptors in response to prolonged or repeated agonist stimulation. Receptor down-
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 regulation is achieved via proteosomal and lysosomal GPCR degradation, modulation of 
receptor gene transcription, RNA stability and translation (Tsao and von Zastrow, 2000; 
Bouvier et al., 1989).  
1.2.4.6. GPCR Proteolytic Degradation 
 Two specific compartments contribute to the proteolytic degradation of GPCRs, 
the proteosome and lysosome (Hislop et al., 2011; Clague and Urbe, 2010). Proper cell 
signalling requires selective trafficking of membrane proteins to lysosomes for 
degradation. A major mechanism of lysosomal targeting involves protein ubiquitination 
on lysine residues and sorting via the endosomal sorting complex required for transport 
(ESCRT) machinery (Katzmann et al., 2001). Proteosomal degradation of cytosolic 
proteins is signalled by polyubiquitination whereas multiple monoubiquitination or 
polyubiquitination signals membrane proteins for lysosomal sorting and degradation. 
Ubiquitinylated proteins are not recycled back to the plasma membrane, but instead are 
sorted into intraluminal vesicles in endosomes, forming multivesicular bodies. When 
these MVBs fuse with lysosomes, lipases degrade the ILV membrane as well as the 
transmembrane proteins (Marchese et al., 2008; Katzmann et al., 2002). Mu-opioid 
(MOR) and β2AR both undergo agonist-dependent ubiquitination and receptor 
degradation and β2AR mutation of Lys residues internalizes normally, but does not 
downregulate in response to prolonged agonist exposure (Hislop et al., 2011; Xiao and 
Shenoy, 2011). However, several GPCRs including delta-opioid (DOR) have been shown 
to target to lysosomes independent of ubiquitination (Tanowitz and Von Zastrow, 2002).  
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 1.2.4.7. Transcriptional Downregulation 
 Total cell receptor loss involves not only degradation of existing receptor 
proteins, but also alterations in receptor transcription and translation. Interestingly, GPCR 
activation of second messenger dependent signalling may function as positive or negative 
feedback regulators of GPCR gene and protein expression. For example, cAMP 
activation induces PKA-mediated β2AR phosphorylation and also decreases the level of 
β2AR mRNA, ultimately decreasing receptor population while serotonin treatment of C6 
glioma cells leads to a PKC-dependent decrease in 5HT2A receptor mRNA levels (Anji 
et al., 2001; Bouvier et al., 1989). Other GPCRs, including AT1R, dopamine D1 and 
thyroid-stimulating hormone receptors also show agonist-induced decreases in receptor 
mRNA (Collins et al., 1992).  
1.3. GPCR TRAFFICKING 
 Intracellular trafficking is a crucial mechanism to ensure proper targeting and 
function of receptor signalling and deregulated trafficking has been shown to play a role 
in multiple disorders and pathologies. This section will highlight the major steps in 
receptor intracellular trafficking as it relates to function and signalling.  
1.3.1. ER/Golgi to Plasma membrane 
As transmembrane proteins, GPCRs are synthesized and processed in the 
endoplasmic reticulum (ER). Folding and post-translational modifications such as 
glycosylation and ubiquitination, oligomerization take place in this compartment as well 
as association with accessory proteins (Braakman and Bulleid, 2011). Accumulating 
evidence suggests that receptor dimerization is necessary for correct plasma membrane 
targeting for some GPCRs and there are reports of dimerization mutations in hormone-
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 activated GPCRs that result in ER retention.  One example of this is heterodimerization 
of GABAB receptor subunits, which masks an ER retention sequence in the C-terminus of 
GABAB and allows the dimer to reach the plasma membrane (Margeta-Mitrovic et al., 
2000). It is becoming clear that proper receptor targeting and function is dependent on 
dimer formation. For example, the GABAB receptor requires both GABAB1 and GABAB2 
subunits in order to reach the plasma membrane as well as activate G proteins (Duthey et 
al., 2002; Pin et al., 2004). Dimerization is also essential for receptor-G protein coupling. 
GABAB1 requires co-expression with GABAB2 in order to couple functionally to the G-
protein signalling cascade (Galvez et al., 2001; Margeta-Mitrovic et al., 2000). This is not 
just due to plasma membrane localization as a mutant form of GABAB1 that lacks its ER 
retention signal and can reach the cell surface on its own still requires GABAB2 for 
functional activity (Margeta-Mitrovic et al., 2000).  Additionally, heterodimerization 
between the α1D- and α1B-adrenoceptors, was shown to be necessary for the proper cell-
surface expression of the α1DAR subtype (Hague et al., 2006). 
1.3.2. Receptor Internalization 
 The internalization and intracellular trafficking of GPCRs is a highly regulated 
process that, in addition to contributing to GPCR desensitization, is also required for 
receptor dephosphorylation and resensitization (Ferguson, 2001). GPCRs may internalize 
in either a constitutive manner or in response to agonist activation: once the receptor is 
desensitized at the cell surface, it must then be internalized into the cell where it is 
sequestered or targeted for resensitization or degradation (Figure 1.3) (Ferguson, 2001).  
There are multiple means of receptor internalization employed by the cell including lipid 
rafts, caveolin, pinocytosis and the most common, clathrin-mediated endocytosis.    
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Figure 1.3. Clathrin-mediated endocytosis and intracellular trafficking of agonist-
activated receptors. Ligand-activated receptors are phosphorylated on intracellular 
residues by G protein-coupled receptor kinases (GRKs) and bound by the adaptor protein, 
β-arrestin (βarr). β-arrestin then recruits the clathrin adaptor protein, AP2 as well as 
clathrin, which assembles to form clathrin-coated pits. The GTPase dynamin severs the 
pit from the membrane, forming a clathrin coated vesicle. Once internalized, clathrin 
uncoats from the vesicle, during which arrestin may or may not also dissociate from the 
receptor. The vesicle is then trafficked to early endosomes, where the acidic pH 
facilitates agonist dissociation from the receptor and phosphates are removed by G 
protein-coupled receptor phosphatases (GRP). Internalized receptors may be sequestered 
in early endosomes, trafficked to the lysosome and degraded or recycled back to the 
plasma membrane as a fully functional receptor. 
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 1.3.2.1. Clathrin-mediated Endocytosis 
 Clathrin is a triskelion membrane coat protein that when assembled, forms a 
polyhedron lattice, which surrounds membrane and encourages invagination and clathrin-
coated pit formation (Hinrichsen et al., 2006; Kirchhausen and Harrison, 1981). Clathrin 
coated vesicles transport molecules from the plasma membrane, endosomes and trans-
Golgi network. Several adaptor molecules, including adaptor protein-2 (AP-2), epsin and 
β-arrestin recruit clathrin and other accessory proteins to the site of invagination and 
facilitate clathrin assembly (Wolfe and Trejo, 2007). β-arrestin is an important player in 
clathrin-mediated GPCR internalization. Once β-arrestin associates with agonist-activated 
and GRK-phosphorylated GPCRs, it recruits AP2 and clathrin, initiating receptor 
endocytosis (Ferguson et al., 1996; Goodman et al., 1996; Laporte et al 1999).   Once the 
clathrin coated pit is formed, the GTPase dynamin severs the pit from the membrane, thus 
forming a clathrin-coated vesicle (Ungewickell and Hinrichsen, 2007; Praefcke and 
McMahon, 2004). 
1.3.3. Early Endosomal Sorting and Trafficking 
 Once the coated vesicle is internalized, clathrin disassembles and uncoates the 
vesicle (McMahon and Boucrot, 2011). Internalized receptor is trafficked to the early 
endosome where it can be sorted for retention, recycling or degradation. A key 
determinant of receptor fate occurs in the process of uncoating, when β-arrestin may or 
may not also dissociate from the internalized receptor (Oakley et al., 2000). Class A 
receptors, such as the β2 adrenergic receptor and α1b adrenergic receptor contain few 
phosphorylation sites and therefore form a transient association with β-arrestin 1 and 2. 
However, class B receptors, including AT1 and V2 vasopressin receptors contain multiple 
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 phosphorylation sites and form high affinity, prolonged association with arrestins 
(Anborgh et al., 2000; Oakley et al., 2000; Zhang et al., 1996). The presence of clusters 
of phosphorylated Ser and Thr residues in some GPCRs may stabilize the interaction with 
arrestins (Oakley et al., 2000). β-arrestin dissociation is assumed to allow access for 
protein phosphatases to cleave phosphates from the receptor, which in turn allows the 
receptor to recycle and resensitize at the cell surface, but there is no direct experimental 
evidence to support this assumption (Lefkowitz, 1998). However, if β-arrestins cannot 
dissociate, phosphatases are unlikely to access the phosphorylated receptor and 
dephosphorylate and resensitize the receptor (Ferguson and Caron, 1998; Ferguson et al., 
1998; Ferguson, 2001; Ferguson, 2007).   
1.3.3.1. Recycling Endosomes 
 Recycling and resensitization of internalized receptors to the plasma membrane 
represents a much more efficient way to re-initialize signal transduction than novel 
receptor synthesis.  GPCR sorting into the recycling pathway can either occur via a 
default trafficking mechanism or through a regulated process. Studies of nutrient 
receptors supported the idea that receptor recycling occurs via a default “bulk” membrane 
flow from endosomes to the plasma membrane (Gruenberg, 2001; Gruenberg and 
Stenmark, 2004; Maxfield and McGraw, 2004; Mayor et al., 1993). However, this model 
does not allow for the dependency of GPCR recycling on specific protein interactions 
(Anborgh et al., 2000; Cao et al., 1999; Dale et al., 2004; Seachrist et al., 2000). Many 
GPCRs, including β2AR, μ-opioid and endothelin receptors contain specific plasma 
membrane sorting sequences, necessary for endocytic delivery back to the cell surface 
(Cao et al., 1999; Paasche et al., 2005; Tanowitz and von Zastrow, 2003). Many GPCR 
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 recycling sequences, including those found on the β1AR and β2AR encode motifs 
recognized by a variety of postsynaptic density 95/disc large/zonula occludens-1 (PDZ)-
containing proteins. Other protein trafficking molecules, such as Rab small G proteins 
(discussed in detail below) also differentially regulate receptor recycling. 
1.3.3.2. Lysosomes 
 Lysosomes are acidic intracellular membrane-bound organelles distinguished 
from endosomes by their lack of mannose-6-phosphate receptor (Luzio et al., 2007). 
Lysosomes contain lysosomal-associated proteins, lysosomal integral membrane proteins 
I and II, lysosomal acid phosphatase and acid hydrolases, which function optimally at 
acidic pH. As mentioned above, a major mechanism for endosome-lysosome trafficking 
involves the ESCRT machinery targeting ubiquitinated GPCRs to the lysosome. For 
example, lysines in the third intracellular loop (Lys-263 and Lys-270) and in the carboxyl 
tail (Lys-348, Lys-372, and Lys-375) of the β2AR are involved in ubiquitination and 
lysosomal degradation (Xiao and Shenoy, 2011). There are, however, multiple other 
mechanisms of lysosomal targeting, including GPCR-associated sorting proteins (GASP) 
and sorting nexin-1 (Gaborik and Hunyady, 2004; Tanowitz and von Zastrow, 2002). 
Additionally, lysosomal targeting may involve Rab5 and/or Rab7 as discussed in detail in 
later sections (Seachrist and Ferguson, 2003).  
1.3.4. Role of the Receptor Carboxyl-Terminal Tail in Trafficking 
 While it is well known that the C-tails of GPCRs mediate receptor desensitization 
through phosphorylation of serine and threonine residues and the association with β-
arrestin, there is also much evidence to support the importance of GPCR C-tails in the 
coordination of receptor intracellular trafficking. Chimeric receptor constructs 
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 demonstrate specific residues that determine the fate of different receptors. For example, 
chimeric receptors in which the C-tails of β2AR and AT1R were exchanged demonstrated 
that the C-tail of β2AR does not form a stable association with β-arrestin, which may 
account for this receptor’s rapid and efficient recycling (Anborgh et al., 2000). 
Meanwhile, although wild type AT1R is neither dephosphorylated nor recycled, a 
chimeric AT1R containing the β2AR C-tail does dissociate from β-arrestin and promotes 
partial receptor recovery.  
 Many proteins involved in protein scaffolding and/or transport associate with 
GPCR C-tails. Molecules such as PDZ-containing proteins associate with GPCRs via 
protein modular domains commonly found in the carboxyl-terminal tail to mediate 
protein targeting (Cao et al., 1999; Magalhaes et al., 2011; Romero et al., 2011; Xia et al., 
2003). The Homer family of proteins contain Enabled/VASP Homology-1 (EVH-1) 
domains that associate with a proline-rich region in the C-tails of mGluR1/5 and α1DAR 
(Roche et al., 1999). Homer proteins regulate the targeting of mGluRs to different 
subcellular compartments, mediate their insertion into the plasma membrane and 
facilitate receptor activation (Ango et al., 2002; Ciruela et al., 1999; Coutinho et al., 
2001; Roche et al., 1999; Tadokoro et al., 1999).  
 Other protein trafficking molecules have also been shown to associate with the 
C-tail of GPCRs to mediate receptor localization. For example, Rab5a has been shown to 
interact with the AT1AR carboxyl-terminal tail and retain the receptor in Rab5a-positive 
early endosomes (Seachrist et al., 2002; Dale et al., 2004).  Rab11 binding to the 
thromboxane A2 receptor is mediated by residues 335-345 that are localized within the 
central region of the thromboxane A2 receptor carboxyl-terminal tail and Rab11 binding 
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 to the β2AR involves a bipartite binding motif, with arginine 333 and lysine 348 
representing the essential amino acid residues mediating Rab11 binding to the receptor 
(Hamelin et al., 2005; Parent et al., 2009).  
1.4. EFFECTS OF INTRACELLULAR TRAFFICKING ON GPCR 
SIGNALLING 
 Agonist-activation of signal transduction cascades through GPCRs comprises 
both G protein-dependent and -independent signalling resulting in parallel signalling 
cascades and complex signalling networks. Because cells express hundreds of different 
receptors, a mechanism to organize signal cascades must be put in place. One major 
mechanism of spatiotemporal signal organization includes protein intracellular trafficking 
(Jean-Alphonse and Hanyaloglu, 2011). In addition to rapid and effective signal 
desensitization, the endocytosis and intracellular trafficking of GPCRs can spatially and 
temporally determine G protein-dependent and independent signalling pathways. 
Receptors such as the β2AR, which recycle quickly and efficiently also resensitize to 
persistent or repeated agonist activation whereas receptors such as AT1R, which are 
retained in early endosomes remain desensitized much longer (Anborgh et al., 2000; 
Oakley et al., 2000). However, chronic GPCR stimulation may cause altered GPCR 
trafficking away from the recycling to the degradative pathway leading to receptor 
downregulation (Hislop et al., 2011; Xiao and Shenoy, 2011). Conversely, GPCR 
recycling has been shown to actually change the signalling of the receptor. For example, 
β2AR endocytosis and recycling switches the receptor’s traditional coupling with Gαs to 
Gαi (Wang et al., 2007).  
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  Membrane trafficking of GPCRs provides novel compartments for G protein 
signalling. GPCR signalling via heterotrimeric G proteins is traditionally associated with 
the plasma membrane. However, recent studies indicate that GPCRs may also associate 
with and signal through their cognate G proteins at intracellular sites. Membrane 
permeable agonists also suggest that GPCRs such as the V2 vasopressin receptor and 
estrogen receptor GPR30 signal from the ER/Golgi (Revankar et al., 2005; Robben et al., 
2009). Meanwhile, the β2AR has been shown to be pre-associated with its heterotrimeric 
G proteins as well as adenylyl cyclase II in the ER (Dupre et al., 2006; Dupre et al., 
2007).  
 Few GPCRs have been shown to co-localize with their G proteins at the 
endosomes and display persistent, internalization-dependent G protein signalling. In S. 
cerevisiae, the Gα protein translocates to the endosome where it stimulates PI3K, while 
in mammalian cells, lysophosphtidic acid treatment causes Gβγ to associate with Rab11a, 
PI3K and PKT at the endosome (Garcia-Regalado et al., 2008; Slessareva and Dohlman, 
2006; Slessareva et al., 2006). FRET-based measurement of the cAMP sensitive EPAC 
molecule showed that parathyroid hormone receptor (PTHR) and thyroid-stimulating 
hormone receptor (TSHR) internalization is required for sustained Gαs signalling from 
the endosomal compartment (Calebiro et al., 2010a; Calebiro et al., 2010b; Calebiro et 
al., 2009; Jalnik and Moolenaar, 2010). 
 It is also well established that GPCRs can mediate non-G protein signalling 
pathways from endosomes, mainly via GPCR/β-arrestin complexes, that scaffolds 
association with MAPK molecules and tyrosine kinases (DeWire et al., 2007). This was 
first reported in studies inhibiting receptor internalization when overexpression of either 
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dominant negative β-arrestin or dynamin prohibited β2AR-induced ERK activation 
(Daaka et al., 1998; Lin et al., 1998; Luttrell et al., 1997). It was later shown that β-
arrestin couples β2AR to Src in order to mediate ERK1/2 phosphorylation (Luttrell et al., 
1999). Similarly, phosphorylation of protease-activated receptor-2 (PAR-2) is not 
required for β-arrestin recruitment and internalization, but a phosphorylation-deficient 
PAR-2 mutant is unable to facilitate β-arrestin-dependent MAPK activation (DeFea et al., 
2000). Meanwhile, PAR-2 can increase PI3K activity through a Gαq/calcium-dependent 
pathway involving PYK2 and Src, while inhibiting PI3K activity through a β-arrestin-
dependent mechanism (Wang and DeFea, 2006). It has been proposed that β-arrestin 
facilitates ERK activation by recruiting and scaffolding members of the MAPK pathways 
to internalizing vesicles or endosomes (DeWire et al., 2007; Luttrell et al., 2001; DeFea 
et al., 2000). Moreover, anchoring activated ERK to endosomes may prevent ERK 
translocation to the nucleus, thus encouraging cytoplasmic ERK signalling (Figure 1.4). 
This suggests an important spatial role, as well as temporal control, for GPCR membrane 
trafficking. 
 Less well understood are the direct and indirect roles of GPCR signal 
transduction on regulation of trafficking machinery, though it has been proposed that 
receptors participate in modulation of their own intracellular trafficking (Seachrist et al., 
2002; Yudowski et al., 2009). AT1AR activation causes GTP binding of Rab5a, while 
PKA activation by β2AR regulates Rab4, but not Rab11 recycling pathways and β2AR 
also modulates the Rab8 geranyl-geranylation, altering the ability of Rab8 to associate
  
 
 
 
 
 
 
 
Figure 1.4. GPCR-mediated activation of ERK1/2 signalling. A) Agonist-activation of 
receptors leads to downstream activation of protein kinase-C (PKC), which can activate 
Raf, initiating the MAP kinase cascade. Phosphorylated and activated ERK then 
translocates to the nucleus where it regulates gene transcription through phosphorylation 
of transcription factors. B) β-Arrestin associates with agonist-activated, GRK-
phosphorylated receptors and acts as a scaffold, recruiting tyrosine kinases such as Src, as 
well as components of the MAP kinase cascade. β-arrestin-mediated scaffolding retains 
activated ERK in the cytosol where it phosphorylates target proteins.  
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 with membranes, and thus its activity. Additionally, p38 MAPK activation stimulates the 
formation of Rab5-guanine dissociation inhibitor (GDI) complexes, thereby increasing 
endocytosis (Lachance et al., 2011).  
1.5. ANGIOTENSIN II TYPE 1 RECEPTOR  
 The Angiotensin II receptor family includes angiotensin II type 1 (AT1R), the 
focus of this thesis, and type 2 (AT2R) receptors. The AT1R mediates the cardiovascular 
effects of the AngII peptide hormone including vasoconstriction, angiogenesis, 
atherosclerosis, glomerulosclerosis and cardiac cell growth and hypertrophy. AT2 
receptors, on the other hand are expressed in the fetus, injured tissue, adult brain and 
affect vascular tone and growth oppositely to AT1 receptors (de Gasparo et al., 2000).  
1.5.1. AT1R Signalling 
 The AT1R is coupled through Gαq/11 to the activation of phospholipase Cβ 
resulting in the formation of diacylglycerol and inositol 1,4,5 trisphosphate leading to the 
release of intracellular calcium stores and the activation of PKC (de Gasparo et al., 2000).  
AT1R also couples to Gαo/i in some tissues leading to inactivation of adenylyl cyclase and 
decreased production of cyclic AMP and can also couple to the pertussis insensitive 
Gα12/13, which mediate AngII-induced L-channel activation (de Gasparo et al., 2000). 
AT1R can also mediate G protein-independent signalling mechanisms, such as mitogen 
activated protein kinases (MAPK), JAK/STAT kinases, tyrosine kinase activation (Pyk2, 
Src) and transactivation of growth factor receptors. Multiple amino acid residues 
involved in G protein-coupling and phosphorylation have been isolated (Figure 1.5). 
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Figure 1.5. Snake model identifying amino acid residues of the Angiotensin II Type 
Receptor. Amino acid residues in the extracellular loop regions are involved in binding 
the ligand AngII, while residues in the eighth helix are required for G protein-coupling. 
Multiple serine and threonine residues in the carboxyl-terminal tail have been shown to 
be phosphorylated and are required for desensitization. 
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 1.5.2. AT1R Desensitization, Endocytosis and Intracellular Trafficking 
 Agonist-activation of the AT1R also results in the attenuation of receptor 
signalling as the consequence of receptor phosphorylation by G protein-coupled receptor 
kinases (GRKs) and PKC.  Agonist activation and GRK-mediated phosphorylation of the 
AT1R facilitates the recruitment of the cytosolic adaptor protein, β-arrestin, which 
functions to sterically uncouple the AT1R from the heterotrimeric G protein and targets 
the AT1R for clathrin-mediated endocytosis (Freedman et al., 1995; Ferguson et al., 1995; 
Ferguson et al., 1996; Opperman et al., 1996; Krupnick and Benovic, 1998; Ferguson, 
2001; Ferguson, 2007). Once internalized, GPCRs may be either sequestered in early 
endosomes, dephosphorylated and recycled back to the plasma membrane or targeted to 
lysosomes for degradation (Ferguson, 2001; Gáborik and Hunyady, 2004; Seachrist and 
Ferguson, 2003).  In the case of the AT1R, the receptor is internalized as a complex with 
β-arrestin and is retained in the early endosomal compartment and is not readily 
dephosphorylated and recycled (Anborgh et al., 2000).  
1.6. THE METABOTROPIC GLUTAMATE RECEPTOR FAMILY 
 Glutamate is a major excitatory neurotransmitter whose actions are mediated 
though two types of receptors: ionotropic and metabotropic glutamate receptors (Figure 
1.6). Ionotropic glutamate receptors are ligand-gated cation channels subdivided into N-
methyl-D-aspartate (NMDA), α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid 
(AMPA) and Kainite receptors based in agonist preference. Metabotropic glutamate 
receptors (mGluR) are G protein-coupled receptors, which play an important role in 
processes of synaptic plasticity, such as learning and memory, neuronal development, and 
neurodegeneration. mGluRs are categorized into three classes based on sequence 
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homology and G protein coupling (Niswinder and Conn, 2010). Group I mGluRs, 
including mGluR1a, the focus of this thesis, and mGluR5 are primarily located 
perisynaptically on the postsynaptic cell (Niswiender and Conn, 2010). The prototypic 
mGluR1 has five splice variants (mGluR1a-e), which differ primarily in the length of the 
carboxyl terminus (Conn and Pin, 1997).  There are no alterations in G protein-coupling 
between these variants as this is mediated by residues within the second and third 
intracellular loops as well as the membrane proximal region of the c-tail (Figure 1.7). 
Group II and III receptors are localized to both presynaptic and postsynaptic terminals 
and are negatively coupled to adenylyl cyclase and inhibit action of L-, N- and P/Q-type 
VDCC, thus activating hyperpolarizing potassium currents. Activation of these receptors 
leads to presynaptic inhibition of the release of neurotransmitters, including glutamate 
(Conn and Pin, 1997).  
1.6.1. Group I mGluR Signalling  
 Group I mGluRs are coupled through Gαq to activate PLC production of IP3 and 
DAG generation leading to intracellular calcium release and PKC activation. These 
receptors can also functionally activate a number of G protein-independent signal 
transduction pathways including tyrosine kinases, mitogen activated kinases, ion 
channels and other phospholipases.  The tyrosine kinase Pyk2 uncouples mGluR G-
protein signalling, but facilitates extracellular signal-regulated kinases (ERK) 1/2 
activation (Dhami and Ferguson, 2006; Kim et al., 2008; Niswender and Conn, 2010; 
Ribeiro et al., 2010).  ERK phosphorylates transcription factors such as cAMP response 
element-binding protein (CREB) and Elk-1, facilitating immediate early gene expression 
(Nicodemo et al., 2010). Via G proteins, mGluRs activate K+, Ca2+ and nonselective
  
 
 
 
 
 
 
Figure 1.6. Schematic depiction of the glutamatergic synapse. Depolarization of the 
presynaptic cell results in the membrane translocation of secretory vesicles, which release 
glutamate into the synaptic cleft. Presynaptic Group I mGluRs (mGluR1/5) enhance 
glutamate secretion while presynaptic Group II and III mGluRs inhibit secretion. 
Glutamate diffuses through the synaptic cleft to activate numerous postsynaptic 
glutamate receptors, ultimately resulting in increased calcium release in the postsynaptic 
cell. Ionotropic glutamate receptor channels, including AMPA, NMDA and Kainate-type 
channels are located in the postsynaptic density while metabotropic glutamate receptors 
are predominately found perisynaptically.  
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Figure 1.7. Snake model depicting amino acid residues of the metabotropic 
glutamate receptor 1 (mGluR1). The mGluRs possess a large bi-lobed extracellular 
amino-terminal, which folds to form the characteristic “venus fly trap” domain involved 
in agonist binding. This agonist-binding domain is linked via a Cysteine-rich region to 
the heptahelical transmembrane domains, linked by the intracellular loop domains 
collectively responsible for G protein activation. Ligand binding to a receptor dimer 
stabilises a closed conformation of the lobes, triggering intracellular signal transduction 
by stabilising the two receptors in an active conformation. The carboxyl-terminal tail 
contains numerous serine and threonine residues, which may be phosphorylated by 
second messenger-dependent kinases as well as G protein-coupled receptor kinases. The 
C-tail is also involved in the regulation of receptor function through interaction with 
intracellular proteins including the Homer family and calmodulin. Figure adapted from 
Dhami and Ferguson, 2006.  
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 cation channels have been shown to mediate long-term potentiation, as well as long-term 
depression in neurons, involving mGluR1/5 activation or inhibition (respectively) of 
AMPAR- or NMDAR-mediated transmission (Mao et al., 2008). mGluR activation of 
phospholipase A2 (PLA2) can occur via PKC or ERK (Rozenjurt, 2007; Stella et al., 
1994). PLA2 hydrolyses glycerophospholipids generating arachidonic acid, which can 
then be converted into pro-inflammatory eicosanoids. Phospholipase D (PLD) is 
activated in both PKC-dependent and independent manners PLD activation by mGluRs in 
astrocytes is dependent on PKC and small G proteins of the ARF family (Anwyl, 1999).  
1.6.2. mGluR1 Desensitization, Endocytosis and Intracellular Trafficking 
 Desensitization and endocytosis of mGluRs abandons the GPCR paradigm as 
mGluR1 undergoes constitutive, as well as agonist-induced endocytosis and mGluR1 
desensitization includes phosphorylation-dependent and -independent mechanisms 
(Ferguson, 2007; Dhami and Ferguson, 2006; Bhattacharya et al., 2004; Dhami et al., 
2005, Dhami et al., 2004; Dhami et al., 2002). Phosphorylation-independent mGluR 
desensitization involves the GRK2 RGS homology domain associating with both the 
receptor second intracellular loop and the alpha subunit of the heterotrimeric G protein 
(Bhattacharya et al., 2004; Dale et al., 2000; Dhami and Ferguson, 2006; Ferguson, 
2001b; Ferguson, 2007). Phosphorylation-dependent mGluR desensitization occurs via 
receptor phosphorylation by second messenger-dependent kinases (PKC and CamKII) 
(Dale et al., 2000; Dhami et al., 2002; Dhami et al., 2004). To date, many proteins have 
been implicated in the desensitization of the mGluRs including GRK2, second messenger 
dependent kinases, scaffolding and trafficking molecules, such as, the huntingtin-
interacting protein optineurin (Anborgh et al., 2005; Mundell et al., 2004; Mundell et al., 
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2003; Schoepp and Johnson, 1988).  The endocytosis of mGluR1 is equally complex, 
with differing partners contributing to constitutive versus agonist-induced internalization 
and even different endocytic machinery depending on the agonist (Dhami and Ferguson, 
2006). PKC activation is important for glutamate-induced mGluR1a internalization while 
mGluR1 constitutive internalization can be mediated by scaffolding RalA along with 
phospholipase D2 (PLD2) at the receptor (Bhattacharya et al., 2004a).  
1.7. SMALL G PROTEINS 
 The small, monomeric GTP-binding superfamily contains more than 100 
members with molecular masses ranging from 20 to 30 kDa, classified into five 
subfamilies based on structural similarity: Ras, Rho, Ran Arf and Rab family GTPases 
(Figure 1.8) (Bhattacharya et al., 2004b; Mundell et al., 2003; Exton, 1998). Small G 
proteins play essential roles in signal transduction, growth regulation, cell motility and 
intracellular trafficking among other cellular processes. Ras family members (Ras, Rap 
and Ral) typically regulate cell signalling events that lead to alterations in gene 
transcription while the Rho family also regulates the actin cytoskeleton (Takai et al., 
2001; Wettschureck and Offermanns, 2005; Sah et al., 2000). Ran members regulate 
microtubule organization and protein transport between the nucleus and cytoplasm (Bos, 
1998). The Rab and Arf families control the formation, fusion, and movement of 
vesicular traffic between different membrane compartments (Bos, 1998).  
 As guanine nucleotide binding proteins, members of this superfamily cycle 
between the guanosine triphosphate (GTP) bound “active” state and the guanosine 
diphosphate (GDP) bound “inactive state” and possess intrinsic GTP hydrolysis activity 
(Lundquist, 2006; Zerial and McBride, 2001). In addition to their inherent GTPase 
  
 
 
 
 
 
Figure 1.8. The Ras superfamily of small G proteins. G proteins (also called GTPases) 
cycle between the guanosine triphosphate (GTP)-bound active form and the guanosine 
diphosphate (GDP)-bound inactive forms. In addition to the inherent hydrolyzing activity 
of G proteins, GTP hydrolysis is assisted by GTPase accelerating proteins (GAP) while 
the exchange of GDP for GTP is facilitated by guanine exchange factors (GEF). A large 
class of G protein GEFs include GPCRs themselves. The superfamily of Ras small G 
proteins are categorized into five subfamilies, including Ras, Raf, Rho, Arf, Rab and Ran. 
While the Ras subfamily participates mainly in signal transduction events, Arf, Rab and 
Ran family members facilitate intracellular membrane transport and Rho members 
associate with the cytoskeleton.  
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activity, many members of this family associate with accessory proteins including 
GTPase activating (GAP) proteins, which accelerate GTP hydrolysis, as well as guanine 
exchange factors (GEF), which facilitate the exchange of GDP for GTP (Bos, 1998; 
Takai et al., 2001).  
1.7.1. Overview of the Rab Family of Small GTPases 
 Ras-like in Brain (Rab) are the largest group of small Ras-like G proteins 
comprising 11 members in yeast and over 60 in mammals (Ross, 2008; Rossman et al., 
2005). Rab family members regulate all aspects of intracellular membrane trafficking 
from vesicular targeting, docking and fusion events. They participate in the transport of 
nascent proteins from the trans-Golgi network (TGN), the exocytosis and endocytosis of 
proteins, endocytic sorting and lysosomal degradation of membrane bound proteins 
(Seachrist and Ferguson, 2003; Zerial and McBride, 2001; Stenmark, 2009). Rabs 
reversibly associate with membranes via hydrophobic geranylgeranyl groups attached to 
two C-terminal Cysteine residues. Rab escort proteins (REPs) capture newly synthesized 
Rabs and present them to geranylgeranyl transferase before targeting them to the 
appropriate membrane. GDP dissociation inhibitors (GDIs) recognize Rab-GDP and 
prevent GDP release, while simultaneously chaperoning geranylgeranylated Rabs in the 
cytosol and mediating their delivery to membranes or recycling them back to the cytosol. 
GDI displacement factors (GDFs) recognize specific Rab-GDI complexes and promote 
GDI release, thereby facilitating the association of Rabs with relevant membrane domains 
(Hutagalung and Novick, 2011; Pfeffer and Aivazian, 2004).  
34 
 
 1.7.1.1. Intracellular Localization of Rab Proteins 
 A unique and useful characteristic of Rabs is their tendency to occupy distinct 
and predicable membrane microdomains (Figure 1.9) (Hutagalung and Novick, 2011; 
Stenmark, 2009; Zerial and McBride, 2001). Rab1 and Rab2 are localized to the 
endoplasmic reticulum and pre-Golgi area and mediate ER-Golgi trafficking. Rab 6, 33 
and 40 are found at the Golgi and mediate intra-Golgi trafficking while Rab8 mediates 
constitutive biosynthetic trafficking from the trans-Golgi network to the cell surface and 
has also been implicated in Rab11 mediated recycling (Wang and Wu, 2012; Knodler et 
al., 2010). Rab32 controls mitochondrial fission while Rab13 assembles epithelial cell 
tight junctions. Autophagosome formation is regulated by Rabs 33 and 24 (Chua et al., 
2011; Marzescot and Zarhaoui, 2005; Alto et al., 2002).   Rab3, 26, 27 and 37 regulate 
exocytic events and Rab27 mediates the translocation of melanosomes to the cell 
periphery (Fukuda, 2008; Strom et al., 2002). Rab5 is localized to the plasma membrane, 
early endosomes and phagosomes, where it participates in clathrin-mediated endocytosis 
of plasma membrane proteins (Seachrist and Ferguson, 2003). Rab21 is implicated in 
integrin endocytosis (Pellinen et al., 2006). Rab4 is localized to early endosomes and 
recycling endosomes and is responsible for “fast” recycling of plasma membrane proteins 
while Rab11, which is located in the perinuclear region and Rab35 mediates “slow” 
recycling of plasma membrane proteins (Chua et al., 2010; Seachrist and Ferguson, 
2003). Rab7 and Rab9 are located in late endosomes and lysosomes and traffic proteins 
for degradation (Zerial and McBride, 2001). This thesis focuses on the management of 
GPCRs by Rabs involved in the endocytic pathway including Rab4, Rab5, Rab7, Rab8 
and Rab11 and will henceforth focus on these Rab family members (Figure 1.9).  
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Figure 1.9. Rab Family members coordinate all aspects of endocytic trafficking. 
Rab5 participates in clathrin-mediated endocytosis and early endosomal trafficking of 
endocytic vesicles while Rab7 mediates the late endosomal and lysosomal trafficking of 
proteins for degradation. Rab4 mediates the “fast” recycling route, directly from early 
endosomes to plasma membrane while Rab11 mediates the “slow” perinuclear recycling 
route. Rab8 participates in the plasma membrane targeting of nascent proteins and may 
coordinate with Rab11 for recycling.   
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 1.7.1.2. Structure of Rab Proteins 
 Like other members of the Ras superfamily of small G proteins, Rabs contain 
the GTPase fold and COOH-terminal to the fold is the hyper-variable region as well as 
the CAAX boxes containing two cysteines, which are posttranslationally modified with 
the addition of a geranylgeranyl group, allowing the Rab to associate with membranes 
(Ng and Tang, 2008; Stenmark, 2009; Zerial and McBride, 2001). The switch I and II 
regions of Rabs are the area of nucleotide binding, and both switch regions make contact 
with the γ phosphate of GTP. Effector molecules likely associate with the heterogeneous 
switch domains along with the α3/β5 loop (a loop that connects α helix 3 with β sheet 5) 
that lies adjacent to the switch II domain. Rab GTPases are differentiated from other 
members of the Ras superfamily by a Rab-specific amino acid sequence F1-F5. Rab 
GTPases are evolutionarily well conserved with 55-75% identity between orthologs from 
yeast and mammals (Hutagalung and Novick, 2011; Pfeffer and Aivazian, 2004).  
1.7.1.3. Rab Interacting-Proteins 
 Rabs mediate targeting, docking and fusion of their cognate vesicles via 
association with effector molecules and Rab interacting proteins (Zerial and McBride, 
2001). Membrane tethering complexes often contain GEFs for Rabs that serve to recruit 
them. For example, the Rab5 effector Rabaptin 5 is complexed with the Rab5 GEF 
Rabex5, which amplifies Rab5 activation in microdomains of endosomal membranes 
while Rab5 association with effectors Rabenosyn 5 and Early Endosomal Antigen 1 
(EEA1) recruit members of the SNARE complex to coordinate tethering, docking and 
fusion (Hutagalung and Novick, 2011).   
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 1.7.1.4. Mechanisms of Rab Action 
 GTP bound Rabs can activate sorting adaptors to sort a receptor into budding 
vesicles and via recruitment of PI kinases and phosphatases can alter PI composition and 
trigger uncoating. Rabs can also mediate vesicle transport along actin filaments or 
microtubules by recruiting motor adaptors or binding directly to motors. For example, the 
plus-end-directed, actin-based motor protein myosin Vb facilitates protein trafficking in 
Rab11a-specific recycling vesicles (Hutagalung and Novick, 2011; Pfeffer and Aivazian, 
2004; Stenmark, 2009; Zerial and McBride, 2001).  Rabs mediate vesicle tethering by 
recruiting tethering factors that interact with SNARES or their regulators. Finally, 
following membrane fusion, the Rab hydrolyzes GTP, thus associating with GDP and 
therefore targeted by a GDI back to the donor membrane and then to a GDF.  
 Rab activity can be manipulated by specific functional mutations. These 
mutations are design based on well-characterized amino acid substitutions in the p21ras 
GTPase. Dominant negative and constitutively active Rab mutations are very useful 
tools, which are frequently utilized to study the effect of Rab function in regulation of 
membrane trafficking.  
 Dominant negative Rab mutations are created by substituting an amino acid in the 
N-terminal (equivalent to p21ras S17N) or C-terminal (equivalent to p21ras N116I) of the 
Rab nucleotide binding domain (Millman et al., 2008; Volpicelli et al., 2002). This forces 
the Rab to be constitutively associated with a guanine nucleotide exchange factor, thus 
preventing Rab activation and rendering the Rab defective in guanine nucleotide binding.  
 Constitutively active Rab mutations are created by substituting an amino acid in 
the GTPase region, equivalent to the p21ras Q61L mutant, which exhibits reduced 
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GTPase activity (Stenmark et al., 1994). Thus, the Rab does not hydrolyse GTP to GDP 
and its activity is effectively non-regulated.  
1.7.2. Rabs and Receptor Intracellular Trafficking 
 An explosion of Rab-mediated GPCR trafficking studies in recent years has 
expanded our understanding of the different members of this family of small G proteins 
affects the intracellular targeting of GPCRs. 
1.7.2.1. Rab4  
 Rab4 is involved in the transport of protein from early endosomes to the plasma 
membrane via a direct, “fast” recycling route directly from early endosomes (Table 1.1.). 
Rab4 is involved in the recycling of the AT1R, somatostatin receptor 3, corticotropin 
releasing factor 1α receptor and β2 adrenergic receptor among others (Esseltine et al., 
2011; Yudowski et al., 2009; Holmes et al., 2006; Odley et al., 2004; Seachrist et al., 
2000).  Although the AT1R is not known to be efficiently recycled, fluorescence 
resonance energy transfer (FRET) microscopy shows that during the early recycling 
stage, internalized AT1Rs are associated with Rab4 in the cytoplasm whereas during the 
mid-recycling stage, AT1Rs are associated with both Rab4 and Rab11 in the perinuclear 
compartments (Esseltine et al., 2011; Hunyady et al., 2002; Seachrist et al., 2000). 
Internalized CRF1α receptor transits from Rab5-positive early endosomes to Rab4-
positive recycling endosomes and CRF1α receptor resensitization is blocked by the 
overexpression of wild-type Rab5 and Rab4 GTPases (Holmes et al., 2006). Meanwhile, 
the apelin-13 internalized receptor is rapidly recycled to the cell surface through a Rab4-
dependent mechanism, while dominant negative Rab4 causes the receptor to be trafficked 
 Table 1.1. Rab4-mediated GPCR trafficking and signalling 
Receptor Proposed Function in Receptor Trafficking and Signalling References 
Somatostatin  3 
Angiotensin II type 1 
 
Corticotropin releasing 
factor 1 alpha 
Oxytocin receptor 
Mu-opioid receptor 
Apelin 
 
Thyrotropin releasing 
factor 
Glucagon 
CXC chemokine 2 
Prostaglandin D2 
Neurokinin 
Beta 2 adrenergic 
 
 
Beta 1 adrenergic 
Rapid SSTR3 trafficking 
Facilitates AT1R dephosphorylation, thereby decreasing desensitization and 
increasing resensitization 
Rab4 overexpression blocked CRF1αR  resensitization  
 
 
Recycling of phosphorylated MOR 
Rab4 rapidly recycled apelin-13 receptor while Rab4DN caused receptor 
trafficking to lysosomes 
Localized with both phosphorylated and dephosphorylated TRH 
 
Facilitates actin- and arrestin-dependent GR recycling 
CA RhoB  reroutes CXCR2 from Rab11 to Rab4 recycling 
Specifically recycles DP2 receptor, not CRHT2 
Rab4 disruption attenuated NK1R resensitization 
β2AR activation results in increased Rab4-positive vesicle fusion with PM 
Transgenic Rab4DN decreased catecholamines response and caused 
abnormal accumulation of β2AR in the sarcoplasm  
Transgenic overexpression of Rab4 in the mouse myocardium increased 
βAR in the plasma membrane and cAMP production leading to cardiac 
hypertrophy 
Tower-Gilchrist et al., 2011 
Hunyady et al., 2002; 
Esseltine et al., 2011 
Holmes et al., 2006 
 
Conti et al., 2009 
Wang et al., 2008 
Lee et al., 2010 
 
Jones and Hinkle, 2009 
 
Krilov et al., 2008 
Neel et al., 2007 
Gallant et al., 2007 
Roosterman et al., 2004 
Yudowski et al., 2009; 
Seachrist et al., 2000; 
Odley et al., 2004 
Filipeanu et al., 2006 
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 to lysosomes (Lee et al., 2010). Somatostatin receptor 3 traffics through Rab4-, and 
Rab11-containing endosomes and expression of the inactiveRab4/S22N, and 
Rab11/S25N inhibits receptor trafficking (Tower-Gilchrist et al., 2011).  Similarly, Rab4 
or Rab11 dominant-negative mutants and small interfering RNA both significantly impair 
the recycling of the wild-type μ-opioid receptor (Wang et al., 2008). 
1.7.2.2. Rab5 
 Rab5 is one of the more intensely studied members of the large and diverse family 
of Rab GTPases (Table 1.2.). Enriched at the plasma membrane and early endosomes, 
Rab5 coordinates the endocytosis of proteins via clathrin-coated vesicles and transport to 
early endosomes where proteins may be sorted for retention, recycling or degradation 
(Seachrist and Ferguson, 2003). Rab5a has been shown to interact with the AT1AR 
carboxyl-terminal tail and retain the receptor in Rab5a-positive early endosomes (Dale et 
al., 2004; Seachrist et al., 2002).  Co-expression of cannabinoid receptor 2, muscarinic 
acetylcholine receptor M4 and human NPY receptors with dominant negative Rab5 
results in a significant reduction in receptor internalization (Grimsey et al., 2011; Lecat et 
al., 2011; Volpicelli et al., 2001). Conversely, although dominant-negative Rab5-S34N 
did inhibit receptor internalization, Rab5 and TRH receptor do not colocalize at the 
plasma membrane immediately after TRH addition, but overlap extensively by 15 min 
(Jones and Hinkle, 2009). Cysteinyl leukotriene receptor is internalized through a 
clathrin- arrestin- and Rab5-dependent pathway and internalized adenosine A (2A) 
receptors also co-localize with clathrin and Rab5 (Parhamifar et al., 2009; Mundell et al., 
2000). Both phosphorylated and nonphosphorylated μ-opioid receptor internalize via 
Rab5-dependent pathway after agonist stimulation (Wang et al., 2008).  
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 Table 1.2. Rab5-mediated GPCR trafficking and signalling 
Receptor Proposed Function in Receptor Trafficking and Signalling References 
Cannabinoid 2 
angiotensin II type 1 
 
 
corticotropin releasing 
factor 
Melanocortin  
Cysteinyl leukotriene 1 
Dopamine 2 
 
Neurokinin 
CXC chemokine 2 
Endothelin A 
 
Endothelin B 
Oxytocin 
mu-opioid 
 
C5a anaphylatoxin 
chemotactic  
Thyrotropin releasing 
 
 
Platelet activating 
factor 
Somatostatin 1 
TPbeta 
Rab5DN attenuated CB2 internalization 
Rab5a associates with last 10 amino acids and Rab5aDN or truncated 
AT1AR prevents AT1AR trafficking into large, hollow cored vesicular 
structures. AT1AR activation facilitates Rab5a GTP binding.  
Rab5 overexpression blocked CRF1αR  resensitization  
 
 
Clathrin, arrestin-3, and Rab5 mediates internalization of CysLT(1)R 
Rab5aCA facilitates while Rab5aDN attenuates β-arrestin-mediated D2R 
Endocytosis and ERK1/2 activation 
Rab5aDN caused retention of the NK1R in early endosomes 
Rab5DN mutant decreases CXCR2 endosomal sequestration 
 
 
 
 
Rab5 facilitates phosphorylated and nonphosphorylated MOR 
internalization 
 
 
Rab5 and phosphorylated TRHR colocalized at 15 min and 
dephosphorylated receptor colocalized with Rab4 but not with Rab5. 
Rab5DN inhibited receptor internalization.  
PAFR activation triggered signal-regulating kinase-1/MAPK kinase-3/p38 
MAPK assembly with Rab5a and Rab GDI, thus activating Rab5a 
 
Amino acids 335-344 of the TPbeta C-tail essential for the directing the 
Grimsey et al., 2011 
Seachrist et al., 2001; Dale et 
al., 2004; Esseltine et al., 
2011 
Holmes et al., 2006 
 
Roy et al., 2011 
Parhamifar et al., 2010 
Iwata et al., 2005 
 
Roosterman et al., 2004 
Fan et al., 2003 
Bremnes et al., 2000; Paasche 
et al., 2001 
Bremnes et al., 2000;  
Conti et al., 2009 
Wang et al., 2008 
 
Cui et al., 2009 
 
Jones and Hinkle, 2009 
 
 
McLaughlin et al., 2008 
 
Roosterman et al., 2007 
Hamelin et al., 2005 
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Adenosine (2B) 
Neurotensin 1 
Beta 2 adrenergic 
 
 
Ghrelin 
Human prostacyclin 
 
 
Rhodopsin 
 
M4 muscarinic 
 
Neuropeptide Y 
Metabotropic glutamate 
1 
receptor from the Rab5-positive vesicles to the perinuclear recycling 
endosome 
Involved in β arrestin-1 mediated endocytosis of A(2B)AR 
 
Rab5DN impaired β2AR internalization and β2AR-positive vesicles 
remained closely associated with plasma membrane. Rab5CA internalized 
β2AR to enlarged endosomes 
 
Rab5a associates with C-tail of hIP in agonist-dependent manner and hIP 
stimulation triggered Rab5a translocation from cytosolic to membrane 
fraction.  
Dynamin- and Rab5-dependent endocytosis necessary to prevent early 
onset of rhabdomere degeneration in Drosophila. 
Rab5DN inhibits m4 endocytosis while Rab5CA enhances m4 intracellular 
distribution and produces enlarged vacuoles 
Facilitates clathrin-mediated endocytosis of NPY receptor 
Rab5b siRNA prevents DHPG-mediated LTD in neurons. Group I mGluRs 
are linked to Rab5b synthesis 
 
 
Mundell et al., 2000 
Vandenbulcke et al., 2000 
Seachrist et al., 2000 
 
 
Holliday et al., 2007 
O’Keeffe et al., 2008 
 
 
Pinal and Pichaud, 2011 
 
Volpicelli et al., 2001 
 
Lecat et al., 2011 
Baskys et al., 2005 
 
 
 
 
 1.7.2.3. Rab7 
 Rab7 is enriched at late endosomes and lysosomes where it mediates the 
trafficking of targeted proteins to the lysosome for degradation (Table 1.3.). CXCR2 type 
1 PDZ binding motif truncation increases ligand-mediated receptor degradation and Rab7 
dominant negative overexpression prevents CXCR2 from trafficking to lysosomes 
(Baugher and Richmond, 2008; Fan et al., 2003). Rab7 also targets the apelin-13 receptor 
to lysosomes and Rab7 overexpression can change the fate of AT1AR from Rab5-
mediated sequestration to Rab7-mediated degradation (Lee et al., 2010; Dale et al., 
2004). 
1.7.2.4. Rab8 
 Rab8 is localized to Golgi, vesicles and membrane ruffles and is involved in 
trafficking of basolateral proteins in polarized epithelial cells, as well as neurite 
outgrowth (Table 1.4.) (Ng and Tang, 2008). Rab8 has been shown to regulate ionotropic 
glutamate AMPA receptor synaptic delivery and recycling in rat hippocampal spines and 
is documented in the polarized transport of rhodopsin in photoreceptor cells (Brown et 
al., 2007; Gerges et al., 2004; Moritz et al., 2001; Deretic, 1997). Rab8 has recently been 
shown to directly associate with different regions of the α2B- and β2-adrenergic receptors 
and a GDP-bound dominant negative Rab8 mutant blocks cell surface expression and 
ERK1/2 activation of α2BAR but not β2AR (Dong et al., 2010). Rab8 has also been 
implicated in non-clathrin mediated endocytosis and is associated with macropinosomes 
generated at ruffling membrane domains (Hattula et al., 2006). 
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 Table 1.3. Rab7-mediated GPCR trafficking and signalling 
Receptor Proposed Function in Receptor Trafficking and Signalling References 
Apelin 
Angiotensin II type 1 
 
GABA(A) 
Prostaglandin EP4 
 
 
C5a anaphylatoxin 
CXC chemokine 2 
 
Beta 2 adrenergic 
Neurotensin 1 
Rab7 targeted the receptor to lysosomes 
Rab7 associates with last 10 amino acids of AT1R and wild-type Rab7 and 
Rab7CA increased AT1AR lysosomal targeting and degradation 
 
EP(4), γ-secretase and Rab7 co-localised after agonist stimulation in cells 
and also in the brain of wild-type mice but not of EP(4) receptor null mice. 
 
 
CXCR2 type 1 PDZ binding motif truncation increases ligand-mediated 
receptor degradation 
PI3K inhibitors reroute β2AR from recycling to degradative pathways 
Lee et al., 2010 
Seachrist et al., 2001; Dale et 
al., 2004; Esseltine et al., 
2011 
Davis et al., 2010 
Hoshino et al., 2009 
 
Cui et al., 2009 
Fan et al., 2003; Baugher and 
Richmond 2008 
Awwad et al., 2007 
Vandenbulcke et al., 2000 
 
Table 1.4. Rab8-mediated GPCR trafficking and signalling 
Receptor Proposed Function in Receptor Trafficking and Signalling References 
Alpha 2B adrenergic 
Beta 2 adrenergic 
 
CXC chemokine 4 
CCR5 
Rhodopsin 
DN Rab8 reduced α2BAR plasma membrane expression 
β2AR modulates the Rab geranyl-geranylation 
DN Rab8 reduced β2AR plasma membrane expression 
CXCR4-CCR5 homodimer transport from endoplasmic reticulum to 
plasma membrane when CD4 co-receptor is present 
Rab8DN caused rapid retinal degeneration in Xenopus 
Dong et al., 2010 
Lachance et al., 2011; Dong 
et al., 2010 
Charette et al., 2011 
 
Moritz et al., 2001 
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 1.7.2.5. Rab11  
 Rab11 is another extensively studied protein transport molecule (Table 1.5.). 
Rab11 is localized to early endosomes and the perinuclear regions and is crucial for 
recycling and resensitization of many GPCRs and other receptors (Seachrist and 
Ferguson, 2003). Like Rab4, Rab11 mediates protein trafficking from endosomes back to 
the plasma membrane. However, unlike the direct Rab4 route from early endosomes to 
plasma membrane, Rab11 coordinates a “slow” recycling route through the perinuclear 
region and Rab11 and has often been shown to coordinate with or be in competition with 
Rab4 for recycling (Esseltine et al., 2011; Hunyady et al., 2002). For example, Rab11 
mediates the recycling of nonphosphorylated MOR, while Rab4 mediates phosphorylated 
μ-opioid receptor recycling (Wang et al., 2008). Dominant negative Rab11 causes 
decreased β2AR membrane expression and mediates recycling of constitutively 
internalized TPβ receptor (Parent et al., 2009; Hamelin et al., 2005; Theriault et al., 
2004). Rab11 also participates in M4 muscarinic receptor recycling via myosin Vb, a 
Rab11a effector (Volpicelli et al., 2002). In addition to recycling, Rab11 has been shown 
to mediate other antrograde trafficking pathways and along with Rab6, Rab3 and Rab8, 
Rab11 is also linked to post-Golgi trafficking of rhodopsin and coordinates CXCR4-
CCR5 homodimer transport from endoplasmic reticulum to the plasma membrane (Satoh 
et al., 2005; Deretic, 1997). 
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 Table 1.5. Rab11-mediated GPCR trafficking and signalling 
Receptor Proposed Function in Receptor Trafficking and Signalling References 
Somatostatin 3 
Cannabinoid 2 
Angiotensin II type 1 
 
Beta 2 adrenergic 
 
 
 
 
Melanocortin 2 
Human prostacyclin 
 
 
CXC chemokine 4 
 
CCR5 
Vasopressin 
CXC chemokine 2 
 
LPAR 
 
Mu-opioid 
 
Delta-opioid 
 
C5a anaphylatoxin 
Glucagon 
Regulates slow receptor trafficking 
Rab11DN impaired receptor return to plasma membrane 
Rab11 associates with AT1R C-tail to mediate recycling 
 
β2AR modulates the Rab geranyl-geranylation 
endoplasmic reticulum to plasma membrane  
PI3K inhibitors reroute β2AR from recycling to degradative pathways 
DN Rab11 causes decreased β2AR membrane expression 
Actin-dependent recycling of β2AR 
 
Rab11a increased recycling of hIP, while Rab11DN impaired recycling.  
Interaction between hIP and Rab11a via Val299-Gln320 sequence within 
the hIP C-tail domain 
Gα13 and Rho mediate actin-dependent trafficking of CXCR4 into the 
Rab11 compartment 
CXCR4-CCR5 homodimer transport from ER to PM 
 
RhoB CA mutant reroutes CXCR2 from Rab11 to Rab4 recycling 
 
LPA promotes Rab11a interaction with Gβγ, activating PI3K and AKT  
Recycling of nonphosphorylated MOR 
 
 
DN Rab11 abolished the ability of Src blockers to prevent DOR 
desensitization 
 
Facilitates actin- and arrestin-dependent GR recycling 
Tower-Gilchrist et al., 2011 
Grimsey et al., 2011 
Dale et al., 2004; Esseltine et 
al., 2011 
Lachance et al., 2011 
 
 
Parent et al., 2009 
Millman et al., 2008 
Roy et al., 2011 
Wikstrom et al., 2008;  
 
 
Reid et al., 2010 
Kumar et al., 2011  
Charette et al., 2011 
Innamorati et al., 2001 
Fan et al., 2003; Neel et al., 
2007 
Garcia-Regaldo et al., 2008 
 
Liang et al., 2008; Wang et 
al., 2008 
Archer-Lahlou et al., 2009 
 
Cui et al., 2009 
Krilov et al., 2008 
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Calcium sensing 
 
Somatostatin 1 
TPbeta 
 
 
Neurokinin 1 
M4 muscarinic 
Chemoattractant 
homologous receptor 
expressed on TH2 cells 
Neurotensin 1 
GhrelinR 
Rhodopsin 
 
 
Endothelin A 
Endothelin B 
DN Rab11a decreased CaR-mediated PTHrP secretion but not CaR-
dependent ERK1/2 
 
Rab11 interacts directly with the first intracellular loop and the C-tail of 
TPbeta and mediates recycling of constitutively internalized TPbeta 
receptor 
Rab11aDN inhibited NK1R recycling 
Regulates M4 recycling via myosin Vb, a Rab11a effector 
Specifically recycles CRTH2, not DP2 receptor 
 
 
 
 
Rhodopsin colocalizes with Rab11 and disruption of  Rab11 activity 
inhibits rhabdomere morphogenesis and rhodopsin-positive vesicles 
accumulate in the cytosol.  
Reyes-Ibarra et al., 2007 
 
Roosterman et al., 2007 
Hamelin et al., 2005; 
Theriault et al., 2004 
 
Roosterman et al., 2004 
Volpicelli et al., 2002 
Gallant et al., 2007 
 
 
Vandenbulcke et al., 2000 
Holliday et al., 2007 
Satoh et al., 2005 
 
 
Paasche et al., 2001 
Paasche et al., 2001 
 1.7.3. Rabs and Receptor Signalling 
1.7.3.1. Rab4 
 Previously, it has been shown that the dephosphorylation and resensitization of 
the β2AR occurs as the receptor transits between the Rab5-positive early endosome and 
the Rab4-positive rapid recycling endosome (Seachrist et al., 2000). Transgenic 
overexpression of Rab4 in the mouse myocardium significantly increased the number of 
βAR in the plasma membrane and augmented cAMP production at the basal level and in 
response to isoproterenol stimulation (Odley et al., 2004). Expression of dominant 
negative Rab4 impaired β2AR responsiveness to endogenous and exogenous 
catecholamine and Rab4 inhibition prevented resensitization after isoproterenol-induced 
in vivo adrenergic desensitization (Filipeanu et al., 2006).  Moreover, it has been reported 
that phosphorylated µ-opioid receptor is preferentially recycled through Rab4-positive 
endosomes (Wang et al., 2008).  CRF1α receptor resensitization was blocked by the 
overexpression of wild-type Rab5 and Rab4 GTPases and dephosphorylated receptor 
colocalized with Rab4 but not with Rab5 (Holmes et al., 2006). 
1.7.3.2. Rab5 
 As stated above, dephosphorylation and resensitization of the β2AR occurs as the 
receptor transits between the Rab5-positive early endosome and the Rab4-positive rapid 
recycling endosome and CRF1α receptor resensitization was blocked by the 
overexpression of wild-type Rab5 (Holmes et al., 2006; Seachrist et al., 2000). Rab5 has 
also been shown to be involved in other aspects of GPCR signalling. Interestingly, 
Purvanov et al., 2010 demonstrate an interaction of Drosophila Rab5 and the G protein 
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 Go, in vitro and in vivo. Purified Rab5 and Go proteins associate with each other and Go 
contributes to Rab5 activation and endosome fusion. Serotonin, by cooperating with 
mGluRs, regulates synaptic plasticity through a mechanism dependent on p38 
MAPK/Rab5-mediated enhancement of AMPA receptor internalization in a 
clathrin/dynamin-dependent manner (Zhong et al., 2008). Further studies established a 
functional link between phosphatidic acid-derived DAG and the activation of p38 
mitogen-activated protein kinase and the subsequent phosphorylation of the Rab5 effector 
EEA1, which has been demonstrated to be required for the induction of MOR 
endocytosis (McLaughlin et al., 2008). Additionally, Rab5b plays an important role in 
Group I mGluR-mediated neuroprotection and synaptic plasticity. While DHPG 
treatment of neurons typically leads to long term depression (LTD) in Rab5b siRNA 
treated neurons, DHPG no longer causes LTD. Additionally, group I mGluRs are linked 
to Rab5b synthesis (Baskys et al., 2007; Arnett et al., 2004).  
1.7.3.3. Rab8 
 Rab8 has been shown to coordinate with Rab11 to modulate plasma membrane 
targeting of receptors. Like Rab11, Rab8 associates with the actin motor protein myosin 
Vb to regulate trafficking (Roland et al., 2007). β2AR also modulates the geranyl-
geranylation of Rab8, thus facilitating the Rab association with membranes and Rab8 
activity (Lachance et al., 2011). Dominant negative or depletion of Rab8 by siRNA 
significantly attenuates ERK1/2 activation by α2BAR but not β2AR and inhibits plasma 
membrane delivery of α2BAR from the TGN (Parent et al., 2009).  Our lab has previously 
demonstrated that the Rab8 effector molecule, optineurin associates with and desensitizes 
mGluR1 IP3 signalling (Anborgh et al., 2005). Rab8 also coordinates with Rab11 to 
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 mediate the synaptic delivery of AMPARs during long-term potentiation and constitutive 
receptor cycling (Brown et al., 2007; Gerges et al., 2004). After Rab11 targets AMPAR-
containing endosomes from the dendritic shaft into spines, Rab8 directs receptor insertion 
into the synaptic membrane (Brown et al., 2007). 
1.7.3.4. Rab11 
 In addition to recycling and resensitizing receptors to the plasma membrane, 
Rab11 has been shown in recent years to participate in many other aspects of receptor 
signalling. For example, DN Rab11 causes decreased β2AR membrane expression 
through decreased receptor recycling, but additionally, β2AR itself also modulates the 
geranyl-geranylation of Rab11, thus determining the membrane association state of the 
Rab and its activity (Lachance et al., 2011). Rab11 also coordinates with other signalling 
and regulatory molecules including heterotrimeric G proteins and other small G proteins. 
Gα13 and Rho mediate actin-dependent trafficking of CXCR4 into the Rab11 
compartment while a RhoB constitutively active mutant reroutes CXCR2 from Rab11 to 
Rab4 recycling pathways (Kumar et al., 2011; Reid et al., 2010; Neel et al., 2007; Fan et 
al., 2003). Additionally, LPA promotes Rab11a interaction with Gβγ, causing PI3K 
recruitment and AKT phosphorylation (Garcia-Regaldo et al., 2008).  
1.8. HYPOTHESIS AND SPECIFIC OBJECTIVES 
 In recent years, our lab and others have provided increasingly convincing 
evidence that Rab small G proteins comprise a major component of intracellular 
trafficking machinery and it is now apparent that GPCR trafficking actively affects signal 
transduction. Rabs directly associate with, and actively direct GPCR signalling through 
intracellular localization of receptors and signalling molecules. Our research presented 
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 here further supports the hypothesis that intracellular trafficking of GPCRs can 
actively contribute to and alter receptor signal transduction.  
 The aim of this thesis is to elucidate the role that receptor trafficking plays in 
signal transduction by addressing the following three questions: 
1. Do multiple Rab proteins associate with AT1R to alter receptor desensitization 
or resensitization? 
2. Does Rab8 associate with mGluR1 to modulate its intracellular trafficking and 
signalling? 
3. What alterations do previously uncharacterized mutations in mGluR1 exhibit in 
mGluR1 intracellular localization and signal transduction? 
The data presented in chapters 2, 3 and 4 of this thesis summarize my research aimed at 
answering important questions regarding the regulation of two prototypic GPCRs.  
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CHAPTER 2. 
RAB GTPASES BIND AT A COMMON SITE WITHIN THE 
ANGIOTENSIN II TYPE I RECEPTOR CARBOXYL-TERMINAL 
TAIL: EVIDENCE THAT RAB4 REGULATES RECEPTOR 
PHOSPHORYLATION, DESENSITIZATION AND 
RESENSITIZATION1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1 A version of this chapter has been published: Esseltine JL, Dale LB and Ferguson SS 
(2011) Rab GTPases bind at a common site within the angiotensin II type I receptor 
carboxyl-terminal tail: Evidence that Rab4 regulates receptor phosphorylation, 
desensitization and resensitization. Mol Pharm 79:175-84. 
78 
 
 1.1. INTRODUCTION 
 The angiotensin II type 1 receptor (AT1R) is a member of the G protein-coupled 
receptor (GPCR) superfamily, the largest family of integral membrane receptors and 
represents an important pharmacological target for drug therapy in hypertension 
(Hoffman and Lefkowitz, 1996).  The AT1R is coupled through Gαq/11 to the activation of 
phospholipase Cβ resulting in the formation of diacylglycerol and inositol 1,4,5 
trisphosphate leading to the release of intracellular calcium stores and the activation of 
PKC.  Agonist activation of the AT1R also results in the attenuation of receptor signalling 
as the consequence of receptor phosphorylation by GRKs and PKC.  Agonist activation 
and GRK-mediated phosphorylation of the AT1R facilitates the recruitment of the 
cytosolic adaptor protein, β-arrestin, which functions to sterically uncouple the AT1R 
from the heterotrimeric G protein and targets the AT1R for clathrin-mediated endocytosis 
(Benovic et al., 1987; Freedman et al., 1995; Ferguson et al., 1995; Ferguson et al., 1996; 
Opperman et al., 1996; Krupnick and Benovic, 1998; Ferguson, 2001; Ferguson, 2007). 
Once internalized, GPCRs may be either sequestered in early endosomes, 
dephosphorylated and recycled back to the plasma membrane or targeted to lysosomes 
for degradation (Ferguson, 2001; Gáborik and Hunyady, 2004; Seachrist and Ferguson, 
2003).  In the case of the AT1R, the receptor is internalized as a complex with β-arrestin 
and is retained in the early endosomal compartment and is not readily dephosphorylated 
(Anborgh et al., 2000).  
 The Rab subfamily of small Ras-like GTPases regulate the intracellular 
trafficking of proteins between intracellular compartments through their ability to 
regulate vesicular targeting, docking and fusion (Seachrist and Ferguson, 2003; Gáborik 
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 and Hunyady, 2004).  Rab protein function is in turn tightly regulated at the level of 
protein expression, localization, membrane association, and activation.  Different Rab 
isoforms regulate different aspects of intracellular trafficking such as internalization 
(Rab5), recycling (Rab4 and Rab11) and degradation (Rab7) and different GPCRs are 
known to preferentially traffic through certain Rab pathways (Seachrist et al., 2000; 
Hunyady et al., 2002; Seachrist et al., 2002; Dale et al., 2004; Hamelin et al., 2005; 
Holmes et al., 2006; Wang et al., 2008; Li et al., 2008; Parent et al., 2009). For example, 
Rab5a has been shown to interact with the AT1AR carboxyl-terminal tail and retain the 
receptor in Rab5a-positive early endosomes.  Nevertheless, overexpression of either Rab7 
or constitutively active Rab11 can redistribute AT1R into either Rab7-positive late 
endosomes or Rab11-positive recycling endosomes, respectively (Seachrist et al., 2000; 
Dale et al., 2004).  Additionally, although AT1R is not readily dephosphorylated and 
efficiently recycled, there is evidence to suggest that the receptor can be recycled via both 
slow (Rab11-mediated) and rapid (Rab4-mediated) pathways (Hunyady et al., 2002; Li et 
al., 2008).  Rab binding to a GPCR is not unique to the AT1R, as Rab11 has been shown 
to bind to the β2-adrenergic receptor (β2AR), thromboxane A2 receptor and prostacyclin 
receptor (Seachrist et al., 2002; Hamelin et al., 2005; Parent et al., 2009; Reid et al., 
2010).  Emerging evidence suggests that Rab interactions with these GPCRs are also 
critical for regulating both the trafficking and activity of these receptors.  For example, 
previous studies with the β2AR have shown that the transit of the receptor from the Rab5-
positive early endosome to the Rab4-positive recycling endosome is required for the 
dephosphorylation of the receptor (Seachrist et al., 2000). 
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  In the present study, we have investigated whether other Rab GTPases (Rab4, 
Rab7 and Rab11) can interact with AT1R carboxyl-terminal tail and compete with Rab5 
for binding.  We report here that Rab4, Rab5, Rab7 and Rab11 each compete for an 
overlapping site in the last 10 amino acid residues of the AT1R carboxyl-terminal tail and 
that proline residue 354 and Cysteine residue 355 represent important amino acid 
residues involved in Rab protein binding.  Moreover, we find that overexpression of 
either wild-type or constitutively active Rab4, but not Rab11, promotes AT1R 
dephosphorylation.  The overexpression of a constitutively active Rab4 mutant also 
results in reduced AT1R desensitization and promotes AT1R resensitization.  Taken 
together, our data indicate that multiple Rab GTPases are able to associate with their 
cargo and that the activity of the AT1R may be regulated by the interaction of different 
Rab GTPases at the carboxyl-terminal Rab binding site. 
2.2. EXPERIMENTAL PROCEDURES 
2.2.1. Materials 
myo-(3H)Inositol and (32P)orthophosphate were acquired from PerkinElmer Life Sciences 
(Waltham, MA).  Dowex 1-X8 (formate form) resin 200–400 mesh was purchased from 
BioRad (Mississauga, ON).  Rabbit anti-GST, -Rab4 (sc-26562), -Rab5a (sc-312) and -
Rab11 (sc-309) antibodies were purchased from Santa Cruz Biotech (Santa Cruz, CA) 
and goat anti-GST as well as ECL Western blotting detection reagents were purchased 
from GE Healthcare (Oakville, Ontario, Canada). Horseradish peroxidase-conjugated 
anti-rabbit and anti-goat IgG secondary antibody was from BioRad (Mississauga, ON).  
QuikChangeTM site-directed mutagenesis kit was from Stratagene (La Jolla, CA).  Rabbit 
anti-FLAG antibody, M2 anti-FLAG agarose and all other biochemical reagents were 
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 purchased from Sigma-Aldrich (St. Louis, MO). 
2.2.2. DNA Construction  
An AT1R mutants lacking the distal 10 amino acids (AT1R-C1) was generated using the 
QuikChangeTM Site-directed mutagenesis kit (Stratagene) to introduce a stop codon after 
residue 319 in the AT1R carboxyl-terminal tail. Subsequently, primers were designed for 
mutagenesis such that amino acid residues within the last 10 amino acid residues of the 
AT1R tail were mutated in pairs to alanine residues using the QuikChange Site-directed 
mutagenesis kit.  
2.2.3. Cell Culture 
Human embryonic kidney (HEK) 293 cells were maintained in Eagle's minimal essential 
medium supplemented with 10% (v/v) heat inactivated fetal bovine serum (Invitrogen, 
Burlington, ON) and 50 µg/ml gentamicin.  Cells seeded in 100 mm dishes were 
transfected using a modified calcium phosphate method as described previously 
(Ferguson and Caron, 2004).  Following transfection (18 h), the cells were incubated with 
fresh medium and allowed to recover for 24 hrs for co-immunoprecipitation studies.  
Otherwise, they were allowed to recover for 6-8 hrs and re-seeded into 24-well dishes 
and then grown an additional 18 hrs prior to experimentation. 
2.2.4. Co-Immunoprecipitation 
HEK 293 cells were transiently transfected with FLAG-tagged AT1R and either GST-
tagged Rab4, Rab4-Q67L, Rab4-S22N, Rab5, Rab7, Rab7-Q67L, Rab7-N125I, Rab11, 
Rab11-Q70L or Rab11-S25N.  Following transfection, the cells were incubated for 20 
minutes in Hepes balanced salt solution (HBSS) at 37°C with or without 100 nM AngII.  
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 The cells were then placed on ice, washed two times with ice-cold phosphate-buffered 
saline (PBS) and lysed with cold-lysis buffer (50 mM Tris, pH 8.0, 150 mM NaCl, 0.1% 
Triton X-100) containing protease inhibitors (1 mM AEBSF, 10 μg/ml leupeptin, and 5 
μg/ml aprotinin).  The lysates were placed on a rocking platform for 15 min at 4°C and 
centrifuged at 15000 x g for 15 min at 4°C to pellet insoluble material.  Cleared 
supernatant containing 250 µg protein were incubated with 25 µL of FLAG M2-affinity 
beads (Sigma) for 1h rotating at 4°C to immunoprecipitate FLAG-AT1R. Following 
incubation, the beads were washed twice with lysis buffer and twice with PBS, and 
proteins were solubilized in a 3X SDS sample buffer containing 2-mercaptoethanol 
(BME).  Samples were separated by SDS-PAGE, transferred to a nitrocellulose 
membrane and immuno-blotted to identify co-immunoprecipitated GST-tagged Rab 
proteins using a primary polyclonal rabbit or goat anti-GST antibody (1:1000 dilution, 
Santa Cruz, GE Healthcare) followed by a horseradish peroxidase-conjugated secondary 
anti-rabbit antibody (1:10000, BioRad) or secondary anti-goat (1:2500, BioRad). 
Receptor and Rab protein expression was determined by immunoblotting 10 μg of protein 
from each cell lysate used for immunoprecipitation.  Proteins were detected using 
chemiluminescence with the ECL kit from GE Healthcare.  
2.2.5. Whole cell phosphorylation 
AT1R phosphorylation was measured as described previously (Anborgh et al., 2000).  
HEK 293 cells were transiently transfected with FLAG-AT1R along with either pEGFP 
(control), GFP-tagged Rab4, Rab4Q67L, Rab4S22N, Rab5, Rab5-S34N, Rab5-Q79L, 
Rab11, Rab11Q70L or Rab11S25N. Seventy-two hours post transfection cells were 
rinsed twice and incubated at 37°C for one hour in phosphate-free HBSS (5 mM 
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 NaHCO3, 20 mM HEPES, 11 mM glucose, 116 mM NaCl, 4.7 mM KCl, 1.2 mM 
MgSO4, 2.5 mM CaCl2, pH 7.4).  Cells were then incubated at 37°C for one hour in 100 
µCi/mL [32P]orthophosphate, and treated for 10 min with and without 100 nM AngII, 
rinsed and allowed to recover at 37°C for 0, 20 or 40 min in phosphate-free HBSS.  Cells 
were placed on ice and lysates were collected in the presence of protease inhibitors (0.1 
mM PMSF, 10 μg/ml leupeptin, and 5 μg/ml aprotinin) and phosphatase-inhibitors 
(10mM NaF and 10mM Na4P2O7) and incubated with M2 anti-FLAG affinity agarose for 
2-3 hours to immunoprecipitate receptor protein.  Beads were washed and bound proteins 
were solubilized in SDS-PAGE sample buffer. Equal amounts of receptor protein, as 
determined by protein measurement and flow cytometry were separated by SDS-PAGE 
and receptor phosphorylation was determined via autoradiography at -80°C.  
2.2.6. Measurement of inositol phosphate formation 
Desensitization of AT1R signalling of inositol phosphate was measured as described 
previously (Olivares-Reyes et al., 2001) with some modifications.  HEK 293 cells were 
transiently transfected with the cDNAs as described.  Fourty-eight hours post-transfection 
cells were incubated overnight in inositol-free DMEM with 100 µCi/mL myo-
(3H)Inositol.  Cells were washed twice and incubated for one hour in warm HBSS then 
preincubated for 3 min at 37°C in either HBSS (lacking LiCl) alone or with 100 nM 
AngII (desensitizing stimulus). After a brief acid wash (50 mM glycine, 150 mM NaCl, 
pH 3.0), cells were washed twice and were then incubated with either 10 mM LiCl alone 
or 10 mM LiCl with 100 nM AngII for 10 min.  The resensitization of AT1R-mediated 
IP3 formation was assessed in the same fashion except that desensitized cells were 
allowed to recover for 30 min prior to the second incubation with either 10 mM LiCl 
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 alone or 10 mM LiCl with 100 nM AngII for 10 min. Cells were placed on ice and the 
reaction was stopped with 500 µL of perchloric acid and was neutralized with 400 µl of 
0.72 M KOH, 0.6 M KHCO3.  Total cellular (3H)inositol incorporation was determined in 
50 µl of cell lysate.  Total inositol phosphate was purified by anion exchange 
chromatography using Dowex 1-X8 (formate form) 200-400 mesh anion exchange resin 
and (3H)inositol phosphate formation was determined by liquid scintillation using a 
Beckman LS 6500 scintillation system. 
2.2.7. Statistical Analysis 
Densitometric data were normalized first for protein expression and the maximum value 
was set to 100, with all other values displayed as percentage thereof. One-way analysis of 
variance test (ANOVA) was performed to determine significance, followed by a post-hoc 
Tukey multiple comparison test or Bonferroni’s multiple comparisons test to determine 
which means were significantly different (p < 0.05) from one another.  
2.3. RESULTS 
2.3.1. Rab4, Rab5, Rab7 and Rab11 all interact with the AT1R  
 Previous research showed direct association between Rab5a and AT1R, as well as 
co-localization of the AT1R in Rab7- and Rab11-positive endosomes following Rab 
GTPase overexpression (Seachrist et al., 2002; Dale et al., 2004).  Thus, we investigated 
whether Rab binding to the human AT1R C-tail was either exclusive to Rab5 or was also 
observed for Rab4, Rab7 and Rab11.  HEK293 cells were transiently transfected with 
FLAG-AT1R and either GST-tagged Rab4, Rab5, Rab7 or Rab11.  We find that similar to 
what we observed previously for Rab5a, each of the GST-Rab4, GST-Rab7 and GST-
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Rab11 proteins could be co-immunoprecipitated with the FLAG-AT1R from HEK 293 
cells (Figure 2.1A and 1B).  We found that in the absence of agonist treatment 
significantly more GST-Rab11 and significantly less Rab4 protein could be co-
immunoprecipitated with the FLAG-AT1R, when compared to GST-Rab5 (Figure 2.1A 
and 1B).  Treatment of cells with 100 nM AngII to activate the FLAG-AT1R resulted in a 
small and statistically insignificant increase in GST-Rab5 and GST-Rab7 binding to the 
receptor, but had no effect on the association of either Rab4 or Rab11 (Figure 2.1A and 
1B). We also examined whether endogenous Rab4, Rab5 and Rab11 could be co-
immunoprecipitated with the FLAG-AT1R from HEK 293 cells.  We found that Rab4 
could be co-immunoprecipitated and that agonist stimulation increased Rab4 co-
immunoprecipitation with the FLAG-AT1R by 1.6 ± 0.3 fold (P< 0.05) (Figure 2.1C).  
However, agonist treatment had no effect upon the co-immunoprecipitation of either 
Rab5 or Rab11 with the receptor (Figure 2.1D and 1E). 
 The rat AT1AR was previously shown to preferentially bind to the GDP-bound 
form of Rab5 (Rab5-S34N) and the GDP-bound form of Rab11 interacted specifically 
with the thromboxane A2 receptor (Seachrist et al., 2002; Hamelin et al., 2005).  We 
found that wild-type Rab4, dominant-negative Rab4-S22N, and constitutively active 
Rab4-Q67L did not exhibit a preference for binding to the FLAG-AT1R (Figure 2.2A).  
In contrast, constitutively active Rab7-Q67L mutant exhibited preferential binding to the 
FLAG-AT1R (Figure 2.2B).  Unlike what was previously observed for the thromboxane 
 Figure 2.1. Rab4, Rab4, Rab7 and Rab11 each co-immunoprecipitate with 
AT1R. (A) Representative immunoblot showing the co-immunoprecipitation of 
GST-Rab4, GST-Rab5, GST-Rab7 and GST-Rab11 with the FLAG-AT1R from 
HEK 293 cells in the absence (-) and presence (+) of 100 nM AngII treatment for 
20 min.  (B)  Densitometric analysis of GST-Rab4, GST-Rab5, GST-Rab7 and 
GST-Rab11 co-immunoprecipitated with the FLAG-AT1R from HEK 293 cells in 
the absence (-) and presence (+) of 100 nM AngII treatment for 20 min. Data 
represents the mean ± SD of 5 independent experiments. Data were normalized 
for both individual Rab protein expression levels and normalized to maximum 
Rab protein binding to the AT1R in each experiment. *p< 0.05 compared to Rab5 
co-immunoprecipitated with theAT1R and correspondingly treated. (C) 
Immunoblot demonstrating the co-immunoprecipitation of endogenous Rab4 
protein with the FLAG-AT1R from HEK 293 cells in the absence (-) and presence 
(+) of 100 nM AngII treatment for 20 min.  Rab4 co-immunoprecipitated with 
GFP antibody (Con) is used as a control. Data represents the mean ± SD of 4 
independent experiments.  (D) Immunoblot demonstrating the co-
immunoprecipitation of endogenous Rab5 protein with the FLAG-AT1R from 
HEK 293 cells in the absence (-) and presence (+) of 100 nM AngII treatment for 
20 min.  Rab5 co-immunoprecipitated with GFP antibody (Con) is used as a 
control. Data represents the mean ± SD of 4 independent experiments.  (E) 
Immunoblot demonstrating the co-immunoprecipitation of endogenous Rab11 
protein with the FLAG-AT1R from HEK 293 cells in the absence (-) and presence 
(+) of 100 nM AngII treatment for 20 min.  Rab11 co-immunoprecipitated with 
GFP antibody (Con) is used as a control. Data represents the mean ± SD of 4 
independent experiments. 
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 Figure 2.2. Co-immunoprecipitation of wild-type, dominant negative and 
constitutively active Rab4, Rab7 and Rab11 GTPases with the AT1R. (A) 
Representative immunoblot and densitometric analysis showing the co-
immunoprecipitation of GST-Rab4 (WT), constitutively active GST-Rab4-Q67L 
(CA) and dominant-negative GST-Rab4-S22N (DN) with FLAG-AT1R from 
HEK 293 cells.  (B) Representative immunoblot and densitometric analysis 
showing the co-immunoprecipitation of GST-Rab7 (WT), constitutively active 
GST-Rab7-Q67L (CA) and dominant-negative GST-Rab7-N125I (DN) with 
FLAG-AT1R from HEK 293 cells.  *p< 0.05 compared to wild-type Rab7 co-
immunoprecipitated with the AT1R. (C) Representative immunoblot and 
densitometric analysis showing the co-immunoprecipitation of GST-Rab11 (WT), 
constitutively active GST-Rab11-Q70L (CA) and dominant-negative GST-Rab7-
S25N (DN) with FLAG-AT1R from HEK 293 cells.  *p< 0.05 compared to wild-
type Rab11 co-immunoprecipitated with the AT1R. Data represents the mean ± 
SD of 3-5 independent experiments. All data were normalized for individual Rab 
protein expression levels in each experiment.  
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A2 receptor wild-type Rab11 interacted with the FLAG-AT1R, but both constitutively 
active Rab11-Q70L and dominant-negative Rab11-S25N mutants did not effectively 
interact with FLAG-AT1R (Figure 2.2C). This observation suggests that GTP hydrolysis 
is required for Rab11 binding to the AT1R.  Taken together, the data indicated that Rab4, 
Rab5, Rab7 and Rab11 each bind to the AT1R but that the association of each of the Rab 
GTPases was mediated by different activation states of the GTPases. 
2.3.2. Identification of the AT1R Rab GTPase binding site  
 Previously, we demonstrated that the deletion of the last 10 amino acid residues of 
the rat AT1AR C-tail (AT1AR-C1) resulted in a loss of AT1AR colocalization with GFP-
Rab5a (Dale et al., 2004).  Therefore, we tested whether the deletion of the distal 10 
amino acid residues of the human AT1R would result in both the loss of Rab5 binding, as 
well as a loss of Rab4, Rab7 and Rab11 binding to a human FLAG-AT1R-C1 construct.  
We found that the deletion of the last 10 amino acid residues resulted in a significant 
decrease in Rab4, Rab5, Rab7 and Rab11 protein that was co-immunoprecipitated with 
the FLAG-AT1R-C1 mutant (Figure 2.3A-D).  Therefore, we examined which amino acid 
residues localized with the distal AT1R C-tail sequence KKPAPCFEVE were required for 
Rab4, Rab5, Rab7 and Rab11 binding to the receptor by performing alanine scanning 
mutagenesis of pairs of amino acid residues (Figure 2.3A).  We found that Rab4, Rab5, 
Rab7 and Rab11 binding to FLAG-AT1R-KK, FLAG-AT1R-PA, FLAG-AT1R-FE and 
FLAG-AT1R-VE mutant receptors was unaffected by alanine substitutions at the 
corresponding residues (Figure 2.3A-D).  In contrast, Rab4, Rab5, and Rab11 were not 
co-immunoprecipitated effectively with the FLAG-AT1R-PC alanine substitution mutant 
(Figure 2.3A, 2.3B and 2.3D).  Although Rab7 binding to the FLAG-AT1R-PC alanine 
 Figure 2.3. Identification of the Rab GTPase binding site within the AT1R 
carboxyl-terminal tail. (A) Representative immunoblot showing the co-
immunoprecipitation of Rab4 with either the wild-type AT1R (WT) or AT1R-C1 
(1-349), AT1R-K350A/K351A (KK), AT1R-P352A/A353G (PA), AT1R-
P354A/C355A (PC), AT1R-F356A/E357A (FE), and AT1R-V358A/E359A (VE) 
mutants from HEK 293 cells.  (B) Representative immunoblot showing the co-
immunoprecipitation of Rab5 with either the wild-type AT1R (WT) or AT1R 
mutants from HEK 293 cells.  (C) Representative immunoblot showing the co-
immunoprecipitation of Rab7 with either the wild-type AT1R (WT) or AT1R 
mutants from HEK 293 cells.  (D) Representative immunoblot showing the co-
immunoprecipitation of Rab11 with either the wild-type AT1R (WT) or AT1R 
mutants from HEK 293 cells.  Data represents the mean ± SD of 3-5 independent 
experiments. Data were normalized for both individual Rab protein expression 
levels and wild-type Rab protein binding to the AT1R in each experiment. *p< 
0.05 compared to wild-type Rab co-immunoprecipitated with the AT1R. 
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substitution mutant was reduced, binding was not statistically significantly different from 
control (Figure 2.3C).  None of the alanine substitutions to the AT1R C-tail affected the 
coupling of the AT1R to the activation of IP3 formation (Figure 2.4).  Taken together, the 
data suggested that proline residue 354 and Cysteine residue 355 played an important role 
in the binding of the Rab4, Rab5, Rab7 and Rab11 GTPases to the AT1R and that each of 
these different Rab GTPases bind to the same site on the receptor.  
2.3.3. Rab GTPases compete with each other for association with AT1R 
 
 Because Rab4, Rab5, and Rab11 interact with an overlapping site in the AT1R C-
tail and the overexpression of constitutively active Rab7 and Rab11 was previously 
shown to alter the intracellular trafficking of the receptor (Dale et al., 2004), we 
examined whether Rab GTPases compete for binding to the AT1R.  We found that the co-
immunoprecipitation of GST-Rab5 with the FLAG-AT1R could be antagonized by the 
overexpression of increasing amounts of HA-Rab11 protein (Figure 2.5A).  Moreover, 
despite the fact that GST-Rab4 was apparently a weak FLAG-AT1R-interacting protein, 
the overexpression of HA-Rab4 effectively prevented GST-Rab11 co-
immunoprecipitation with FLAG-AT1R in an expression-dependent manner (Figure 
2.5B).  Unexpectedly, increasing expression levels of HA-Rab11 did not result in the 
attenuation of GST-Rab4 binding to FLAG-AT1R (Figure 2.5C). 
2.3.4. Rab4 but not Rab11 affects the phosphorylation state and desensitization of 
AT1R signalling 
 
 Because Rab 4, Rab5 and Rab11 GTPases appeared to compete for a common 
binding site on the carboxyl-terminal tail of the AT1R, we examined whether the 
overexpression of wild-type, dominant-negative and constitutively active Rab4, Rab5 and 
  
 
 
 
 
 
 
 
 
 
Figure 2.4. Agonist-stimulated AT1R inositol phosphate formation. Shown is agonist-
stimulated (100 nM AngII, 10 min) inositol phosphate formation mediated by either the 
wild-type FLAG-AT1R (WT) or FLAG-AT1R-C1 (1-349), FLAG-AT1R-K350A/K351A 
(KK), FLAG-AT1R-P352A/A353G (PA), FLAG-AT1R-P354A/C355A (PC), FLAG-
AT1R-F356A/E357A (FE), and FLAG-AT1R-V358A/E359A (VE) mutants from HEK 
293 cells. Data represents the mean ± SD of 3 independent experiments. 
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 Figure 2.5. Competition between Rab GTPases for co-immunoprecipitation 
with FLAG-AT1R. (A) Representative immunoblots and densitometric analysis 
of the co-immunoprecipitation of GST-Rab5 with FLAG-AT1R in the absence or 
presence of increasing amounts of HA-Rab11.  *p< 0.05 compared GST-Rab5 co-
immunoprecipitated with the AT1R in the absence of HA-Rab11. (B) 
Representative immunoblots and densitometric analysis of the co-
immunoprecipitation of GST-Rab11 with FLAG-AT1R in the absence or presence 
of increasing amounts of HA-Rab4.  *p< 0.05 compared to GST-Rab11 co-
immunoprecipitated with the AT1R in the absence of HA-Rab4.  (C) 
Representative immunoblots and densitometric analysis of the co-
immunoprecipitation of GST-Rab4 with FLAG-AT1R in the absence or presence 
of increasing amounts of HA-Rab11.  *p< 0.05 compared to GST-Rab4 co-
immunoprecipitated with the AT1R in the absence of HA-Rab11. Data represents 
the mean ± SD of 3-5 independent experiments. Data were normalized for both 
GST-Rab protein expression levels and GST-Rab protein binding to the AT1R in 
absence of HA-Rab. 
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Rab11 mutants might lead to altered AT1R phosphorylation and dephosphorylation.  
Consistent with previous studies (Opperman et al., 1996; Anborgh et al., 2000), agonist-
stimulation of the AT1R for 10 min effectively promoted the phosphorylation of the 
AT1R (Figure 2.6A-C).  However, when agonist was washed out for 20 and 40 min, no 
dephosphorylation of the AT1R was observed under control conditions (Figure 2.6A-C).  
In contrast, the overexpression of either wild-type Rab4 or constitutively active Rab4-
Q67L significantly reduced the extent of agonist-stimulated AT1R phosphorylation 
(Figure 2.6A).  Consistent with a role of Rab4 in promoting AT1R dephosphorylation, 
overexpression of a dominant-negative Rab4-S22N mutant resulted in a significant 
increase in agonist-stimulated AT1R phosphorylation, which was reduced to 
phosphorylation levels observed in control cells following agonist washout (Figure 2.6A).  
The overexpression of wild-type Rab5 had no effect on either AT1R phosphorylation or 
dephosphorylation (Figure 2.6B).  However, the overexpression of either constitutively 
active Rab5-Q79L or dominant-negative Rab5-S34N appeared to result in a trend 
towards increased dephosphorylation of the receptor the results did not reach statistical 
significance.  The extent of agonist-stimulated AT1R phosphorylation when compared to 
control cells was not altered by the overexpression of either wild-type, dominant-negative 
Rab11-S25N or constitutively active Rab11-Q67L and none of the Rab11 proteins 
resulted in AT1R dephosphorylation following agonist washout (Figure 2.6C).   
Given that wild-type Rab4 and constitutively active Rab4-Q67L lead to decreased AT1R 
phosphorylation, we examined whether the expression of either wild-type or dominant-
negative Rab4, Rab5 and Rab11 would alter the desensitization and resensitization of the 
AT1R.  To assess AT1R desensitization, cells were pretreated with 100 nM AngII for 3
  Figure 2.6. Whole cell phosphorylation of AT1R in the presence and absence 
of wild-type and mutant Rab4 and Rab11. (A) Representative autoradiograph 
and densitometric analysis of AT1R phosphorylation in absence (control) and 
presence of wild-type Rab4 (WT), constitutively active Rab4-Q67L (CA), and 
dominant-negative Rab4-S22N (DN) mutants.  HEK 293 cells expressing FLAG-
AT1R were treated with 100 nM AngII for 10 min, washed and allowed to recover 
for 0 (desensitization), 20 (resensitized) and 40 (resensitized) min. Data represents 
the mean ± SD of 6 independent experiments. *p< 0.05 compared to 
corresponding control. (B) Representative autoradiograph and densitometric 
analysis of AT1R phosphorylation in absence (control) and presence of wild-type 
Rab5 (WT), constitutively active Rab5-Q79L (CA), and dominant-negative Rab4-
S34N (DN) mutants.  Data represents the mean ± SD of 4 independent 
experiments. *p< 0.05 compared to corresponding control. (C) Representative 
autoradiograph and densitometric analysis of AT1R phosphorylation in absence 
(control) and presence of wild-type Rab11 (WT), constitutively active Rab11-
Q70L (CA), and dominant-negative Rab11-S25N (DN) mutants.  Data represents 
the mean ± SD of 4 independent experiments. *p< 0.05 compared to 
corresponding control. 
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min in HBSS lacking LiCl (desensitizing stimulus), washed and then treated with and 
without AngII for 10 min in HBSS containing LiCl.  Receptor resensitization of AT1R-
mediated IP3 responses was measured in the same way except that cells were allowed to 
recover in the absence of agonist for 30 min prior to being subjected to a second round of 
agonist treatment. The pretreatment of control cells (desensitizing stimulus) reduced 
AT1R-stimulated IP3 formation to between 41 ± 4% and 48 ± 2% of control (naïve) 
response when cells were exposed to a subsequent 10 min exposure to AngII (Figure 
2.7A-C).  The overexpression of constitutively active Rab4-Q67L significantly reduced 
the extent of AT1R desensitization and increased the extent of AT1R resensitization 
(Figure 2.7A).  The overexpression of the constitutively active Rab5-Q67L mutant did 
not alter AT1R desensitization, but facilitated the resensitization response (Figure 2.7B).  
None of the other Rab constructs had any effect on AT1R desensitization and 
resensitization. Taken together these results indicate that Rab4 binding, but not Rab11 
binding, to the AT1R carboxyl-terminal tail alters the phosphorylation status of the AT1R 
leading to reduced AT1R desensitization.  
2.4. DISCUSSION 
 
 In the present study we have investigated whether multiple Rab GTPases might 
associate with the carboxyl-terminal tail of the AT1R tail and influence the activity and 
function of the receptor.  We find that Rab4, Rab5, Rab7 and Rab11 each exhibit the 
capacity to bind to the distal 10 amino acids of the AT1R carboxyl-terminal tail and can 
compete with one another for binding.  Previously, we demonstrated that the AT1R 
preferentially associated with the GDP-bound form of Rab5.  We show here that the 
AT1R does not distinguish between GDP- and GTP-bound forms of Rab4, binds 
 Figure 2.7. Desensitization and resensitization of AT1R-mediated inositol 
phosphate formation. (A) HEK 293 cells transfected with FLAG-AT1R with 
empty pEBG vector (NT), wild-type Rab4 (WT), constitutively active Rab4-
Q67L (CA), and dominant-negative Rab4-S22N (DN) mutants. (B) HEK 293 
cells transfected with FLAG-AT1R with empty pEBG vector (NT), wild-type 
Rab5 (WT), constitutively active Rab5-Q79L (CA), and dominant-negative Rab4-
S34N (DN) mutants.  (C) HEK 293 cells transfected with FLAG-AT1R with 
empty pEBG vector (NT), wild-type Rab11 (WT), constitutively active Rab11-
Q70L (CA), and dominant-negative Rab11-S25N (DN) mutants.  Transfected 
cells were treated either with or without 100 nM AngII for 3 min in the absence of 
LiCl (desensitizing stimulus) and then either washed and subjected to a second 
treatment of 100 nM AngII for 10 min in the presence of LiCL (desensitized) or 
washed and allowed to recover for 30 min prior to a second treatment of 100 nM 
AngII for 10 min in the presence of LiCL (resensitized).  Data were normalized 
for protein expression and basal IP3 formation and desensitized and resensitized 
IP3 responses compared to naive control cells that were not subjected to 
desensitizing stimulus.  Data are representative of 5 independent experiments. *p< 
0.05 compared to corresponding control. 
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 preferentially to GTP-bound Rab7 and interacts with wild-type Rab11 and does not 
associate with either constitutively active or dominant negative Rab11 mutants.  We have 
also identified two amino acid residues (proline 354 and Cysteine 355) within the Rab 
binding domain of the AT1R carboxyl-terminal tail that are essential for the association of 
Rab4, Rab5 and Rab11 but not Rab7.  The association of different Rab GTPases with the 
AT1R carboxyl-terminal tail has different functional outcomes, with Rab5 promoting the 
retention of the AT1R in early endosomes (Seachrist et al., 2002), Rab7 facilitating the 
trafficking of the AT1R to lysosomes (Dale et al., 2004) and Rab4 promoting the 
dephosphorylation and resensitization of the receptor.  Taken together, our data indicate 
that the association of different Rab GTPases with the carboxyl-terminal tail domain of 
the AT1R may regulate different functional outcomes for AT1R signalling in tissues that 
may express differing levels of each of the relevant Rab GTPases as the overexpression 
of a constitutively active Rab4-Q67L mutant decreases AT1R desensitization, while 
facilitating resensitization. 
 In the current study, we have demonstrated that the domain required for Rab 
GTPase interactions with AT1R are identical for Rab4, Rab5, and Rab11.  Previously, we 
identified that the Rab5 binding domain resides within the distal 10 amino acids of AT1R 
carboxyl-terminal tail and that deletion of this motif resulted in altered AT1R trafficking 
to lysosomes as opposed to the retention of the receptor in early endosomes (Dale et al., 
2004).  We have further defined the critical residues required for Rab GTPase binding to 
the AT1R and show that proline 354 and Cysteine 355 are essential for binding Rab4, 
Rab5, and Rab11.  Previously, it has been shown that the dephosphorylation and 
resensitization of the β2AR occurs as the receptor transits between the Rab5-positive 
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 early endosome and the Rab4-positive rapid recycling endosome (Seachrist et al., 2000).  
Moreover, it has been reported that phosphorylated μ-opioid receptor is preferentially 
recycled through Rab4-positive endosomes (Wang et al., 2008).  We find here, that the 
overexpression of a constitutively active Rab4-Q67L mutant decreases both AT1R 
phosphorylation and desensitization, while promoting the resensitization of the receptor.  
Thus, these data are consistent with the hypothesis that the Rab4-positive recycling 
endosome functions as the compartment in which GPCR dephosphorylation is mediated 
by phosphatases.   
 Several GPCRs have now been reported to associate with Rab GTPases including 
the β2AR, thromboxane A2 receptor and prostacyclin receptor (Hamelin et al., 2005; 
Parent et al., 2009; Reid et al., 2010).  However, the residues that we have identified to be 
essential for Rab GTPase binding to the AT1R are not conserved in any of these GPCRs.  
Rab11 binding to the thromboxane A2 receptor is mediated by residues 335-345 that are 
localized within the central region of the thromboxane A2 receptor carboxyl-terminal tail 
and Rab11 binds α-helix 8 at the proximal end of the prostacyclin receptor.  In contrast, 
Rab11 binding to the β2AR involves a bipartite binding motif, with arginine 333 and 
lysine 348 representing the essential amino acid residues mediating Rab11 binding to the 
receptor (Parent et al., 2009).  Thus, to date there is no clearly defined consensus motif 
for Rab GTPase association with GPCRs.  However, previous work from our laboratory 
using yeast two hybrid screen suggest that the regional of the AT1AR carboxyl-terminal 
tail that is proximal to the seventh transmembrane spanning domain of the AT1AR may 
also be involved in Rab5 binding (Seachrist et al., 2002).  Thus, the fact that we do not 
observe complete loss of binding of the Rab GTPases to the carboxyl-terminal tail of the 
105 
 
 receptor suggests that secondary residues within the membrane proximal domain of the 
receptor likely also contribute in part to Rab protein binding.   
 Rab GTPases not only influence the intracellular trafficking and recycling of 
GPCRs by directly interacting with these vesicular cargo proteins, but Rab GTPases also 
indirectly influence the trafficking of receptors between intracellular compartments as a 
consequence of their intrinsic activity.  Following their internalization, many GPCRs 
have been shown to either recycle to the cell surface via the Rab4-mediated rapid 
pathway directly from sorting endosomes or via the Rab11-mediated slow pathway from 
perinuclear recycling endosomes.  The recycling of other GPCRs, including the 
corticotrophin releasing factor receptor 1, somatostatin-3 receptor, vasopressin V2 
receptor, neurokinin-1 receptor, chemokine CXC receptor-2, m4 muscarinic 
acetylcholine receptor and protease receptor, are also differentially regulated by Rab4 and 
Rab11 (Innamorati et al., 2001; Kreuzer et al., 2001; Schmidlin et al., 2001; Signoret et 
al., 2001; Fan et al., 2002; Volpicelli et al., 2002; Roosterman et al., 2003; Holmes et al., 
2006).  Thus, potential alterations in individual Rab GTPase protein expression may have 
profound effects on GPCR activity.  This could occur as the consequence of either direct 
competition for GPCR binding or by increasing the relative efficiency of the intracellular 
trafficking and membrane fusion of vesicular compartments within the cell that is 
regulated by the Rab GTPase.  Rab GTPase protein expression and activity has been 
demonstrated to be regulated by a number of different signals.  First, Rab1, Rab4 and 
Rab6 protein expression is altered in dilated cardiomyopathy model of heart failure and 
overexpression of Rab4 in the heart leads to altered β2AR desensitization and 
resensitization (Wu et al., 2001; Odley et al., 2004).  Second, parasitic infection of 
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 cardiomyocytes in vitro with the protozoan Tyranosoma cruzi results in the 
downregulation of both Rab7 and Rab11 protein expression (Batista et al., 2006).  
Finally, insulin is able to stimulate GTP-loading of Rab11 in cardiomyocytes indicating 
the potential of Rab GTPases to serve as substrates for GPCR activated kinases such as 
phosphatidylinositol 3-kinase (Schwenk and Eckel, 2007).  Thus, taken together 
alterations in Rab GTPase expression and activity have the potential to both directly and 
indirectly influence GPCR signalling under both physiological and pathophysiological 
conditions suggesting that these proteins may represent targets for the treatment of 
cardiovascular-related diseases. 
 In HEK 293 cells, the AT1R is internalized to and retained in early endosomes, 
where it remains phosphorylated and does not recycle to the plasma membrane (Anborgh 
et al., 2000; Seachrist et al., 2002; Dale et al., 2004).  We find that the overexpression of 
different Rab GTPases can specifically alter the intracellular trafficking fate of the AT1R 
with Rab7 overexpression favouring the trafficking of the receptor to lysosomes and 
Rab4 overexpression favouring the dephosphorylation of the receptor.  In contrast, 
although Rab11 effectively interacts with the AT1R, the interaction of the wild-type 
Rab11 does not influence the dephosphorylation of the receptor, although it can promote 
plasma membrane recycling (Dale et al., 2004).  Interestingly, Rab4 is able to effectively 
displace Rab11 binding to the AT1R, despite the observation that Rab11 is more 
effectively co-immunoprecipitated with the receptor.  Therefore, even small differences 
in Rab4 expression may lead to profound changes in AT1R activity.  However, Rab 
binding to the AT1R, if competitive, should be reciprocal and Rab11 protein expressed at 
sufficiently high levels should be able to compete for binding.  It is possible that in our 
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 experiments we have not achieved Rab11 expression that can displace Rab4 from the 
receptor at complimentary expression levels.  Moreover, the overexpression of one Rab 
protein may shift the receptor from one cellular compartment to another that is not 
available to the competing Rab protein.  It is also possible that Rab GTPases selectively 
bind to different receptor sites depending upon their activation state, since wild-type 
Rab7 does not bind to the receptor as effectively as Rab7-Q70L and wild-type Rab7 
binding is not significantly impaired when the AT1R C-tail is truncated.  This may 
explain why we previously observed that truncation of the AT1R C-tail resulted in the 
targeting of the receptor to endosomes (Dale et al., 2004).  Nevertheless, depending on 
the complement of Rab GTPases expressed in different tissue and cell types, it is likely 
that the AT1R will exhibit differences in its functional regulation ranging from prolonged 
desensitization associated with impaired dephosphorylation and resensitization to rapid 
resensitization associated with receptor dephosphorylation.  
To date, few GPCRs, including the AT1R, β2AR, thromboxane A2 receptor and 
prostacyclin receptor have been shown to directly associate with members of the Rab 
family.  Emerging evidence suggests that these interactions are critical to proper 
trafficking and regulation of these receptors.  Understanding the role of Rabs in the 
regulation of GPCR redistribution into different intracellular compartments will serve to 
improve our understanding of the molecular and physiological consequences of GPCR 
signalling.  It is now evident that multiple small GTP-binding proteins, including Rabs 
interact with GPCRs and future studies should reveal whether GPCRs either interact with 
or regulate additional components of the intracellular trafficking machinery. 
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CHAPTER 3 
 
RAB8 MODULATES METABOTROPIC GLUTAMATE RECEPTOR 
SUBTYPE 1 INTRACELLULAR TRAFFICKING AND SIGNALLING 
IN A PKC-DEPENDENT MANNER1 
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 3.1. INTRODUCTION 
 Glutamate is the primary excitatory neurotransmitter in the brain and its actions 
are mediated though two types of receptors: ionotropic glutamate receptors that are 
ligand-gated cation channels and metabotropic glutamate receptors (mGluR) that are G 
protein-coupled receptors (GPCRs) (Olney, 1994; Dingledine et al., 1999; Pin et al., 
2003).  mGluRs play an important role in processes underlying learning and memory, 
neuronal development, and neurodegeneration (Nakanishi, 1994; Pin et al., 1994; Pin and 
Duvoisin, 1995; Conn and Pin, 1997; Dale et al., 2002). mGluRs are categorized into 
three subclasses based on sequence homology and G protein coupling specificity. Group 
1 mGluRs include mGluR1 and mGluR5, which are coupled through Gαq to the 
activation of phospholipase C, which in turn catalyzes the formation of inositol 1,4,5 
trisphosphate and diacylglycerol, which mediate the release of intracellular calcium 
stores and the activation of protein kinase C (PKC) (Conn and Pin, 1997; Dhami and 
Ferguson, 2006; Niswender and Conn, 2010).  
 The GPCR desensitization paradigm involves receptor phosphorylation by either 
second messenger-dependent protein kinases or G protein-coupled receptor kinases 
(GRKs) followed by β-arrestin binding, which functions to uncouple the receptor from 
the G protein and targets GPCRs for clathrin-mediated endocytosis (Krupnick and 
Benovic, 1998; Ferguson, 2001). However, Group I mGluR desensitization and 
endocytosis is mediated by GRK2 in a phosphorylation-independent manner and does not 
require β-arrestin (Ferguson, 2001; Dhami et al., 2002; Dhami et al., 2004; Dhami et al., 
2005; Dhami and Ferguson, 2006; Ferguson, 2007; Ribeiro et al., 2011). PKC also 
contributes to the regulation of glutamate-induced mGluR1a internalization whereas 
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 constitutive mGluR1a internalization is mediated by RalA and phospholipase D2 
(Mundell et al., 2003; Bhattacharya et al., 2004; Mundell et al., 2004).  
 Optineurin, a protein we have previously shown to contribute to the attenuation of 
mGluR1a signalling, has also been shown to be a Rab8 effector protein (Hattula and 
Peränen, 2000; Anborgh et al., 2005).  Rab8 is a member of the Rab GTPase family of 
small G proteins that are involved in regulating the trafficking, docking and fusion of 
vesicles between intracellular membrane compartments (Zerial and McBride 2001; 
Seachrist and Ferguson, 2003; Gaborik and Hunyady, 2004). Rab8 is localized to the 
Golgi apparatus, intracellular membrane vesicles and membrane ruffles and is involved in 
trafficking of basolateral proteins in polarized epithelial cells, neurite outgrowth, delivery 
and recycling of the ionotropic glutamate AMPA receptors at synapses and has recently 
been shown to directly associate with the α2B- and β2-adrenergic receptors (ARs) 
(Deretic, 1997; Gerges et al., 2004; Gerges et al., 2005; Brown et al., 2007; Ng and Tang, 
2008; Dong et al., 2010).  Since Rab8 has been shown to interact with optineurin, in the 
present study we have investigated whether Rab8 contributes to the regulation of 
mGluR1a desensitization and endocytosis.  We report that Rab8 interacts with mGluR1a 
in an agonist-regulated manner to antagonize mGluR1a endocytosis and coordinates the 
attenuation of mGluR1a-stimulated IP3 formation and release of Ca2+ from intracellular 
stores in PKC-regulated manner.     
3.2. EXPERIMENTAL PROCEDURES 
3.2.1. Materials  
 myo-[3H]-Inositol was acquired from PerkinElmer Life Sciences (Waltham, MA).  
Dowex 1-X8 (formate form) resin 200 - 400 mesh was purchased from BioRad 
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 (Mississauga, ON, Canada).  Goat anti-glutathione-S-transferase (GST) antibodies as 
well as ECL Western blotting detection reagents were purchased from GE Healthcare 
(Oakville, ON, Canada). Horseradish peroxidase-conjugated anti-rabbit and anti-goat IgG 
secondary antibody was obtained from BioRad (Mississauga, ON, Canada). Anti-Gαq/11 
rabbit polyclonal antibody was purchased from Santa Cruz Biotechnology Inc. (Santa 
Cruz, CA, USA). Anti-mGluR1a rabbit polyclonal antibody was obtained from Upstate 
(Lake Placid, NY, USA).  Rabbit polyclonal phospho-p44/44 MAP kinase 
(Thr202/Tyr402), p44/44 MAP kinase antibodies were obtained from Cell Signalling 
Technology (Pickering, ON, Canada).  Alexa Fluor 488 donkey anti-mouse IgG, Alexa 
Fluor 568 donkey anti-rabbit IgG, Zenon Rabbit Alexa Fluor 555 and Fluo-4 AM ester 
calcium indicators were purchased from Invitrogen/Molecular Probes (Burlington, ON, 
Canada).  Rabbit anti-FLAG antibody, M2 anti-FLAG agarose and all other biochemical 
reagents were purchased from Sigma-Aldrich (Oakville, ON, Canada). 
3.2.2. Cell Culture 
 Human embryonic kidney (HEK) 293 cells were maintained in Eagle's minimal 
essential medium supplemented with 8% (v/v) heat inactivated fetal bovine serum 
(Invitrogen, Burlington, ON) and 50 µg/ml gentamicin.  Cells seeded in 100 mm dishes 
were transfected using a modified calcium phosphate method as described previously 
(Ferguson and Caron, 2004).  Following transfection (18 h), the cells were incubated with 
fresh medium and allowed to recover for 24 hrs for co-immunoprecipitation studies.  
Otherwise, they were allowed to recover for 6-8 hrs and re-seeded into 24-well dishes 
and then grown an additional 18 hrs prior to experimentation. 
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 3.2.3. Primary Hippocampal Neuronal Culture 
 Hippocampi from embryonic day 18 CD-1 mice were processed, as described 
previously (Xie et al., 2000) and maintained in Neurobasal medium supplemented with 
B27, glutamax and pen/strep. Neurons were transfected at DIV 7-10 using a modified 
calcium phosphate technique and imaged 24 hr later.  
3.2.4. Co-Immunoprecipitation 
 HEK 293 cells were transiently transfected with the cDNAs as described in the 
Figure Legends.  Following transfection, the cells were incubated for 15 minutes in 
HEPES balanced salt solution (HBSS) at 37°C with or without 30 μM quisqualate.  The 
cells were then placed on ice, washed two times with ice-cold phosphate-buffered saline 
(PBS) and lysed with cold-lysis buffer (50 mM Tris, pH 8.0, 150 mM NaCl, 0.1% Triton 
X-100) containing protease inhibitors (1 mM AEBSF, 10 μg/ml leupeptin, and 5 μg/ml 
aprotinin).  The lysates were placed on a rocking platform for 15 min at 4°C and 
centrifuged at 15000 x g for 15 min at 4°C to pellet insoluble material.  Cleared 
supernatant containing 250 µg protein was incubated with 25 µL of FLAG M2-affinity 
beads for 1h rotating at 4°C to immunoprecipitate FLAG-mGluR1a. Following 
incubation, the beads were washed twice with PBS, and proteins were solubilized in a 3X 
SDS sample buffer containing 2-mercaptoethanol (BME).  Samples were separated by 
SDS-PAGE, transferred to a nitrocellulose membrane and immunoblotted to identify co-
immunoprecipitated GST-tagged Rab8 protein using a primary goat anti-GST antibody 
(1:1000 dilution) followed by a horseradish peroxidase-conjugated secondary anti-goat 
(1:2500 dilution). Receptor and Rab8 protein expression was determined by 
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 immunoblotting 10 μg of protein from each cell lysate used for immunoprecipitation.  
Proteins were detected by chemiluminescence.  
3.2.5. Biotinylation Assay 
 HEK 293 cells were transiently transfected with the cDNAs as described in the 
Figure Legends.  For cell surface biotinylation 48 hours post transfection cells were 
incubated in 37ºC HBSS for 1 hour and then treated vehicle or 30 μM quisqualate. Cells 
were then placed on ice, washed in ice-cold HBSS and cell surface proteins labelled with 
1.5 mg/ml biotin for 1 hour and biotin was subsequently quenched with 100 mM glycine 
for 30 min. For internalization experiments, cells were labelled with biotin on ice, 
quenched and then cells were treated with vehicle or 30 μM quisqualate for the times 
indicated in the Figure Legends to induce mGluR1a internalization.  Cell surface biotin 
was stripped from the cells using 150 mM MesNa. The cells were then placed on ice, 
washed two times with ice-cold phosphate-buffered saline (PBS) and lysed with cold-
lysis buffer (50 mM Tris, pH 8.0, 150 mM NaCl, 0.1% Triton X-100) containing protease 
inhibitors (1 mM AEBSF, 10 μg/ml leupeptin, and 5 μg/ml aprotinin).  The lysates were 
placed on a rocking platform for 15 min at 4°C and centrifuged at 15000 x g for 15 min at 
4°C to pellet insoluble material.  Cleared supernatant containing 250 µg protein was 
incubated with 35 µL of neutravidin-affinity beads for 1h rotating at 4°C to 
immunoprecipitate biotin-labeled proteins. Following incubation, the beads were washed 
twice with PBS, and proteins were solubilized in a 3X SDS sample buffer containing 
BME.  Samples were separated by SDS-PAGE, transferred to a nitrocellulose membrane 
and immunoblotted to identify biotinylated mGluR1a proteins using a primary rabbit anti 
mGluR1a antibody (1:1000 dilution) followed by a horseradish peroxidase-conjugated 
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 secondary anti-rabbit (1:10000 dilution). Receptor and Rab8 protein expression was 
determined by immunoblotting 10 μg of protein from each cell lysate used for 
biotinylation.  Proteins were detected by chemiluminescence. 
3.2.6. Inositol Phosphate Formation 
 HEK 293 cells were transiently transfected with the cDNAs as described in the 
Figure Legends.  48 hours post-transfection cells were incubated overnight in inositol- 
and glutamate-free DMEM with 100 µCi/mL myo-[3H]-inositol.  For PKC inhibition 
experiments, cells were washed twice and incubated for one hour in 37ºC HBSS then 
preincubated for 10 min at 37°C with either DMSO (control) alone or with 1 μM 
bisindolymaleimide I or 5 μM chelerythrine chloride. For all other experiments cells were 
incubated for one hour in 37ºC HBSS and were then incubated with 10 mM LiCl alone 
for 10 min followed by 30 μM quisqualate treatment for 30 min.  Cells were placed on 
ice and the reaction was stopped with 500 µL of perchloric acid and neutralized with 400 
µl of 0.72 M KOH, 0.6 M KHCO3.  Total cellular [3H]-inositol incorporation was 
determined in 50 µl of cell lysate.  Total inositol phosphate was purified by anion 
exchange chromatography using Dowex 1-X8 (formate form) 200 - 400 mesh anion 
exchange resin and [3H]-inositol phosphate formation was determined by liquid 
scintillation using a Beckman LS 6500 scintillation system. 
3.2.7. ERK Activation 
 HEK 293 cells were transiently transfected with FLAG-mGluR1 and pEGFP 
(control) or GFP-Rab8. 48 hours post-transfection cells were serum starved overnight in 
glutamate-free DMEM and stimulated for 0, 1, 5 or 15 min with 30 μM quisqualate. Cells 
were lysed and proteins were solubilized in a 3X SDS sample buffer containing BME.  
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 Samples were separated by SDS-PAGE, transferred to a nitrocellulose membrane and 
immunoblotted to identify phosphorylated and total extracellular regulated kinase 
(ERK1/2) antibody (1:1000 dilution) followed by a horseradish peroxidase-conjugated 
secondary anti-Rabbit antibody (1:10,000 dilution). Receptor and Rab8 protein 
expression was determined by immunoblotting 10 μg of protein from each cell lysate.  
Proteins were detected by chemiluminescence. 
3.2.8. Confocal Microscopy 
 Confocal microscopy was performed using a Zeiss LSM510 META laser 
scanning confocal microscope equipped with a Zeiss 63X, 1.4 numerical aperture, oil 
immersion lens (North York, ON, Canada).  HEK293 cells expressing GFP-Rab8 and 
FLAG-mGluR1a were serum starved for 1 hr  at 37°C in HBSS (116 mM NaCl, 20 mM 
HEPES, 11 mM glucose, 5 mM NaHCO3, 4.7 mM KCl, 2.5 mM CaCl2, 1.2 mM MgSO4, 
1.2 mM KH2PO4, pH 7.4). HEK293 cells were prelabelled with Alexa Fluor 568-
conjugated anti-FLAG polyclonal rabbit antibody. Cells were then treated with 30 μM 
quisqualate and live cells imaged over a 30 min time period at 37°C.  Primary mouse 
hippocampal neurons were transiently transfected with FLAG-mGluR1a, fixed with 
periodate lysine paraformaldehyde and permeabilized with 0.1% Triton X-100. Receptor 
was labelled with rabbit polyclonal anti-FLAG and endogenous Rab8 labelled with 
mouse monoclonal anti-Rab8a antibody. Colocalization studies were performed using 
dual excitation (488, 543 nm) and emission (band pass 505-530 nm and long pass 560 nm 
for Alexa Fluor 488 and 568, respectively) filter sets. 
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 3.2.9. Calcium Imaging 
 DIV 7-10 hippocampal neurons were transiently transfected with either empty 
pEGFP (control) or GFP-Rab8 and imaged 24 hr later. Transfected cells were identified 
via confocal microscopy at 488nm excitation and band pass 505-530 emission after 
which cells were loaded with 10 μM fluo-4 for 30 min at room temperature and imaged 
using the same parameters. Cells were stimulated with 100 μM DHPG and 1 μM 
ionomycin. 
3.2.10. Statistical Analysis 
 Densitometric data were normalized first for protein expression and the control 
value was set to 100, with all other values displayed as percentage thereof. One-way 
analysis of variance test (ANOVA) was performed to determine significance, followed by 
a post-hoc Tukey multiple comparison test or Bonferroni’s multiple comparisons test to 
determine which means were significantly different (p < 0.05) from one another. 
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3.3. RESULTS 
3.3.1. Agonist-stimulated Rab8 interaction with the mGluR1a C-tail 
Previously, we demonstrated that the Rab8 effector optineurin was an mGluR1a 
interacting protein by yeast two hybrid and that it played a role in antagonizing mGluR1a 
G protein signalling (Anborgh et al., 2005). Therefore, in the present study, we 
investigated whether Rab8 might also interact with mGluR1a. To do this, HEK 293 cells 
were transiently transfected with FLAG-tagged mGluR1a or FLAG-mGluR1b and GST-
tagged Rab8 and the co-immunoprecipitation of GST-Rab8 with either FLAG-mGluR1a 
or FLAG-mGluR1b was assessed.  We found that GST-Rab8 was co-immunoprecipitated 
with FLAG-mGluR1a in the absence of agonist, but that this association was increased 
two fold (92 ± 23%) in response to 30 μM quisqualate treatment (Figure 3.1A and 3.1B).  
In contrast, GST-Rab8 co-immunoprecipitation with Flag-mGluR1b (which lacks an 
extended intracellular C-tail) was reduced to 72 ± 7% of control FLAG-mGluR1a 
immunoprecipitation (Figure 3.1A and 3.1B).  Agonist treatment did not increase GST-
Rab8 co-immunoprecipitation with FLAG-mGluR1b (Figure 3.1A and 3.1B).  Therefore, 
agonist-dependent increases in Rab8 association with mGluR1a required interactions 
with the extended mGluR1a C-tail. 
To determine whether endogenous Rab8 colocalizes with FLAG-mGluR1a, 
primary hippocampal neurons (DIV 14) were fixed and labelled for FLAG-mGluR1a and 
endogenous Rab8 protein distribution and imaged using confocal microscopy. 
Interestingly, while FLAG-mGluR1a and Rab8 share partial overlapping populations in 
the neuronal cell body (Figure 3.2A), they show little colocalization in neuronal 
projections in the absence of agonist (Figure 3.2B). However, following the treatment of 
  
 
 
 
 
 
 
 
 
Figure 3.1. Agonist-dependent co-immunoprecipitation of Rab8 with mGluR1a. (A) 
Representative immunoblot and (B) densitometric analysis showing the co-
immunoprecipitation of GST-Rab8 with the FLAG-mGluR1a and FLAG-mGluR1b in the 
absence (-) and presence (+) of 30 μM quisqualate (Quis) treatment for 15 min.  HEK 
293 cells were transiently transfected with 1 μg of plasmid cDNA encoding either FLAG-
mGluR1a or FLAG-mGluR1b along with 2 μg of plasmid cDNA encoding GST-Rab8. 
48 h post-transfection cells were stimulated and lysates were collected and FLAG-
mGluR1 was immunoprecipitated. Proteins were separated by SDS-PAGE, transferred to 
nitrocellulose and immunoblotted for FLAG-mGluR1 and GST-Rab8. Data represents the 
mean ± SD of 3 independent experiments.  Data were normalized for both GST-Rab 
protein expression levels and FLAG-mGluR immunoprecipitation and normalized to 
GST-Rab protein binding to the mGluR1a in absence of agonist. *p< 0.05 compared to 
GST-Rab8 co-immunoprecipitated with the mGluR1a in the absence of agonist.  
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Figure 3.2. Colocalization of mGluR1 and Rab8 in primary hippocampal neurons. 
(A) Representative micrographs showing localization of endogenous mGluR1 and Rab8 
protein in neuronal cell body. (B) Representative micrographs showing localization of 
mGluR1 and Rab8 in neuronal projections. DIV 14 neurons were treated with and 
without 100 μM DHPG for 30 min, fixed and labelled for endogenous mGluR1a (red) 
and Rab8 (green).  Arrows highlight colocalization. Bars represent 5 μm. Images 
represent 3 independent experiments.  
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hippocampal neurons with 100 μM (S)-3,5-dihydroxylphenylglycine (DHPG), both 
FLAG-mGluR1a and Rab8 immunofluorescence exhibited colocalization in the spines of 
these projections (Figure 3.2B).  Thus, agonist treatment appeared to increase FLAG-
mGluR1a and endogenous Rab8 association in primary cells. 
3.3.2. Rab8 antagonizes mGluR1a endocytosis to increase cell surface expression 
 Rab8 has been shown to differentially regulate the trafficking of the α2BAR and 
β2AR and contributes to the regulation of the synaptic delivery and recycling of the 
ionotropic glutamate AMPA receptor (Deretic, 1997; Gerges et al., 2004; Brown et al., 
2007; Ng and Tang, 2008; Dong et al., 2010). Therefore, we investigated whether Rab8 
overexpression would affect FLAG-mGluR1a intracellular trafficking in HEK 293 cells. 
Initial experiments using confocal microscopy determined whether Rab8 overexpression 
resulted in an alteration of cell-surface FLAG-mGluR1a in live HEK 293 cells labelled 
with Zenon 555 Alexa Fluor-labelled primary mouse FLAG monoclonal antibody. 
Control cells expressing FLAG-mGluR1a alone showed steady receptor internalization 
upon treatment with 30 μM quisqualate (Figure 3.3, upper panels).  However, in cells 
overexpressing GFP-Rab8 FLAG-mGluR1a internalization was not observed (Figure 3.3, 
lower panels). To quantify the extent of FLAG-mGluR1a internalization in the absence 
and presence of Rab8, we tested FLAG-mGluR1a endocytosis using a cell surface 
biotyinylation assay following 5 and 15 min exposures to 30 μM quisqualate.  We found 
that following the 15 min exposure of FLAG-mGluR1a to agonist that FLAG-mGluR1a 
internalization was significantly reduced in HEK 293 cells overexpressing Rab8, when 
compared to control cells (Figure 3.4A).  When we assessed the overall cell surface 
expression of FLAG-mGluR1a, we found that the fraction of 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
igure 3.3. Live cell imaging of mGluR1a endocytosis in the absence and presence of 
ab8. Representative confocal micrograph showing internalization of FLAG-mGluR1a 
 the presence and absence GFP-Rab8. Live HEK 293 cells transfected 1 μg of plasmid 
er panels) or without (upper panels) 2 
g of plasmid cDNA encoding GFP-Rab8 were labelled with Zenon AlexaFluor 555 on 
ed to 37°C and stimulated with 30 μM Quis for 15 min. Bars represent 5 μm. 
3 independent experiments.  
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 Figure 3.4. Effect of Rab8 on mGluR1a endocytosis and cell surface 
xpression. (A) Representative immunoblot and densitometric analysis of 
ternalized biotinylation of FLAG-mGluR1a.  HEK 293 cells transiently 
xpressing 1 μg FLAG-mGluR1a and 2 μg either pEBG (control) or GST-Rab8 
laced on ice and cell surface proteins were biotinylated. Cells were then 
imulated with 30 μM Quis for 0, 5 or 15 min to induce internalization and cell 
rface biotin stripped away. Biotin-labelled proteins were collected with 
 0, 5 or 15 min, placed on ice 
and cell surface proteins were biotinylated. Biotin-labelled proteins were collected 
with neutravidin-conjugated beads, separated by SDS-PAGE, transferred to 
nitrocellulose and immunoblotted for mGluR1a. Data represent changes in cell 
surface mGluR1 expression. Data were normalized for protein expression and are 
representative of 6 independent experiments. *p < 0.05 compared to 
corresponding control. 
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neutravidin-conjugated beads, separated by SDS-PAGE, transferred to 
nitrocellulose and immunoblotted for mGluR1a. Data were normalized for protein 
expression.  Data are representative of 6 independent experiments. *p< 0.05 
compared to corresponding control. (B) Representative immunoblot and 
densitometric analysis of cell surface biotinylation of FLAG-mGluR1a. HEK 293 
cells transiently expressing 1 μg FLAG-mGluR1a and 2 μg either pEBG (control) 
or GST-Rab8 were stimulated with 30 μM Quis for
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 FLAG-mGluR1a at the cell surface following 15 min agonist treatment was significantly 
greater than in control cells (Figure 3.4B).  Therefore, Rab8 appeared to prevent 
mGluR1a endocytosis and increase cell surface mGluR1a expression. 
3.3.3. Rab8 antagonizes mGluR1a inositol phosphate and calcium signalling 
 The Rab8 effector molecule, optineurin is known to contribute to 
phosphorylation-independent G protein-uncoupling and desensitization of mGluR1a 
(Anborgh et al., 2005).  Therefore, we assessed whether Rab8 overexpression would 
result in altered FLAG-mGluR1a- and FLAG-mGluR1b-stimulated inositol phosphate 
(IP) formation in HEK 293 cells.  We found that the over-expression of Rab8 resulted in 
a significant reduction in the maximal response for quisqualate-stimulated IP formation 
in FLAG-mGluR1a expressing cells reducing the maximum response to 70 ± 7% when 
compared to control FLAG-mGluR1a expressing cells (Figure 3.5A).   However, Rab8 
overexpression had no effect on the maximal response for quisqualate-stimulated IP 
formation in FLAG-mGluR1b expressing cells (Figure 3.5B).  Thus, consistent with what 
ulated association of Rab8 with mGluR1a versus 
mGluR1b, Rab8 overexpression selectively attenuated mGluR1a and not mGluR1b G 
protein signalling. 
 To determine whether Rab8 GDP for GTP exchange was required for the 
attenuation of FLAG-mGluR1a-stimulated IP formation, we assessed whether FLAG-
mGluR1a-stimulated IP formation would be inhibited in the presence of either dominant-
negative (Rab8-S22N) or constitutively active (Rab8-Q70L) proteins. We found that the 
overexpression of wild-type Rab8, Rab8-S22N and Rab8-Q70L resulted in a reduction of 
FLAG-mGluR1a stimulated IP formation to a similar extent (Figure 3.6A). To determine 
was observed for agonist-stim
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Figure 3.5. Effect 
 
 
 
of Rab8 on mGluR1a- and mGluR1b-mediated inositol phosphate 
) fo
and stimulated with 30 μM Quis for 30 min in the presence of LiCl. Data were 
corresponding control. 
(IP rmation. Inositol phosphate formation in HEK 293 cells transfected with 1 μg 
plasmid cDNA encoding (A) FLAG-mGluR1a or (B) FLAG-mGluR1b with 2 μg empty 
pEGFP vector or GFP-Rab8. Transfected cells were treated for 10 min with 10 mM LiCl 
normalized for protein expression and basal IP formation.  Lower panels show relative 
mGluR1a and mGluR1b protein expression in GFP and GFP-Rab8 transfected cells.  
Data are representative of 3-5 independent experiments. *p< 0.05 compared to 
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igure 3.6. Effect of Rab8 nucleotide binding mutants on mGluR1a-mediated 
ositol phosphate formation. (A) Inositol phosphate (IP) formation in HEK 293 cells 
ansfected with 1 μg of plasmid cDNA encoding FLAG-mGluR1a with 2 μg of plasmid 
DNA encoding GFP-tagged Rab8 wild type (WT), constitutively active Rab8-Q67L 
A), and dominant-negative Rab8-S34N (DN) mutants.  Transfected cells were treated 
r 10 min with 10 mM LiCl and stimulated with 30 μM quisqualate (Quis) for 30 min in 
e presence of LiCl. Data were normalized for protein expression and basal IP 
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formation. (B) Representative immunoblot showing the co-immunoprecipitation of GFP-
tagged Rab8WT, Rab8CA and Rab8DN with the FLAG-mGluR1a in the absence  (-) and 
presence (+) of 30 μM Quis treatment for 15 min. HEK 293 cells were transiently 
transfected with 1 μg of plasmid cDNA encoding FLAG-mGluR1a along with 2 μg of 
plasmid cDNA encoding GFP-tagged Rab8WT, Rab8CA or Rab8DN. 48 h post-
transfection cells were stimulated and lysates were collected, separated by SDS-PAGE, 
transferred to nitrocellulose and immunoblotted for mGluR1a and GFP-Rab8. Data 
represents 3-5 independent experiments. 
 whether Rab8 associated with the receptor in a nucleotide-specific manner, we also 
examined the agonist-stimulated co-immunoprecipitation of wild-type Rab8, Rab8-S22N 
and Rab8-Q70L with FLAG-mGluR1a. Although FLAG-mGluR1a interactions with both 
wild type Rab8 and constitutively active Rab8-Q70L were increased upon agonist 
stimulation, agonist did not regulate the association of dominant-negative Rab8-S22N 
with the receptor (Figure 3.6B).  Thus, although Rab8 associated with mGluR1a in a 
GTP-dependent manner, the Rab8-dependent attenuation of mGluR1a G protein 
as independent of the nucleotide-binding state of the GTPase.   
Because we found that Rab8 significantly attenuated FLAG-mGluR1a-mediated 
mation in HEK 293 cells, we investigated whether Rab8 overexpression might also 
ttenuate DHPG-stimulated Ca2+ release mediated by endogenous mGluR1 expressed in 
rimary hippocampal neurons. To assess this, primary mouse hippocampal neurons 
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gulation (Figure 3.7). In order to investigate 
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(DIV7-10) were transiently transfected with either pEGFP (control) or GFP-Rab8.  
Neurons were imaged to identify cells that were transfected with GFP protein, and GFP 
protein positive cells were then subsequently loaded with the calcium indicator fluo-4 
AM and the same cell imaged for DHPG-mediated for calcium release as evidence by an 
increase in cellular fluorescence. The treatment of hippocampal neurons with 100 μM 
DHPG resulted in an increase in Fluo-4 fluorescence in both untransfected and pEGFP 
transfected neurons as expected (Figure 3.7).  However, in GFP-Rab8 positive neurons 
DHPG-stimulated increases in intracellular Ca  concentration, as measured by increased 
Fluo-4 fluorescence, was attenuated (Figure 3.7). All of the cells exhibited similar 
responses to challenge with ionomycin indicating that GFP-Rab8 overexpression was not 
causing a generalized defect in Ca2+ re
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neurons. Fluorescent intensity analysis of Ca2+ release as represented by the fluorescent 
calcium indicator Fluo-4. DIV7-10 primary mouse hippocampal neurons were transiently 
transfected with 10 μg of plasmid cDNA encoding either pEGFP (control) or GFP-Rab8. 
after which they were loaded with 5 μM of the calcium indicator Fluo-4 AM for 30 min 
at room temperature and the same field of view was imaged for calcium release with the 
addition of 100 μM DHPG followed by 10 μM ionomycin (iono). Data representative of 
 
 
Figure 3.7. Effect of Rab8 on DHPG-stimulated Ca2+-release in hippocampal 
Twenty four hours after transfection neurons were imaged to identify transfected cells, 
3 independent experiments.  
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 whether Rab8 overexpression also affected other aspects of mGluR1a signalling, we 
examined FLAG-mGluR1a-stimulated ERK1/2 phosphorylation in HEK 293 cells 
(Figure 3.8).  We found that agonist-stimulated FLAG-mGluR1a-mediated ERK1/2 
phosphorylation was not affected by the overexpression of Rab8, but that basal ERK1/2 
phosphorylation was decreased in cells expressing both FLAG-mGluR1a and Rab8 
(Figure 3.8).  Therefore, Rab8 appeared to selectively regulate FLAG-mGluR1a-
stimulated IP formation in HEK 293 and Ca2+ release in response to the activation of 
endogenous mGluR1 in primary mouse hippocampal neurons. 
3.3.4. Rab8 decrease of mGluR1a mediated IP3 signalling is PKC-dependent 
Second messenger dependent kinases, such as PKC, can contribute to the 
esensitization of agonist activated group 1 mGluRs (Schoepp and Johnson, 1988; 
errero et al., 1994; Desai et al., 1999; Francesconi and Duvoisin, 2000; Ferguson, 
001). Because we found that Rab8 expression causes a significant decrease in FLAG-
GluR1a-mediated IP formation, we sought to determine whether PKC-mediated 
esensitization of mGluR1a signalling might be influenced by Rab8 expression.  To test 
is, HEK 293 cells were pretreated with one of two PKC inhibitors, 
isindolylmaleimide-1 (Bis-1) or chelerythrine chloride. We found that the pretreatment 
 
d
H
2
m
d
th
b
of HEK 293 cells with either 1 μM Bis-1 or 5 μM chelerythrine chloride for 10 minutes 
prevented the Rab8-mediated uncoupling of mGluR1a-stimulated IP formation to DMSO 
control levels (Figure 3.9).  This observation suggested a role for PKC-mediated 
phosphorylation in the observed Rab8-dependent attenuation of FLAG-mGluR1a IP 
signalling.
133 
 
  
is a representative immunoblot and densitometric analysis of p42/44 (ERK1/2) 
phosphorylation. HEK 293 cells were transiently transfected with 1 μg of plasmid cDNA 
encoding FLAG-mGluR1a along with 2 μg of plasmid cDNA encoding either pEGFP 
(control) or GFP-Rab8. Cells were stimulated for 0, 1, 5 or 15 min with 30 μM Quis, 
phosphoryl
Figure 3.8. Effect of Rab8 on mGluR1a-stimulated ERK1/2 phosphorylation. Shown 
lysates were collected, separated by SDS-PAGE and transferred to nitrocellulose and 
ated ERK1/2 was detected by immunoblot. Data were normalized for total 
ERK expression. Data represents the mean ± SD of 3-5 independent experiments.  
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Figure 3.9. PKC inhibition prevents Rab8-dependent attenuation of mGluR1a-
mediated IP formation.  HEK 293 cells were transfected with 1 μg of plasmid cDNA 
encoding FLAG-mGluR1a along with 2 μg empty pEGFP vector (Control) or GFP-Rab8. 
Cells were pre-incubated for 10 min with either DMSO alone or with either 1 μM 
bisindolymaleimide I or 5 μM chelerythrine chloride followed by 10 mM LiCl for 10 min 
and then 10 μM quisqualate for 30 min. Data were normalized for protein expression and 
basal IP formation.  Data are representative of 5 independent experiments. *p< 0.05 
compared to control. 
 3.4. ISCUSSION 
To date only a few Rab isoforms including Rab3, Rab8 and Rab23 have been 
own to be enriched in the brain and play a role in neurons (Evans et al., 2003; Geppert 
t al., 1997; Ng and Tang, 2008). Rab8 is essential in several areas of polarized neuronal 
ansport as well as in plasma membrane trafficking in epithelial cells and Rab8 siRNA 
nockdown prevents maturation of hippocampal neurons in culture (Huber et al., 1995; 
an Ijzendoorn et al., 2003; Ng and Tang, 2008). Studies now link Rab8 to a variety of 
ifferent human diseases, including polycystic kidney disease, microvillus inclusion 
isease and Bardet-Biedl syndrome, emphasizing the physiological importance of protein 
afficking in human disease (Nachury et al., 2007; Ng and Tang, 2008). Here we show 
at Rab8 associates with mGluR1a, but not its alternatively spliced variant, mGluR1b, 
hich lacks an extended carboxyl-terminal tail suggesting that Rab8 binds to the 
arboxyl-terminal tail of mGluR1a in an agonist-regulated manner.  Other Rabs, 
cluding Rab4, Rab5, Rab7 and Rab11 have previously been reported to associate with 
e carboxyl-terminal tail of the angiotensin II type 1 receptor and other GPCRs 
nborgh et al., 2000; Seachrist et al., 2002; Dale et al., 2004; Hamelin et al., 2005; 
arent et al., 2009; Reid et al., 2010; Esseltine et al., 2011). Additionally, Rab8 has 
D
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recently been shown to associate with different regions of the α2BAR and β2AR carboxyl-
terminal tails and differentially modulates their trafficking to the cell surface from the 
trans-Golgi network (TGN) (Dong et al., 2010). We find that the association of Rab8 
contributes to attenuated mGluR1a endocytosis, increased cell surface expression and 
functions to uncouple mGluR1a from G protein signalling by a mechanism that requires 
PKC activity.   
136 
 
 Agonist-activated mGluR1a preferentially binds Rab8 wild type and GTP bound 
ssion.  This increase in cell surface expression might be explained by one 
constitutively active mutant Rab8Q70L, but not GDP bound dominant negative mutant 
Rab8-S22N.  This differs from the α2BAR and β2AR, which were recently shown to 
preferentially bind the GDP bound dominant negative mutant Rab8-S22N (Dong et al., 
2010). However, although this study did not investigate whether agonist activation 
regulated Rab8 interactions with the α2BAR and β2AR, Rab8 knockdown resulted in 
attenuated cell surface expression of the α2BAR.  Rab8 also has documented roles in the 
intracellular trafficking of other receptors such as the transferrin receptor, and has been 
shown to drive synaptic delivery of ionotropic glutamate AMPA receptors and their 
insertion into synaptic membranes (Henry and Sheff, 2008; Brown et al., 2007). 
However, to date, most studies have focused on the role of Rab8 in regulating receptor 
delivery to the plasma membrane from areas such as the TGN or recycling endosomes 
(Deretic, 1997; Gerges et al., 2004; Gerges et al., 2005; Brown et al., 2007; Dong et al., 
2010). We present data here implicating Rab8 in the inhibition of mGluR1a 
internalization. Similar to our findings, the Rab8 effector molecule optineurin is also 
implicated in attenuating the internalization of transferrin receptors (Nagabhushana et al., 
2010; Park et al., 2010). Rab5 has a well documented role in facilitating endocytosis of a 
number of receptors including the angiotensin II type 1 receptor and β2AR (Seachrist et 
al., 2000; Seachrist et al., 2002; Dale et al., 2004). However, to our knowledge, Rab8 
represents the first example of a wild-type Rab protein that contributes to the attenuation 
of receptor endocytosis.  
Interestingly, we find that Rab8 overexpression leads to an increase in cell surface 
mGluR1a expre
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 of two 
 that mGluR1a displays no difference in Rab8-mediated IP 
signal 
mechanisms: 1) Rab8 overexpression increases cell surface expression by either 
reducing constitutive mGluR1a internalization or agonist-stimulated internalization of 
mGluR1a as the consequence of the release of endogenous glutamate into the media by 
HEK 293 cells. 2) Rab8 overexpression facilitates the movement of receptors from the 
TGN to the plasma membrane.  This would be similar to what was observed for the 
α2BAR, where Rab8 knockdown led to impaired TGN to plasma membrane transport of 
the receptor (Dong et al., 2010).  In hippocampal neurons, endogenous Rab8 along with 
the mGluR1a redistribute to spine regions after agonist stimulation, suggesting that Rab8 
may regulate the localization of mGluR1a to synapse. This might be similar to the 
reported role of Rab8 in the neuronal trafficking and insertion of the ionotropic AMPA-
type glutamate receptor at synapses (Gerges et al., 2004, Gerges et al., 2005).  
 Our laboratory has previously reported that the Rab8 effector molecule, 
optineurin associates with mGluR1a resulting in attenuated mGluR1a-stimulated IP 
formation (Anborgh et al., 2005). In the present study, we find that Rab8 also contributes 
to the regulation of mGluR1a G protein signalling. We find that Rab8 overexpression 
specifically contributes to the uncoupling of mGluR1a-, but not mGluR1b-stimulated IP 
formation.  This inability of Rab8 to regulate mGluR1b signalling is correlated with the 
observations that mGluR1b lacks an extended carboxyl-terminal tail, and that Rab8 does 
not effectively associate with this mGluR1 variant. Therefore, the association between 
Rab8 and mGluR1a appears to be crucial for the ability of Rab8 to regulate mGluR1a 
signalling. We also show
attenuation when co-expressed with Rab8 nucleotide binding mutants, indicating 
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 that Rab8 nucleotide-binding status does not play a role in regulating mGluR1a 
signalling.  
 Rab8-mediated attenuation of mGluR1a signalling is reversed by PKC inhibition, 
suggesting that Rab8 modulates PKC-dependent desensitization of mGluR1a.  Similar to 
the decrease in IP formation found in HEK293 cells following Rab8 overexpression, we 
also find that GFP-Rab8 overexpression in primary mouse hippocampal neurons 
significantly reduces intracellular Ca2+ release in response to the activation of 
endogenously expressed group I mGluRs with DHPG. This role for PKC in Rab8-
mediated attenuation of mGluR1a signalling is likely dependent upon PKC-dependent 
mGluR1a phosphorylation (Hermans and Challis, 2001).  
Dominant negative or depletion of Rab8 by siRNA significantly attenuates 
mGluR1a endocytosis and signalling.  In contrast to what has previously been shown for 
ERK1/2 activation by the α2BAR, but not the β2AR and inhibits plasma membrane 
delivery of α2BAR from the TGN (Dong et al., 2010).  We find here, that although Rab8 
overexpression blocks second messenger formation in response to mGluR1a, agonist-
stimulated ERK1/2 phosphorylation is unaltered in the presence of the GTPase.  
However, we did find basal ERK1/2 phosphorylation in mGluR1a expressing cells was 
significantly attenuated in cells co-expressing Rab8.  Thus, Rab8 may selectively 
contribute to the regulation of agonist-stimulated G protein-signalling, as opposed to 
regulating G protein-independent signalling mediated by the association of other proteins 
with mGluR1a such as Pyk2 (Nicodemo et al., 2010).  However, the diminished basal 
ERK1/2 activity may be associated with attenuated basal mGluR1a endocytosis.  
In summary, our results establish a novel role for Rab8 in the regulation of 
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 other GPCRs and Rabs, this is the first report of a Rab GTPase inhibiting GPCR 
endocytosis, while simultaneously attenuating receptor signalling. This opens a new and 
exciting avenue of research to improve our understanding of the molecular and 
physiological consequences of Rab GTPase-mediated regulation of GPCR signalling.   
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 4.1. INTRODUCTION 
 
Metabotropic glutamate receptors mediate the actions of the excitatory 
neurotransmitter, glutamate. These class C receptors are characterised by a large 
extracellular amino-terminal glutamate binding region comprised of 2 globular domains, 
which form a distinctive “venus fly trap” (VFT) (Conn and Pin, 1997). The specific 
amino-terminal glutamate binding region has been identified as a stretch of 24 amino 
acids whose mutations affect glutamate affinity (Dhami and Ferguson, 2006; O’Hara et 
a  
for allosteric coupling between the V nsmembrane domains (Huang et al., 
011). This region also participates in receptor dimerization via the formation of a 
ysteine bridge between receptor pairs, the disruption of which leads to receptor loss of 
ano et al., 2001; Romano et al., 1996).  
 The second intracellular loop of mGluR is involved in G protein coupling and 
Rs (mGluR1 and mGluR5) primarily couple 
through Gαq and also activate G protein-independent signal transduction pathways 
itogen activated kinases (Gerber et al., 2007; Nicodemo et al., 2010). Group I 
mGluR-mediated ERK1/2 activation can occur via PKC, β-arrestin or through the non-
receptor tyrosine kinases Src and Pyk2 (Emery et al., 2010; Nicodemo et al., 2010; 
Thandi et al., 2002).  
Receptor activation is quickly followed by signal desensitization, a tightly 
or chronic receptor 
esensitization includes phosphorylation-dependent and -independent mechanisms 
 
l., 1993). Adjacent to the VFT domain is a 70 amino acid Cysteine-rich domain required
FT and the tra
2
C
function (Rondard et al., 2008; Rom
selectivity (Pin et al., 1994). Group 1 mGlu
including m
regulated process essential to prevent aberrant signalling 
overstimulation (Ferguson, 2001a). Desensitization of mGluRs is complex as mGluR1 
d
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 (Ferguson, 2007; Dhami and Ferguson, 2006; Dhami et al., 2005, Dhami et al., 2004; 
ami
tory proteins 
. Homer proteins link mGluR1/5 to the activation of IP3 receptors, 
ERK1/
Dh  et al., 2002). GRK2-mediated mGluR desensitization is phosphorylation-
independent, whereby the GRK2 RGS homology domain associates with lysine residues 
691 and 692 in the receptor second intracellular loop as well as the Gαq/11 subunit of the 
heterotrimeric G protein (Dale et al., 2000; Dhami et al., 2005; Dhami and Ferguson, 
2006; Ferguson, 2007). Meanwhile, second messenger-dependent kinases such as PKC 
mediate phosphorylation-dependent mGluR desensitization in the receptor second 
intracellular loop as well as carboxyl-terminal tail (Francesconi and Duvoisin, 2000; 
Ciruela et al., 1999). Threonine 695 within the second intracellular loop is a target for 
PKC phosphorylation and mutation at this residue specifically disrupts PKC-mediated 
receptor desensitization (Francesconi and Duvoisin, 2000; Medler and Bruch, 1999).  
GPCR C-tails are responsible for association with many regula
involved in protein scaffolding and/or transport. For example, the Homer family of 
proteins is comprised of 3 family members each encoding multiple splice variants 
(Shiraishi-Yamaguchi and Furuichi, 2007). Homers associate with PPxxFR motif in the 
C-tails of mGluR1/5 via their amino-terminal ENA/VASP homology domains and 
regulate the subcellular distribution, plasma membrane target and signalling of mGluR1/5 
(Ango et al., 2002; Ciruela et al., 1999; Coutinho et al., 2001; Roche et al., 1999; 
Tadokoro et al., 1999)
2 phosphorylation and the modulation of ion channel activity (Mao et al., 2005; 
Kammermeier et al., 2000; Yamamoto et al., 2005; Ango et al., 2011). 
Recently, genetic screening studies of multiple tumour types has identified several 
naturally occurring pathological mutations in the ligand binding and intracellular 
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 regulatory domains of mGluR1a (Kan et al., 2010; Parsons et al., 2008; Sjoblom et al., 
2006; Wood et al., 2007).  In the present study, we have examined the effect of eight 
mutations identified in lung adenocarcinoma and squamous cell cancer including: 
mutations in the orthosteric glutamate binding region (D44E and A168) and Cysteine-
rich region of the amino-terminal domain (R375G and G396V), intracellular loop 2 
(R684C, G696W and G668V) and Homer binding motif (P1148L) on mGluR1a 
signalling.  We find that a subset of these mutations result in altered mGluR1a-stimulated 
G protein-coupling, biased ERK1/2 phosphorylation, intracellular retention in the 
endoplasmic reticulum (ER), as well as lost Homer binding that are associated with 
altered subcellular localization of mGluR1a 
4.2. EXPERIMENTAL PROCEDURES 
4.2.1. 
m Cell Signaling 
Techno
Materials  
 
 myo-(3H)Inositol was acquired from PerkinElmer Life Sciences (Waltham, MA).  
Dowex 1-X8 (formate form) resin 200–400 mesh was purchased from BioRad 
(Mississauga, ON, Canada).  Normal donkey serum was purchased from Jackson 
ImmunoResearch (West Grove, PA, USA). ECL Western blotting detection reagents 
were purchased from GE Healthcare (Oakville, ON, Canada). Horseradish peroxidase-
conjugated anti-rabbit and anti-goat IgG secondary antibody were obtained from BioRad 
(Mississauga, ON, Canada) and anti-mGluR1 rabbit polyclonal antibody purchased from 
Upstate (Lake Placid, NY, USA).  Rabbit polyclonal phospho-p42/44 MAP kinase 
(Thr202/Tyr402), p42/44 MAP kinase antibodies were obtained fro
logy (Pickering, ON, Canada).  Alexa Fluor 488 donkey anti-Rabbit IgG, Alexa 
Fluor 568 donkey anti-rabbit IgG and Zenon Rabbit Alexa Fluor 555 were purchased 
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 from Invitrogen/Molecular Probes (Burlington, ON, Canada). Rabbit anti-FLAG 
antibody, M2 anti-FLAG agarose and all other biochemical reagents were purchased from 
Sigma-Aldrich (Oakville, ON, Canada). 
4.2.2. Cell Culture 
 
 Human embryonic kidney (HEK) 293 cells were maintained in Eagle's minimal 
essential medium supplemented with 8% (v/v) heat inactivated fetal bovine serum 
(Invitrogen, Burlington, ON) and 50 µg/ml gentamicin.  Cells seeded in 100 mm dishes 
(Ferguson and Caron, 2004).  Following transfection (18 h), the cells were incubated with 
fresh medium and allowed to recover for 
 
were transfected using a modified calcium phosphate method as described previously 
24 hrs for co-immunoprecipitation studies.  
-8 hrs and re-seeded into 12- well or 24-
an additional 18 hrs prior to experimentation. 
4.2.3. ERK Activation and Immuno Blotting 
 HEK 293 cells were transiently transfected with the cDNAs described in the 
Figure Legends. Forty-eight hours post-transfection cells were serum starved overnight in 
glutamine-free DMEM and stimulated for the indicated times with 30 μM quisqualate. 
The cells were then placed on ice, washed two times with ice-cold phosphate-buffered 
saline (PBS) and lysed with cold-lysis buffer (50 mM Tris, pH 8.0, 150 mM NaCl, 0.1% 
Triton X-100) containing protease inhibitors (1 mM AEBSF, 10 μg/ml leupeptin, and 5 
μg/ml aprotinin) and phosphatase inhibitors (10 mM NaF, 5 μM Na VO ).  The cells 
sample buffer containing 2-mercaptoethanol (BME).  Samples were separated by SDS-
Otherwise, they were allowed to recover for 6
well dishes and then grown 
 
3 4
were placed on a rocking platform for 15 min at 4°C and centrifuged at 15000 x g for 15 
min at 4°C to pellet insoluble material.  Cell extracts were solubilized in a 3X SDS 
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 PAGE, transferred to a nitrocellulose membrane and immunoblotted to identify 
phosphorylated (active) and total p42/44 (ERK1/2) (1:1000 dilution, Cell Signalling) 
followed by a horseradish peroxidase-conjugated secondary anti-rabbit antibody 
eceptor protein expression was determined by immunoblotting 10 
g of protein from
 
 Triton X-100) 
μg/ml leupeptin, and 5 μg/ml 
SDS-PAGE, transferred to a nitrocellulose membrane and immunoblotted to identify co-
immunoprecipitated YFP-tagged GRK2 protein using a primary mouse anti-GFP 
antibody (1:1000 dilution) followed by a horseradish peroxidase-conjugated secondary 
anti-mouse antibody (1:2500 dilution). Receptor and GRK2 protein expression was 
(1:10000, BioRad). R
μ  each cell lysate.  Proteins were detected using chemiluminescence 
with the ECL kit from GE Healthcare.  
4.2.4. Co-immunoprecipitation 
 HEK 293 cells were transiently transfected with cDNAs as described in the 
Figure Legends.  Following transfection, the cells were incubated for 15 min in HEPES 
balanced salt solution (HBSS) at 37°C with or without 30 μM quisqualate.  The cells 
were then placed on ice, washed two times with ice-cold phosphate-buffered saline (PBS) 
and lysed with cold-lysis buffer (50 mM Tris, pH 8.0, 150 mM NaCl, 0.1%
containing protease inhibitors (1 mM AEBSF, 10 
aprotinin).  The lysates were placed on a rocking platform for 15 min at 4°C and 
centrifuged at 15000 x g for 15 min at 4°C to pellet insoluble material.  Cleared 
supernatant containing 250 µg protein was incubated with 25 µL of FLAG M2-affinity 
beads for 1h rotating at 4°C to immunoprecipitate FLAG-mGluR1a. Following 
incubation, the beads were washed twice with PBS, and proteins were solubilized in a 3X 
SDS sample buffer containing 2-mercaptoethanol (BME).  Samples were separated by 
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 determined by immunoblotting 10 μg of protein from each cell lysate used for 
immunoprecipitation.  Proteins were detected by chemiluminescence.  
 
 HEK 293 cells were transiently transfected with cDNAs as described in the 
Figure Legend.  Fourty-eight hours post-transfection cells were incubated overnight in 
inositol- and glutamine-free DMEM with 100 µCi/
4.2.5. Measurement of inositol phosphate formation 
mL myo-[3H]-Inositol.  For all 
or one hour in warm HBSS (116 mM NaCl, 20 mM experiments cells were incubated f
HEPES, 11 mM glucose, 5 mM NaHCO3, 4.7 mM KCl, 2.5 mM CaCl2, 1.2 mM MgSO4, 
1.2 mM KH2PO4, pH 7.4) and were then incubated with 10 mM LiCl alone for 10 min 
followed by 30 μM quisqualic acid in LiCl for 30 min.  Cells were placed on ice and the 
reaction was stopped with 500 µL of perchloric acid and neutralized with 400 µl of 0.72 
M KOH, 0.6 M KHCO3.  Total cellular [3H]-inositol incorporation was determined in 50 
µl of cell lysate.  Total inositol phosphate was purified by anion exchange 
chromatography using Dowex 1-X8 (formate form) 200-400 mesh anion exchange resin 
and [3H]-inositol phosphate formation was determined by liquid scintillation using a 
Beckman LS 6500 scintillation system. 
4.2.6. Confocal microscopy 
 
 Confocal microscopy was performed using a Zeiss LSM- 510 META laser 
scanning confocal microscope equipped with a Zeiss 63X, 1.4 numerical aperture, oil 
immersion lens (North York, ON, Canada).  For live cell imaging, HEK 293 cells 
expressing FLAG-mGluR1a constructs were serum starved for 1 hr at 37°C in HBSS. 
HEK 293 cells were pre-labelled with Zenon Alexa Fluor 568-conjugated with anti-
FLAG polyclonal rabbit antibody (Invitrogen). Cells were then either kept on ice or 
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 stimulated with 30 μM quisqualate for 30 min at 37°C.  For fixed cell imaging, cells were 
washed three times at room temperature PBS, fixed for 10 min at room temperature with 
llowe
 
or 10 min in 5 μM EDTA, gently removed from 
aldehyde final concentration. Cell surface mean 
 
Periodate-Lysine-Paraformaldehyde (PLP) fixative (McLean and Nakone, 1974) 
fo d by 10 min permeablilization with 0.01% Triton X-100. Cells were blocked with 
3% normal donkey serum (Jackson ImmunoResearch) and labelled with Rabbit anti-
FLAG polyclonal rabbit antibody followed by donkey anti-rabbit Alexa Fluor 488 
antibody. Endoplasmic reticulum was labelled with red fluorescence protein (RFP)-fused 
lysine-aspartate-glutamate-leucine (KDEL) ER retention sequence. Colocalization studies 
were performed using dual excitation (488, 543 nm) and emission (band pass 505-530 nm 
and long pass 560 nm for Alexa Fluor 488 and 568, respectively) filter sets. 
4.2.7. Flow Cytometry  
 HEK 293 cells were transiently transfected with the cDNAs described in the 
Figure Legends. Fourty-eight hours after transfection cells were placed on ice and 
washed in ice-cold HBSS. Flag-tagged mGluR1a constructs were labelled with primary 
rabbit anti-Flag antibody (1:500) followed by secondary goat anti-rabbit AlexaFluor-488 
antibody (1:500). Cells were incubated f
dish by pipetting and fixed in 3.6% form
fluorescence was assessed by flow cytometry.  
4.2.8. Statistical Analysis 
 Densitometric data were normalized first for protein expression and the control 
value was set to 100, with all other values displayed as percentage thereof. One-way 
analysis of variance test (ANOVA) was performed to determine significance, followed by 
a post-hoc Tukey multiple comparison test or Bonferroni’s multiple comparisons test to 
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 cell surface 
n of FLAG-mGluR1a was affected by each of the mutations 
ontrol transfected cells (Figure 4.2B). The 
reduction in cell surface FLAG-mGluR1a-R375A and -G396A expression was associated 
ith an increased retention of both receptor mutants in the ER as demonstrated by 
increased colocalization with the ER marker construct KDEL-GFP (Figure 4.3).  Thus, 
both the R375A and -G396A mutations result in a significant reduction of mGluR1a 
expression at the cell surface as a consequence of ER retention. 
determine which means were significantly different (p < 0.05) from one another.  
4.3. RESULTS 
4.3.1. Mutations in the cysteine-rich domain contribute to receptor dimerization 
and cell surface expression 
 Eight naturally occurring mGluR1 mutations were previously identified in variety 
of tumour types with four mutations localized to the amino-terminal domain of mGluR1 ( 
D44E, A168V, R375G and G396V) three mutations localized to the mGluR1 second 
intracellular loop (R684C, G688V and R696W) and one mutation localized to the Homer 
binding motif (P1148L) (Figure 4.1) (Kan et al., 2010; Parsons et al., 2008; Sjoblom et 
al., 2006; Wood et al., 2007).  Initial experiments examined whether the
expression and dimerizatio
introduced into the coding sequence for mGluR1a. Immunoblot analysis demonstrated 
that FLAG-mGluR1 mutations R375G and G396V, which are localized at the border of 
the glutamate binding domain and cysteine-rich regions, exhibited a reduction in dimer 
formation (Figure 4.2A). Consistent with a loss of mGluR1a dimerization, cell surface 
expression of FLAG-mGluR1a-R375A and -G396A exhibited reduced cell surface 
expression as assessed by flow cytometry; with cell surface expression reduced to 39.7 ± 
5.1% and 43.4 ± 3.2 % of wild type mGluR1a c
w
 Figure 4.1. Eight naturally occurring single nucleotide polymorphisms in 
mGluR1a. Eight mutations have been identified within the coding sequence for 
: A168V, a mutation in the orthosteric glutamate binding 
 squamous cell carcinoma) and G396V 
(identified in lung adenocarcinoma); three mutations in the second intracellular 
located within the Homer binding region in the carboxyl-terminal mGluR1, 
mGluR1a including
region identified in lung adenocarcinoma; two mGluR1a variants in the cysteine-
rich region, R375G (identified in
loop including: the  glioblastoma mutation, R684C, the squamous cell carcinoma 
mutation, G688V, and the colorectal cancer G696W mutation located close to the 
putative PKC phosphorylation site T695A. A colorectal cancer mutation is 
P1148L.   
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Figure 4.2. Cell surface expression and intracellular localization of mGluR1a 
variants. (A) Representative immunoblot of HEK 293 cells expressing 2 μg Flag-tagged 
mGluR1 constructs highlighting the monomeric (lower) and dimeric (upper) species of 
the receptor. (B) HEK 293 cells expressing 2 μg Flag-tagged mGluR1a constructs were 
immunolabelled and cell surface mean fluorescence was assessed by flow cytometry. 
Data were normalized for total protein expression and represent the standard error of the 
mean of four independent experiments. *, p < 0.001 compared to wild type. 
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e to endoplasmic reticulum. 
confocal micrographs illustrating receptor intracellular localization (red) and co-
 
 
 
Figure 4.3. mGluR1 variants localiz Representative 
localization with the endoplasmic reticulum (green). HEK293 cells expressing 2 μg Flag-
tagged mGluR1 constructs were fixed and immunolabelled for total cellular compliment 
of receptor. Images are representative of 3 independent experiments. Bars represent 5 
µm.  
 4.3.2. Mutations in the amino-terminus exhibit altered basal and agonist-activated 
activity 
 Group I mGluRs activate both IP3 and ERK signal transduction cascades and 
exhibit high basal activity (Dale et al., 2000). Interestingly, three of the four amino-
terminal mGluR1 variants we examined (A168V, R375G, G396V) showed significantly 
reduced basal IP3 formation (in the absence of agonist) compared to wild type and 
FLAG-mGLuR1a-R375G exhibited basal IP3 formation that was indistinguishable from 
non-transfected cells (Figure 4.4A). Quisqualate-mediated activation of FLAG-
mGluR1a-A168V (a site located within the glutamate binding region) resulted in a 63 ± 
17% increase in IP3 formation when compared to control FLAG-mGluR1a transfected 
cells (Figure 4.4B). Quisqualate-stimulated FLAG-mGLuR1a-R375G IP3 formation was 
comparable to FLAG-mGluR1a transfected cells, despite reduced cell surface expression. 
However, glutamate-stimulated FLAG-mGLuR1a-R375G IP3 formation was reduced to 
29 ± 4% of FLAG-mGluR1a transfected cells (Figure 4.4C). Therefore, activation of this 
mutant by glutamate and quisqualate resulted in divergent signalling patterns.  
4.3.3. R375G displays functional selectivity toward ERK1/2 
To examine whether the mGluR1a mutations associated with various cancer cell 
nes also affected other mGluR1a-activated cell signalling pathways, we examined 
 
li
whether the mutations influenced the ability of mGluR1a to stimulate ERK1/2 
phosphorylation in HEK293 cells.  Similarly to what we found for IP3 formation, all four 
amino-terminal mutations also exhibited decreased basal ERK1/2 phosphorylation, but 
still displayed a statistically significant increase in ERK1/2 activation in response to 
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 Figure 4.4.  Mutations in mGluR1 alter basal and agonist-activated inositol 
phosphate formation. (A) Basal IP3 formation in HEK 293 cells transiently 
transfected with 2 μg Flag-tagged mGluR1a constructs. Cells were labelled 
anion exchange chromatography and [3H]-inositol phosphate formation was 
overnight with myo-(3H)Inositol in glutamine-free DMEM, incubated for 10 min 
with 10 mM LiCl followed by (B) 30 μM quisqualic acid or (C) 100 μM 
glutamate for 30 min.  Total cellular (3H)inositol was collected and purified by 
determined by liquid scintillation. Data were normalized for protein expression 
and represent the standard error of the mean of four independent experiments. *, p 
< 0.01 compared to wild type with the same treatment.  
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quisqualate treatment (Figure 4.5A). Interestingly, although FLAG-mGluR1a-R375G 
demonstrated decreased basal ERK1/2 phosphorylation, quisqualate-mediated ERK1/2 
phosphorylation in FLAG-mGluR1-R375G expressing cells resulted in significantly 
increased ERK1/2 phosphorylation following 1, 5 and 10 min agonist stimulation when 
compared to wild-type FLAG-mGluR1a (Figure 4.5B).  In contrast, ERK1/2 
phosphorylation in response to the activation of either FLAG-mGluR1a-R696W or -
P1148L was significantly reduced when compared to wild-type FLAG-mGluR1a.  
Therefore, the R375G mutant appeared to be biased towards the activation of the ERK1/2 
pathway, whereas the R696W and P1148L mutations were biased for G protein-mediated 
signalling.  
4.3.4. GRK2 binding to mGluR1a mutants 
 Several of the identified mGluR1a mutations are localized to the second 
intracellular loop domain of the receptor, including R684C, G688V and G696W, a 
domain that is important for GRK2 binding and phosphorylation-independent 
desensitization of the receptor.  We find that association of GRK2 with these FLAG-
mGluR1a variants was unchanged compared to wild-type FLAG-mGluR1a as determined 
by co-immunoprecipitation (Figure 4.6A). Additionally, these mGluR1 second 
intracellular loop mutations all continue to be desensitized by GRK2 overexpression 
(Figure 4.6B). Interestingly, although R696W showed no alterations in IP3 formation, 
agonist-activation of this mutant failed to induce ERK1/2 phosphorylation (Figure 4.5B).  
Therefore, mutation in this region does not alter GRK2 association or GRK2-mediated 
IP3 desensitization, but showed reduced receptor-mediated ERK1/2 activity.
 Figure 4.5. Changes in mGluR1-mediated ERK1/2 activation. HEK 293 cells 
were transiently transfected with 2 μg FLAG-mGluR1a constructs. Forty-eight 
DMEM and stimulated for (A) 15 min or (B) 0, 1, 5 or 15 min with 30 µM 
quisqualate. Cell lysates were collected, subjected to SDS-page and 
immunoblotted for phosphorylated and total p42/44 (ERK1/2). Data were 
3-5 independent experiments. ns, not significant from unstimulated. *, p < 0.05 
compared to wild type. 
hours post-transfection cells were serum starved overnight in glutamine-free 
normalized for protein expression and represent the standard error of the mean for 
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Figure 4.6. Effect of mGluR1a mutations on GRK2 binding and receptor 
desensitization. (A) HEK 293 cells were transiently transfected with 2 μg Flag-
tagged mGluR1 constructs along with 1 μg GFP-GRK2. Forty-eight hours after 
transfection cells were lysed and FLAG-mGluR1a was immunoprecipitated. 
Samples were separated by SDS-PAGE, transferred to a nitrocellulose membrane 
and immunoblotted to identify co-immunoprecipitated YFP-tagged GRK2 
protein. Receptor and GRK2 protein expression was determined by 
immunoblotting 10 μg of protein from each cell lysate used for 
immunoprecipitation. (B) HEK 293 cells were transiently transfected with 2 μg 
Flag-tagged mGluR1 constructs along with 1 μg empty pEGFP or GFP-GRK2. 
Cells were labelled overnight with myo-(3H)inositol in glutamine-free DMEM, 
incubated for 10 min with 10 mM LiCl followed by 30 μM quisqualate for 30 
min.  Total cellular [3H]-inositol was collected and purified by anion exchange 
chromatography and (3H)inositol phosphate formation was determined by liquid 
scintillation. Data were normalized for protein expression and represent the 
standard error of the mean of three independent experiments.  
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 4.3.5. Attenuated Homer binding to FLAG-mGluR1a P1148L  
 The carboxyl-terminus mGluR1a encodes a Homer binding motif and the 
association of Homers with mGluR1a has been show to modulate both the subcellular 
localization and signalling of mGluR1a (Brakeman et al., 1997; Wood et al., 2007; 
Kammermeier, 2008; Bertaso et al., 2010; Ronesi et al., 2008, 2012). The introduction of 
the P1148L mutations into the C-tail of FLAG-mGluR1a did not affect IP3 formation in 
response to agonist activation of the receptor (Figure 4.4), but diminished agonist-
stimulated ERK1/2 phosphorylation and resulted in a loss of Homer 1b binding to the 
receptor (Figure 4.5B and 4.7). Co-immunoprecipitation experiments show this mutant 
exhibits decreased association with Homer 1 compared to wild type mGluR1 (Figure 
4.7). Moreover, the P1148L mutation resulted in altered subcellular localization of 
mGluR1a to membrane ruffles, multinucleated cells and increased filopodia formation in 
HEK 293 cells, an effect that was not observed for the wild-type receptor (Figure 4.8).  
4.4. DISCUSSION 
In the present study, we have characterised the intracellular localization, 
signalling, association with regulatory molecules and cellular morphology of eight 
previously unstudied naturally occurring mGluR1 mutations (Kan et al., 2010; Parsons et 
al., 2008; Sjoblom et al., 2006; Wood et al., 2007).  A unique characteristic of class C 
GPCRs is their constitutive dimerization at the cell surface (Kniazeff et al., 2011). Group 
I mGluRs have been shown to homodimerize through covalent linkage via disulphide 
bonding at cysteine 140 within the large extracellular amino-terminal domain, although 
mutation of this residue is not sufficient to inhibit dimerization (Kniazeff et al., 2004; 
ay and Hauschild, 2000; Robbins et al., 1999). Here we identify two mGluR1a variants, R
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lysates. 48h post-transfection, co-immunoprecipitated proteins and total lysates resolved 
 
 
 
 
 
Figure 4.7. mGluR1 P1148L is deficient in Homer1 binding. HEK293 cells were co-
transfected with HA-Homer1 and empty vector (‘-’), or indicated FLAG-tagged mGluR1 
constructs. Anti-FLAG was used to immunoprecipitate (‘IP’) mGluR1 from resultant 
by SDS–PAGE were immunoblotted (‘IB’) with anti-FLAG and anti-HA antibodies.
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igure 4.8. Homer binding mutant mGluR1 P1148L promotes filopodia formation. 
) Representative confocal micrographs illustrating receptor localization and cell 
orphology. HEK293 cells expressing 2 μg Flag-tagged mGluR1 constructs were fixed 
nd immunolabelled for total cellular compliment of receptor. Images are representative 
standard error of the mean of three independent experiments.  
 
 
 
 
 
 
 
 
 
F
(A
m
a
of 3 independent experiments. Bars represent 5 µm. (B) Graph scoring the number of 
cells displaying filopodia. NIH-3T3 cells transiently expressing Flag-mGluR1 wild type 
or P1148L were fixed and immunolabelled for total cellular compliment of the receptor 
and number cells displaying filopodia were counted per field of view. 100 cells from 
three separate experiments were counted randomly and a data represent the average 
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 R375G and G396V, which migrate on a western blot exclusively at the size of the 
er (~140 kDa). The amino-terminal region of these mutations is consistent with 
ovalent linkages are not essential for dimerization of all 
roup I mGluRs, suggesting that multiple interactions are involved in the dimerization of 
ese receptors (Sato et al., 2003; Romano et al., 2001, 1996). However, it is becoming 
roper receptor targeting and function of many GPCRs is dependent on dimer 
rmation (Milligan, 2010). For example, the GABAB receptor requires both GABAB1 
nd GABAB2 subunits in order to reach the plasma membrane as well as activate G 
., 2002; Pin et al., 2004). Heterodimerization of 
ABAB receptor subunits masks an ER retention sequence in the carboxyl-terminus of 
ABAB (Margeta-Mitrovic et al., 2000). Additionally, heterodimerization between the 
1D- and α1B-adrenoceptors, was shown to be necessary for the proper cell-surface 
xpression of the α1DAR subtype (Hague et al., 2006). Dimerization is also essential for 
ceptor-G protein coupling. GABAB1 requires co-expression with GABAB2 in order to 
lling cascade (Galvez et al., 2001; Margeta-
itrovic et al., 2000). This is not just due to plasma membrane localization as a mutant 
monom
other studies, which report c
G
th
clear that p
fo
a
proteins (White et al., 1998; Duthey et al
G
G
α
e
re
couple functionally to the G protein signa
M
form of GABAB1 that lacks its ER retention signal and can reach the cell surface on its 
own still requires GABAB2 for functional activity (Margeta-Mitrovic et al., 2000). Our 
data would support the concept that dimer formation may contribute to appropriate cell 
surface expression of mGluR1a, as two amino-terminal mutants (R375G and G396V) 
result in ER retention of mGluR1a and reduced cell surface expression. We also find that 
these mGluR1a mutants, exhibit significantly reduced basal inositol phosphate formation.  
However, this reduction in constitutive mGluR1a signalling may be independent of cell 
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 surface expression as another amino-terminal mutation (A168V), which displays the 
same cell surface expression as wild type, also results in attenuated basal activity.  
Group I mGluRs exhibit significant basal G protein activation (Dale et al., 2000). 
However, three amino-terminal mGluR1a mutations, A168V, R375G and G396V as well 
as one second intracellular loop mutant (G688V) exhibited a loss of basal activity in HEK 
293 cells.  The reduction in basal activity for the amino-terminal mGluR1a mutations 
may be the consequence of altered affinity for glutamate that may be released from the 
HEK 293 cells to feedback on the receptor.  However, inconsistent with this notion is the 
observation that the mGluR1a-A168V mutant exhibits increased activation of IP3 
formation in response to agonist treatment.  The intracellular loop mutation G688V also 
resulted in decreased basal mGluR1a activity without affecting agonist-stimulated 
responses.  However, the rationale for the observed reduction in basal activity of the 
mGluR1a-G688V variant remains to be determined. 
It is well established that mGluRs activate downstream mitogenic pathways such 
as the ERK1/2 signalling cascade that contributes to alterations in cell proliferation 
(Rozengurt, 2007). Group I mGluRs activate ERK1/2 in both calcium-dependent and -
independent manners, the latter involving Gβγ and non-receptor tyrosine kinases such as 
Src and Pyk2 (Nicodemo et al., 2010). We have identified three mGluR1a mutants with 
altered ERK activation including mGluR1 R375G, which exhibits markedly increased 
ERK1/2 phosphorylation upon quisqualate stimulation.  Although this mutation does not 
affect quisqualate-stimulated IP3 formation, glutamate-mediated IP3 formation is 
significantly impaired for the R375G mutant.  Taken together, these observations suggest 
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 that mutations localized to the amino-terminal domain of mGluR1a may bias receptor 
signalling towards the ERK1/2 pathway.   
Receptor modulation by regulatory proteins such as GRK2 represents a major 
mechanism controlling the magnitude and duration of GPCR signal transduction. GRK2-
mediated attenuation of mGluR1a signalling occurs as the consequence of the 
concomitant association of the kinase with the second intracellular loop domain of the 
receptor and Gαq/11 (Dhami et al., 2004; Dhami et al., 2005; Dhami and Ferguson, 2006; 
Ferguson, 2007). We investigated here, the effect of three intracellular loop 2 mutations 
on  the association of GRK2 with mGluR1a.  We find that none of the mutations exhibits 
reduced GRK2 association and that GRK2 overexpression results in normal attenuation 
of G protein signalling in response to the activation of mGluR1a second intracellular loop 
mutants.  Interestingly, we also find that ERK1/2 activation in response to activation of 
mGluR1a-R696W is lost, suggesting that this residue may contribute to the regulation of 
ERK1/
(P1148L) does not associate with Homer1b, is uncoupled from the activation of ERK1/2 
2 signalling by the receptor.  Our previous studies have shown that Pyk2 binds to 
the second intracellular loop domain of mGluR1a and may directly contribute to the 
activation of ERK1/2 phosphorylation (Nicodemo et al., 2010). Future studies will be 
required to assess whether this mutation affects Pyk2 binding to mGluR1a.  
Of the many regulatory proteins that interact with Group I mGluRs, the Homer 
family of proteins are predominantly featured as they are synaptically localized and 
couple Group I mGluRs to the activation of a variety of ion channels at the synapse 
(Ango et al., 2002; Ciruela et al., 1999; Coutinho et al., 2001; Roche et al., 1999; 
Tadokoro et al., 1999). Here we show that the naturally occurring mGluR1 variant 
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 phosphorylation and causes enhanced multinucleation and filopodia formation in HEK 
293 cells.  The loss of agonist-stimulated ERK1/2 phosphorylation by the mGluR1a-
P1148L
nctionality of 
differen
 mutant is consistent with recent reports that Homer 1a may contribute in part to 
the coupling of mGluR1a to the activation of ERK1/2 (Mao et al., 2005; Mao et al., 
2008). The mechanism by which the P1148L mutation leads to increased multinucleation 
and filopodia formation is unclear, but likely relevant to the association of this mutation 
with a cancer cell line.  
In this study, we characterised the signalling and intracellular localization of eight 
somatic mutations in mGluR1 identified in genome-wide screens of various cancerous 
tissue samples. We identified two mutations involved in dimerization and plasma 
membrane targeting as well as several mutations differentially affecting IP3 formation 
and MAPK signalling of this receptor. For example, we demonstrate that the R375G 
mutant preferentially couples to ERK1/2 activation while exhibiting decreased basal and 
glutamate-activated inositol phosphate production. Additionally, the A168V mutant 
displays decreased basal and increased agonist-mediated IP3 formation. These alterations 
in the mGluR1a activity may contribute, at least in part, to the phenotype of the cancer 
cell lines in which they were identified. This study sheds new light on the fu
t regions of the receptor as well as further defining the residues involved in 
mGluR1 signalling and the role of mGluR1 signalling in pathologies and may provide an 
exciting opportunity for developing new mGluR1-targeted treatments.  
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5.1. SUMMARY 
 
 The aim of this thesis was to elucidate the role that receptor trafficking plays in 
signal transduction by addressing the following three questions: 
5. Do multiple Rab proteins associate with AT1R to alter receptor desensitization or 
resensitization? 
6. Does Rab8 associate with mGluR1 to modulate its intracellular trafficking and 
signalling? 
7. What alterations do previously unchara s in 
mGluR1 exhibit in intracellular l ignal transduction? 
 The data presented in chap summarize my findings aimed at 
nswering these important questions pertaining to the role intracellular trafficking plays 
 GPCR signal transduction (Figure 5.1). In chapter 2 we learned that, in addition to the 
reviously published Rab5a, other Rab GTPases including Rab4, Rab7 and Rab11 
ssociate with overlapping residues of the angiotensin II type 1 receptor C-tail and 
ompete with each other to regulate receptor phosphorylation, desensitization and 
sensitization. Dale et al., (2004) showed that overexpression of constitutively active 
ab7 and Rab11 mutants could override Rab5a-mediated AT1AR retention in early 
ndosomes, and divert the receptor through Rab7 or Rab11 pathways, suggesting that 
ther Rabs may compete with each other for AT1AR trafficking. Here we found that 
verexpression of Rab4 and Rab11 can each uncouple Rab5 from AT1R. Additionally, 
ab4 can cause Rab11 to dissociate from AT1R. However, Rab11 was unable to 
ncouple Rab4 from the receptor. Additionally, Rab4, but not Rab11, facilitates the 
ephosphorylation of AT1R, thus decreasing the desensitization and enhancing the 
cterized single nucleotide polymorphism
ocalization and s
ters 2, 3 and 4 
a
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mediated endocytosis, we find here that Rab8 blocks mGluR1a endocytosis. In addition 
 
 
 
Figure 5.1. Newly identified roles of Rab family members in GPCR endocytic 
trafficking and signalling. Although Rab5 is well known to participate in clathrin-
to mediating the “fast” recycling route, Rab4, but not Rab11, facilitates 
dephosphorylation of AT1R, thus decreasing desensitization and facilitating 
resensitization. 
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 resensitization of the receptor. β2AR dephosphorylation and resensitization occurs as the 
receptor transits between the Rab5-positive early endosome and the Rab4-positive rapid 
recycling endosome while dephosphorylated CRF1α receptor colocalized with Rab4 but 
not with Rab5 (Seachrist et al., 2000; Holmes et al., 2004). Moreover, it has been 
reported that phosphorylated µ-opioid receptor is preferentially recycled through Rab4-
positive endosomes (Wang et al., 2008).  The dephosphorylation of these and other 
receptors within Rab4 positive recycling vesicles identifies this compartment as a key 
region of GPCR resensitization. The data presented in chapter 2 support the theory that in 
addition to regulating receptor trafficking, the association of different Rab GTPases may 
regulate different functional outcomes for AT1R signalling. 
In chapter 3 we investigated the role of the previously typified exocytic Rab8 in the 
regulation of the metabotropic glutamate receptor 1 (Figure 5.2). We found that through 
association with the long C-tail isoform mGluR1a, Rab8 expression resulted in decreased 
internalization and attenuated IP3 signalling in HEK293 cells and Ca2+ signalling in 
ultiple Rabs have been shown to be involved in both endocytic and exocytic 
vents. However, this is the first time a Rab has been shown to inhibit internalization. A 
onsequence of this Rab8-mediated internalization attenuation is increased overall cell 
rface mGluR1 expression. Surprisingly, the increased cell surface expression did not 
neurons. M
e
c
su
translate into increased receptor signalling, but instead resulted in a PKC-dependent 
attenuation of signalling via increased phosphorylation. In chapter 3, we present a novel 
role for Rab8 in attenuating mGluR1a internalization and signalling, which opens a new 
and exciting avenue of research into the role of Rabs in GPCR regulation. 
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While attenuating mGluR-mediated IP3 and calcium signalling, Rab8 has no effect on 
 
 
 
 
 
 
Figure 5.2. Rab8 coordinates mGluR1a intracellular trafficking and signal 
transduction. Rab8 associates with mGluR1a upon agonist activation and attenuates 
receptor internalization, leading to increased mGluR1a plasma membrane expression. 
mGluR-mediated ERK1/2 phosphorylation.  
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 Finally, in chapter 4 we look at the subcellular localization and signal transduction 
of eight previously uncharacterised mGluR1 variants identified in various cancerous 
tissues. These include four mutations within the amino-terminus, three within the second 
intracellular loop and one located within the Homer binding region in the carboxyl-
terminal tail. We find that two mutants in close proximity in the amino-terminus, R375G 
and G396V do not appear to form dimers, exhibit significantly lower plasma membrane 
expression compared to wild type mGluR1 and co-localize considerably within the ER 
with an ER marker GFP-KDEL. We show that these mutants along with other amino-
terminal mutants exhibit significantly reduced basal IP3 formation as well as decreased 
basal ERK1/2 phosphorylation compared to wild type mGluR1a. Interestingly, the 
mGluR1a A168VA mutant, located in the glutamate binding region, displays 
gnificantly reduced basal signalling. However, it also displays significantly increased 
ation. R375G, on the other hand displays biased agonism and 
functional selectivity. Quisqualate-induced IP3 formation of the R375G variant shows 
little difference from wild type mGluR1a, but R375G exhibits significantly attenuated 
response to the natural ligand glutamate. Consequently, the activation of this receptor 
ariant by different ligands appears to result in divergent signalling patterns. 
GluR1a R375G also exhibits functionally selective signal transduction in 
response to quisqualate. Although quisqualate-activated mGluR1a-R375G shows no 
receptor. We also identified two mGluR1a mutations, which no longer associate with 
si
agonist-induced IP3 form
v
Additionally, m
alterations in IP3 formation compared to wild type, quisqualate treatment induces 
significantly higher ERK1/2 activation. This finding is especially dramatic considering 
that this mutant displays only 40% cell surface expression when compared with wild type 
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convincing evidence that GPCR trafficking actively affects signal transduction and 
this idea that intracellular trafficking of GPCRs not only passively participates in receptor 
1A
tory molecules. GRK2 remains associated with mutations in the second 
intracellular loop and GRK2 overexpression continues to mediate mGluR1a 
desensitization. Additionally, P1148L fails to associate with Homer 1b, is impaired in the 
activation of ERK1/2 phosphorylation and appears to stimulate significant changes in 
cellular morphology including increased filopodia formation and multinucleation. The 
findings presented in chapter 4 opens exciting, previously undocumented roles for 
mGluR1a regions involved in agonist binding and activity including biased agonism or 
functional selectivity.  Taken together, our findings support the important role that 
intracellular trafficking and localization plays in receptor function and signal 
transduction.  
5.2. CONTRIBUTIONS TO THE FIELD OF GPCR RESEARCH 
 
 In recent years, studies from our laboratory and others have provided increasingly 
indeed, receptor signal transduction can modulate the activity of proteins controlling the 
trafficking vesicular cargo (Smythe, 2002). Thus GPCRs represent unique cargo proteins 
that contribute to the regulation of their own intracellular trafficking. Our research 
presented here regarding Rab-mediated GPCR alterations in signalling further supports 
signalling, but can actively alter receptor signalling.  
 Seachrist et al. (2002) demonstrated that AT R activation causes GTP loading of 
Rab5a and upon agonist activation, is endocytosed in a Rab5a-dependent manner and 
sequestered to large, hollow Rab5a-positive early endosomes. Dale et al. (2004) further 
went to show that concurrent overexpression of either Rab7 or Rab11 overcomes this 
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 Rab5a-mediated AT1AR retention in early endosomes and redirects the receptor to either 
Rab7-positive late endosomes or Rab11-positive recycling endosomes, respectively. This 
led to the question we posed in chapter 2: do other Rab GTPases also associate with 
AT1R? If so, do they compete with each other for trafficking of the receptor? 
Interestingly, we found that Rab4, Rab5, Rab7 and Rab11 all associate with the same 
amino acid residues of the AT1R C-tail and compete with each other for association. 
Internalized AT1R usually does not readily dephosphorylate nor recycle and the Rab11 
“slow” pathway has previously been shown to regulate this receptor’s recycling 
(Anborgh et al., 2000; Hunyady et al., 2002; Dale et al., 2004). However, Li et al., 2008 
provided evidence to suggest that in addition to Rab11, the so-called “fast” Rab4 pathway 
athway
pathway, when presented the oppourtunity, it can alter its trafficking patterns in favour of 
 receptor endocytos
recycling of GPCRs, including the corticotropin releasing factor receptor 1, somatostatin-
can also regulate AT1R recycling. Therefore, we sought to determine what recycling 
p  AT1R prefers, and the consequences thereof. We found that indeed AT1R binds 
more to Rab11 than Rab4. However, Rab4 can cause dissociation of Rab11 from the 
receptor but Rab11 is unable to displace Rab4. Additionally, Rab4 expression results in a 
significant decrease in agonist-mediated AT1R phosphorylation and thus significantly 
decreased receptor desensitization, as well as enhanced receptor resensitization. 
Therefore, although AT1R normally associates with the Rab11-mediated slow recycling 
Rab4-mediated fast recycling, thus altering its activity. 
 Rab GTPases have well-documented roles in is and exocytosis. 
Rab5a participates in clathrin-mediated endocytosis of a number of receptors, including 
AT1R, β2AR, CRF among others and Rab4, Rab11, Rab8 are known to facilitate 
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 3 receptor, vasopressin V2 receptor, neurokinin-1 receptor, chemokine CXC receptor-2, 
m4 muscarinic acetylcholine receptor and protease activated receptor, are also 
differentially regulated by Rab4 and Rab11 (Innamorati et al., 2001; Kreuzer et al., 2001; 
Schmidlin et al., 2001; Signoret et al., 2001; Fan et al., 2002; Volpicelli et al., 2002; 
Roosterman et al., 2003; Holmes et al., 2006; Deretic, 1997; Seachrist et al., 2000; 
Seachrist et al., 2002; Trischler et al., 1999). Rab8, specifically was recently shown to 
differentially regulate the TGN to plasma membrane trafficking of α2AR and β2AR and 
has also been shown to coordinate with Rab11 to regulate the insertion of AMPA-type 
glutamate receptors into spines of hippocampal neurons (Brown et al., 2007; Dong et al., 
2010; Gerges et al., 2004). Interestingly, we uncovered a novel role for Rab8 in the 
attenuation of internalization of mGluR1a resulting in an increased plasma membrane 
receptor occupancy. To our knowledge, this is the first example of a Rab protein blocking 
internalization of a receptor and this finding opens up the possibility of Rabs managing 
yet another trafficking pathway with which to participate in receptor regulation.  Contrary 
to other reports, which indicate that Rab8 expression facilitates receptor signalling by 
increased cell surface expression, we found that Rab8-mediated increases in mGluR1a 
plasma membrane expression resulted in decreased receptor signalling both in HEK 293 
cells as well as hippocampal neurons. However, our results are consistent with the role of 
the Rab8 effector molecule optineurin, which was also found to contribute to mGluR1a 
desensitization (Anborgh et al., 2005). This study uncovers a novel role of a Rab GTPase 
in negatively regulating receptor endocytosis and intracellular signal transduction.  
 The signal transduction of the prototypic mGluR1a has been extensively 
characterised, including mutagenesis of many putative regulatory and signalling-related 
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 regions of the receptor. However, recent high-throughput genetic screening studies have 
identified several naturally occurring, previously uncharacterised mGluR1 mutations. In 
chapter 4 we examined these naturally occurring pathological mutations of mGluR1 and 
found them to play a substantial role in signal transduction and cellular localization. We 
have studied three mutations in the amino terminus, which display decreased basal 
signalling, a mutant in the second intracellular loop, which no longer associates with 
GRK2, yet is still desensitized by it, as well as one mutation in the carboxyl-terminal tail, 
which no longer associates with the regulatory protein Homer1, displays altered receptor 
localization, increased filipodia formation and defective ERK1/2 activation. One 
mutation in the Cysteine-rich region of the amino terminus emerged as a significant 
player in intracellular trafficking as well as signalling. Specifically, mGluR1 R375G 
simultaneously exhibited decreased basal IP3 formation while significantly increased 
agonist-activated ERK1/2 formation. These mutations further our understanding of 
mGluR1 signal transduction and intracellular localization and provide the possibility of 
studying previously uncharacterised amino acid residues for the purpose of generating 
novel ligands with functional selectivity.  
5.3. PHYSIOLOGICAL RELEVANCE OF TRAFFIC-DEPENDENT 
SIGNALLING OF GPCRS 
5.3.1. Deregulated Trafficking and Disease  
 
 The majority of pharmaceutical interventions specifically target GPCRs due to 
their critical involvement in all physiological systems and the contribution of receptor 
rturb
Huntington’s diseases among others (Ahren, 2009; Lappano and Maggiolini, 2012; 
pe ations to multiple diseases and disorders such as obesity and diabetes, 
hypertension, cancer and neurodegenerative diseases such as Alzheimer’s and 
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 Johnson and Liggett, 2011; Ribeiro et al., 2011; Thathiah and De Strooper, 2011). 
Mutations in multiple GPCRs, which alter receptor signalling can cause or contribute to 
disease progression, but it is now becoming apparent that disruption of trafficking 
pathways can also contribute to deregulation of GPCR signalling and influence disease 
formation. Because many GPCR ligands do not readily cross the plasma membrane, 
receptor trafficking to and from the plasma membrane is crucial to cellular 
responsiveness. For example, a naturally occurring loss of function mutation in the 
vasopressin receptor is associated with hereditary nephrogenic diabetes insipidus (Rochdi 
et al., 2010; Barak et al., 2001). This mutant is constitutively phosphorylated and 
sequestered in arrestin-positive endocytic vesicles. However, disrupting the receptor-
arrestin complex restores plasma membrane localization and signalling. Altered 
endocytosis and enhanced receptor activity has been linked to Alzheimer’s disease. 
Inhibition of dynamin-dependent endocytosis has been shown to increase Aβ secretion 
and a natural variant in the delta-opioid receptor containing phenylalanine at position 27 
rather than Cysteine matures more efficiently and has higher stability at the plasma 
membrane (Chyung and Selkoe, 2003; Sarajarvi et al., 2011).  Interestingly, this variant 
or protein 
n to rapid and effective signal desensitization, the 
ndocytosis and intracellular trafficking of GPCRs can spatially and temporally 
determine receptor signal transduction and play a role in disease pathology. 
also enhances β and γ-secretase activity leading to amyloid precurs
accumulation.  Therefore, in additio
e
5.3.2. Consequence of Altered Rab Protein Expression and Function 
As discussed above, the role Rabs play in signal transduction is becoming more 
evident, especially the direct regulation of target proteins by Rabs, including Rab-
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 mediated phosphorylation, ubiquitination and palmitoylation of target proteins. Rabs and 
their effector proteins are often associated with diseases, including pathogen-induced as 
well as inherited dysfunctions and are also associated with multiple neurodegenerative 
disorders. For example, neuronal cell death in Parkinson’s disease correlates with Rab5a-
specific endocytosis of α-synuclein and dominant-negative Rab5 reduces neuronal cell 
death due to incomplete endocytosis of α-synuclein (Sung et al., 2001).  Rab7 mutations 
impair GTP hydrolysis and contribute to the hereditary neurological disorder Charcot-
Marie-Tooth disease type 2B (Cogli et al., 2009).  As noted above, Rab8 may play a role 
in the etiology of Huntington’s disease via association with mutant huntingtin (htt) and 
optineurin as mutant htt prevents post-Golgi trafficking by disrupting the Rab8/optineurin 
complex (del Toro et al., 2009). However, Rab11 may also contribute to the pathology of 
Huntington’s disease.  Rab11-dependent vesicle formation in fibroblasts is impaired in 
Huntington patients and Rab11DN-expressing adult mouse brains display similar 
neurodegeneration to the HD mutant mouse model (Li et al., 2009a, b). It is now apparent 
that coordination of Rab proteins and their effectors can play a significant part in the 
onset and development of pathologies and learning more about the role they play in 
normal and diseased states may lead to better treatment options.  
5.4. FUTURE DIRECTIONS 
 
The novel discoveries presented in this thesis highlight a number of interesting 
questions to pursue in the future. Primarily, the precise details of the molecular 
 between Rab 
small G
mechanisms involved in the crosstalk and signal transduction cascades
 proteins and other GPCRs remain to be elucidated. Additionally, we have shown 
that Rab4 influences the phosphorylation state of AT1R. How exactly does Rab4 regulate 
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 the phosphorylation/dephosphorylation of this receptor? Does it block kinase-mediated 
phosphorylation or does it recruit phosphatases to dephosphorylate the receptor? Does 
Rab4 function by itself or does it work in conjunction with an effector molecule? We also 
show that different Rabs compete with each other for association with the receptor and 
that some Rabs are more effective at displacing others. Therefore, a greater understanding 
of how to manipulate the Rab-mediated receptor trafficking may enable us to influence 
receptor signalling. Specifically, if receptors were to be found in cells or tissues 
endogenously expressing higher levels of different Rabs, would their intracellular 
trafficking and signalling patterns differ? It would be extremely interesting to look at 
different GPCRs in endogenous tissues or cells displaying divergent Rab expression 
patterns to discover whether this significantly alters signal transduction. Further, can we 
alter the response of certain cells or tissues to stimulus by manipulating the complement 
of Rabs? In chapter 2 we learned that Rab4, but not Rab11 alters AT1R agonist-induced 
phosphorylation, thus modifying receptor desensitization and resensitization. However, 
we know that as a Class B receptor, AT1R does not usually become dephosphorylated 
and recycled back to the cell surface. Therefore, this raises the question of whether AT1R 
activity might be manipulated in either whole tissues or whole animals by altering the 
expression patterns of Rab GTPases.  It would also be very exciting, for example, to 
nginee
altered or aberrant signalling in these cells compared to wild type litter mates. 
e r a transgenic mouse expressing dominant negative Rab4 in vascular smooth 
muscle cell, to determine whether these animals exhibit differences in vascular tone, 
contraction both under basal conditions and after stimulation with vasoconstrictors such 
as AngII. We could further study the signal transduction in isolated cells to identify any 
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 Investigating the complement of Rabs in different tissue types or diseased tissue and the 
influence on GPCR regulation would grant us greater understanding to the physiological 
role Rabs play in signal transduction.   
In Chapter 3 we reported how Rab8 modulates the trafficking and signalling of 
mGluR1a. We need to first isolate all of the players in this regulatory pathway. For 
example, we know that PKC is involved, as PKC inhibition reverses the Rab8-mediated 
effect on mGluR1a signalling. However, are there other second messenger-dependent 
kinases involved or does PKC exert its effect through regulation of some downstream 
target? Additionally, we identified for the first time a Rab protein that blocks receptor 
internalization. It is a also unclear what the specific mechanism underlying the Rab8-
mediated inhibition of mGluR1a signalling is and what the specific purpose of this 
inhibition may achieve. The consequence of Rab8-mediated attenuation of mGluR1a 
endocytosis is increased receptor localization at the plasma membrane and the concurrent 
reduction in mGluR1a-mediated signalling. Our laboratory has shown that mGluR1a also 
associates with the Rab8 effector molecule, optineurin (Anborgh et al., 2005) and we 
have found here that Rab8 itself plays a similar role to optineurin in the desensitization of 
mGluR1. Therefore, it is of interest to determine whether Rab8-mediated attenuation of 
mGluR1a signalling is either independent of optineurin or works in concert with 
optineurin. The glaucoma-associated optineurin E50K mutant continues to associate with 
mGluR1a, however does not associate with Rab8. Presumably, if Rab8 works in concert 
with optineurin, then expression of this mutant would inhibit the Rab8-mediated 
mGluR1a desensitization. Conversely, if Rab8 works independently of optineurin, there 
should be no effect of expressing with mutant on mGluR1a signalling. There are several 
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 other molecules involved in the desensitization and endocytosis of mGluR1, including 
GRK2, phospholipase D2 and RalA among others (Dhami et al., 2005, 2004, 2002; 
Bhattacharya et al., 2004). In the future it will be of interest to determine if any of these 
molecules play a role in Rab8-modulation of mGluR1a trafficking and signal 
transduction. 
It would be most interesting to engineer a Rab8 conditional knockout, or 
knockdown mouse (as Rab8 null mice have been reported to be lethal 3 weeks after birth, 
(Sato et al., 2007) in order to determine whether these animals display altered behaviour 
such as deficiencies in learning or memory, motor skills, or other behavioural 
characteristics. In addition to being a Rab8 effector molecule, optineurin is also a well 
known htt binding protein. Huntington's disease is a neurodegenerative disorder caused 
by an abnormal polyglutamine expansion in the amino-terminus of the huntingtin protein, 
leading to cell dysfunction and neuronal death (Ribeiro et al., 2011).  Optineurin 
colocalizes with htt in the Golgi apparatus where it participates in post-Golgi trafficking 
and Rab8 coordinates with optineurin to mediate the post-Golgi transport of proteins (del 
Toro et al., 2009). Although wild-type htt does not contribute to optineurin-mediated 
mGluR desensitization, mutant htt synergistically increases optineurin-mediated mGluR 
desensitization in HEK 293 cells as well as in a knock-in mouse model of HD 
(HdhQ111/Q111) (Anborgh et al., 2005). As was found for Rab8-mediated 
desensitization of mGluR signalling, the attenuation of mGluR5 signalling observed in 
HdhQ111/Q111 mice is PKC dependent (Ribeiro et al., 2010). Therefore, it would be 
most interesting to further elucidate the role that Rab8 plays in the etiology of HD. 
Specifically, does Rab8 complex with the receptor, optineurin and htt? Does it 
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 preferentially associate with wild type or mutant htt? Finally, it would be exciting to 
generating a cross between our mutant HdhQ111/Q111 mice with Rab8 knock-down 
mice to see if we reverse mGluR desensitization in this model and alter the Huntington 
phenotype. 
To our knowledge, this is the first example of a Rab protein blocking 
internalization of a receptor and this finding opens up the possibility of Rabs managing 
yet another aspect of receptor trafficking with which to participate in receptor regulation. 
It would be of significant interest to determine whether other Rabs serve a similar 
purpose, or whether Rab8 itself inhibits internalization of other receptors. Our findings 
suggest that, although Rab8 expression leads to an overall increase in cell surface 
receptors, phosphorylation of those receptors by second messenger-dependent kinases is 
increased. Thus, Rab may either function to block mGluR1a internalization ultimately to 
prevent mGluR1a dephosphorylation and resensitization or Rab8 association may block 
other regulatory molecules from accessing the receptor.  
In Chapter 4 we examined several previously uncharacterised naturally occurring 
pathological mutations of mGluR1a, which we found played a substantial role in 
modulating the signal transduction and cellular localization of mGluR1a. We first need to 
delineate the regulatory molecules involved in the altered signal transduction pathways. 
For example, we know that mGluR1a-G696W no longer associates with GRK2, but is 
still uncoupled following GRK2 overexpression. Therefore, this begs the question as to 
just how GRK2 continues to exert its effect on mGluR1a activity. The most probable 
explanation is that GRK2 continues to associate with Gαq/11 through its RGS domain and 
that GRK2 overexpression mediated uncoupling of mGluR1a signalling is the 
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 consequence of its selective interaction with Gαq/11. A good way to test this would be to 
repeat the experiment with kinase-dead GRK2 mutants as well as GRK2 mutants 
deficient in Gαq/11 binding.  We also found that this mGluR1a mutant does not activate 
ERK1/2. It would also be of value to determine whether the association of other 
downst
racellular trafficking and cell 
morpho
ream signalling molecules, such as Pyk2 (Nicodemo et al., 2010) are also affected 
by the mutation, and of course whether this affects mGluR1a signalling via these 
proteins. In addition, GRK2 overexpression reverses mGluR1a-mediated cell death in 
HEK 293 cells (Dale et al., 2000). Thus, it is possible that the mGluR1a-G696W mutant 
may be associated with increased apoptotic cell death.  
Homer proteins are post-synaptic density proteins with known functions in 
receptor trafficking and calcium homeostasis. We have shown that mGluR1a-P1148L no 
longer associates with Homer 1b, and although IP3 signalling is unaffected, consistent 
with other reports, mGluR1a-P1148L can no longer activate ERK1/2 phosphorylation. 
We also found evidence that mGluR1a-P1148L int
logy is altered. What are the physiological consequences of this altered 
phenotype? For example, it would be interesting to test whether the increased filopodia 
formation of mGluR1a-P1178L results in an increase in cell motility. 
One mutation in the Cysteine-rich region of the amino terminus emerged as a 
significant player in intracellular trafficking as well as signalling. Specifically, mGluR1a-
R375G activation by quisqualate resulted in divergent signal transduction outcomes, the 
differential activation of G protein versus ERK1/2 signalling. This “biased agonism” now 
represents an important target for drug design and focuses on the development of 
compounds that can stabilize different receptor conformations, thus encouraging signal 
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 transduction through one pathway or another. It would, therefore, be beneficial to study 
the conformation that this receptor assumes in the presence and absence of different 
agonist binding. Additionally, R375G simultaneously exhibited unchanged quisqualate-
induced IP3 formation as well as significantly increased agonist-activated ERK1/2 
formation. We should probe into the consequences of this functionally selective signal 
transduction to see whether we can manipulate the signal patterns of this receptor variant. 
For example, increased ERK1/2 activity of mGluR1a-R375G may lead to a change in cell 
cycle regulation, apoptosis or growth. 
As these mGluR1a mutants were originally isolated from human tissue, and 
specifi
uteinizing hormone 
recepto
cally diseased tissue, the altered signal transduction portfolios of each raise 
interesting and potentially crucial questions as to the in vivo roles these mGluR1a 
mutants may play in pathology. To that end, creating transgenic animal models of at least 
mGluR1a-R375G and -P1148L would enable us to study the signal transduction and 
intracellular trafficking of these variants in various endogenous cells and tissues as well 
as to study the organism as a whole to look at development, behaviour and pathologies.  
The studies that originally isolated these mutations in mGluR1a also highlighted 
mutations in a number of other GPCRs, including mGluR3, α1aAR, l
r, as well as regulatory molecules GRK1 and Homer2 and downstream effector 
molecules, PLCβ, PLD2 and small G proteins such as Ral, RalGDS, Rab5c, Rab3a (Kan 
et al., 2010; Parsons et al., 2008; Sjoblom et al., 2006; Wood et al., 2007). It would be 
beneficial to study the mutations in these other molecules, and how they interact with 
each other to determine their altered signal transduction and intracellular localization 
mechanisms.  
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